Physiol Rev  AJP: Regulatory, Integrative and Comparative Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Physiol. Rev. 81: 1353-1392, 2001;
0031-9333/01 $15.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (298)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bennett, V.
Right arrow Articles by Baines, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bennett, V.
Right arrow Articles by Baines, A. J.

Physiological Reviews, Vol. 81, No. 3, July 2001, pp. 1353-1392
Copyright ©2001 by the American Physiological Society

Spectrin and Ankyrin-Based Pathways: Metazoan Inventions for Integrating Cells Into Tissues

Vann Bennett and Anthony J. Baines

Howard Hughes Medical Institute and Departments of Cell Biology and Biochemistry, Duke University Medical Center, Durham, North Carolina; and Department of Biosciences, University of Kent, Canterbury, United Kingdom

I. INTRODUCTION
    A.  Overview of the Erythrocyte Membrane Skeleton
II. GENES, PROTEINS, AND PROTEIN INTERACTIONS
    A.  Spectrins
    B.  Ankyrins
    C.  Proteins That Promote Spectrin-Actin Interactions
III. PHYSIOLOGICAL FUNCTIONS
    A.  Overview
    B.  Stabilization of Cell Surface Membranes at Sites of Cell-Cell Contacts
    C.  Cell Sheet Morphogenesis
    D.  Assembly of Voltage-Gated Na+ Channel-Rich Domains in Excitable Cells
    E.  Targeting of Ca2-Release Channels to the Ca2+ Compartment of the ER
    F.  Orientation of Mitotic Spindles in Asymmetric Germ Cell Division in Drosophila
    G.  A Role for Protein 4.1 in Selective and Directed Membrane Protein Accumulation
IV. CLINICAL IMPLICATIONS
    A.  Functional Channelopathies Due to Defects in Ankyrin-Dependent Targeting
    B.  Use-Dependent Dystrophies of Muscle and Nerves Due to Defects in the Spectrin-Based Transcellular Mechanical Coupling Pathway
    C.  Abnormal Nervous System Development Due to L1 CAM Defects
V. SUMMARY AND PERSPECTIVES

    ABSTRACT
Top
Next
References

Bennett, Vann and Anthony J. Baines. Spectrin and Ankyrin-Based Pathways: Metazoan Inventions for Integrating Cells Into Tissues. Physiol. Rev. 81: 1353-1392, 2001.The spectrin-based membrane skeleton of the humble mammalian erythrocyte has provided biologists with a set of interacting proteins with diverse roles in organization and survival of cells in metazoan organisms. This review deals with the molecular physiology of spectrin, ankyrin, which links spectrin to the anion exchanger, and two spectrin-associated proteins that promote spectrin interactions with actin: adducin and protein 4.1. The lack of essential functions for these proteins in generic cells grown in culture and the absence of their genes in the yeast genome have, until recently, limited advances in understanding their roles outside of erythrocytes. However, completion of the genomes of simple metazoans and application of homologous recombination in mice now are providing the first glimpses of the full scope of physiological roles for spectrin, ankyrin, and their associated proteins. These functions now include targeting of ion channels and cell adhesion molecules to specialized compartments within the plasma membrane and endoplasmic reticulum of striated muscle and the nervous system, mechanical stabilization at the tissue level based on transcellular protein assemblies, participation in epithelial morphogenesis, and orientation of mitotic spindles in asymmetric cell divisions. These studies, in addition to stretching the erythrocyte paradigm beyond recognition, also are revealing novel cellular pathways essential for metazoan life. Examples are ankyrin-dependent targeting of proteins to excitable membrane domains in the plasma membrane and the Ca2+ homeostasis compartment of the endoplasmic reticulum. Exciting questions for the future relate to the molecular basis for these pathways and their roles in a clinical context, either as the basis for disease or more positively as therapeutic targets.

    I. INTRODUCTION
Top
Previous
Next
References

Emergence of metazoans from their unicellular ancestors required solutions to a new set of problems imposed by function of cells in the context of tissues and in motile organisms of immense size compared with individual cells. These requirements of communal life include ability of cells to develop micron-scale spatial organization of cell surfaces and of intracellular compartments to optimize cell-cell interactions and intercellular signaling. In addition, cells incorporated into an actively moving organism must deal with enormous mechanical stresses at the plasma membrane-cytoskeleton interface compared with free-living cells. Understanding the molecular basis for such metazoan adaptations represents an interdisciplinary challenge involving biochemistry, cell biology, physiology, and molecular medicine. This review focuses on the molecular physiology of spectrin and the spectrin-associated proteins ankyrin, adducin, and protein 4.1. These proteins were first discovered as components of the membrane skeleton of human erythrocytes (see below) and are required for survival of erythrocytes in the circulation. The erythrocyte membrane proteins are members of closely related families that are associated with membranes in simple metazoans, including Caenorhabditis elegans and Drosophila melanogaster, and are expressed in most vertebrate tissues. Spectrin, ankyrin, adducin, and protein 4.1 are modular proteins that are not present in their assembled state in the completed Saccharomyces cerevisea or Arabidopsis thaliana genomes and so far have not appeared in Zea mays genomic sequences. These proteins therefore are likely to have evolved early in evolution of metazoans, following divergence of plants and fungi, and represent candidates for roles in specialized activities of multicellular animals.

Recent discoveries based on studies involving C. elegans and D. melanogaster as well as gene knock-outs in mice will be reviewed that demonstrate functions of spectrin- and ankyrin-based protein assemblies in diverse roles that are all related to multicellular life. Functions that will be described include morphogenesis of epithelial tissues, targeting of ion channels and cell adhesion molecules to specialized regions in myelinated axons, and sorting of Ca2+ homeostasis proteins to the Ca2+ compartment of the endoplasmic reticulum (ER) of striated muscle. The clinical implications of these observations are only beginning to be appreciated and are discussed. Elucidation of physiological roles of spectrin and ankyrin-associated proteins is based on a strong foundation at a molecular level. The review includes current information regarding gene family members, atomic structures, oligomeric state, and protein interactions. The human erythrocyte remains the best understood in terms of its membrane skeleton, and the review begins with a brief summary of this system.

A.  Overview of the Erythrocyte Membrane Skeleton

The membrane skeleton of mammalian erythrocytes was first visualized in electron micrographs of detergent-extracted erythrocytes (440). The erythrocyte membrane skeleton is organized as a polygonal network formed by five to seven extended spectrin molecules linked to short actin filaments ~40 nm in length (42, 247, 360) (Fig. 1A). The spectrin-actin network of erythrocytes is coupled to the membrane bilayer primarily by association of spectrin with ankyrin, which in turn is bound to the cytoplasmic domain of the anion exchanger (17, 20, 23, 256, 400, 441). The anion exchanger is associated into dimers (305), which associate with separate sites on the membrane-binding domain of ankyrin to form pseudo-tetramers (53, 281, 332, 437). Anion exchanger dimers also are associated on their cytoplasmic surface with band 4.2 (442). Additional membrane connections are provided at the spectrin-actin junction by a complex between protein 4.1, p55, a member of the MAGUK family, and glycophorin C (170, 266, 267) (Fig. 1B).



View larger version (65K):
[in this window]
[in a new window]
 
Fig. 1. Organization of the erythrocyte membrane skeleton. A: electron microscopy of the membrane skeleton. Spectrin tetramers are cross-linked at nodes (junction points) by short filaments of F-actin and 4.1/adducin. Approximately six spectrins interact with each node. At the central region of the spectrin tetramers are bound ankyrin/anion exchanger complexes. [From Liu et al. (247).] B: membrane-cytoskeleton connections in erythrocytes. Ankyrin is linked through its ank-repeat region to dimers of the anion exchanger (gray). Each ankyrin is capable of cross-linking two anion exchanger dimers. The 15th helical repeat of beta -spectrin (yellow) interacts with ankyrin. At the NH2-terminal region of beta -spectrin is a binding site for 4.1 (red). 4.1 forms a ternary complex with the transmembrane protein glycophorin C and the membrane-associated guanylate kinase p55 (green). C: the spectrin-actin junction. Short filaments of F-actin containing 14-16 monomers tether spectrin at the nodes shown in A. The negative (-) end of the filaments is blocked by tropomodulin, and nonmuscle tropomyosin lies along the filament. beta -Spectrin binds actin via its NH2-terminal CH domains (CH1 and CH2) and the first two triple helical repeats (Rpt 1 and Rpt 2). Approximately six spectrins would fit a short actin filament if the spectrins were arranged along the side of the filament as indicated in this figure. This is consistent with the six spectrins per node indicated in A. Spectrin-actin interaction is promoted by protein 4.1 and adducin. Adducin has a high affinity for the positive (+) end of the filaments and possibly recruits other proteins to the positive end.

Several proteins responsible for capping actin and defining the length of actin filaments as well as stabilizing spectrin-actin complexes have been localized to spectrin-actin junctions by electron microscopy (91, 402). Protein 4.1 stabilizes spectrin-actin complexes (400, 401). Adducin associates with the fast-growing end of actin filaments in a complex that caps the filament and promotes assembly of spectrin (135, 222, 223, 239) (Fig. 1C). A nonmuscle isoform of tropomyosin is associated with the sides of actin filaments (127). Tropomyosin is of the same length as actin filaments visualized in electron micrographs and is a candidate to function as a morphometric ruler defining the length of actin filaments in erythrocyte membranes. Tropomodulin caps the slow-growing end of actin filaments in a ternary complex involving tropomyosin (124-126, 421).

Components of the erythrocyte membrane skeleton have been the subject of recent reviews or papers that include discussions of tropomodulin (125), protein 4.1 (68, 118), protein 4.2 (62), p55 (56), spectrin (164, 410), the anion exchanger, and glycophorin C (4, 381). The contributions of these proteins to mechanical properties of erythrocyte membranes have also been summarized (97, 289).

A major function of the spectrin skeleton in erythrocytes is to provide mechanical support for the membrane bilayer and allow survival of these cells in the circulation. The essential nature of the spectrin-skeleton in red cell biology was first demonstrated in mutant mice with deficiencies in alpha - and beta -spectrin and ankyrin (33, 152). Numerous mutations have subsequently been catalogued in humans with hereditary hemolytic anemias. Defects in lateral associations of the spectrin-actin network result in abnormally shaped cells in elliptocytosis and poikilocytosis and include loss of spectrin dimer-tetramer interactions (395) and deficiency of protein 4.1 (67, 120, 383). Defects in membrane associations result in loss of unsupported phospholipid bilayer and spherocytosis. Molecular defects include spectrin deficiency from a variety of causes (1, 2, 52, 94, 112). A substantial literature has documented naturally occurring mutations/deficiencies of skeletal proteins resulting in hereditary hemolytic anemias in humans and mice (reviewed in Refs. 87, 166, 396). An emerging area of interest is mutations resulting from targeted gene knock-outs in mice resulting in hemolytic anemias that may foreshadow human disorders. An example is the beta -adducin null mouse, which exhibits spherocytosis (143).

    II. GENES, PROTEINS, AND PROTEIN INTERACTIONS
Top
Previous
Next
References

Solution of the organization of the spectrin-based membrane skeleton of the human erythrocyte membrane has provided the biochemical equivalent of a high-resolution genetic pathway of interacting membrane structural proteins. The discovery that other tissues express isoforms of ankyrin (18) and spectrin (20, 40, 146, 151, 237, 343) suggested that the erythrocyte membrane skeleton had a broad relevance for other cell types. However, although the basic structural principles established in erythrocytes are likely to apply in other tissues, the organization, protein interactions, and functions of spectrin-based structures are considerably more diverse in other cells. Nevertheless, understanding the physiological roles of these proteins begins with their structure and biochemistry. This section focuses on genes, alternatively spliced variants, protein structure, and protein interactions of generally expressed forms of spectrin, and the proteins that interact with spectrin: ankyrin, protein 4.1, and adducin.

A.  Spectrins

Spectrins are extended, flexible molecules ~200-260 nm in length and 3-6 nm across with actin-binding domains at each end (20, 146, 362, 400). Spectrins are comprised of alpha - and beta -subunits, which are both related to alpha -actinin (43, 105, 319, 387, 408). The alpha - and beta -subunits are associated laterally to form antiparallel heterodimers, and heterodimers are assembled head-head to form heterotetramers (Fig. 2, Table 1).



View larger version (37K):
[in this window]
[in a new window]
 
Fig. 2. The domain structure of spectrin polypeptides and proteins. The alpha - and beta -subunits are composed of discrete folding units or domains. Triple helical repeating units make up the length of each spectrin subunit. At the NH2 termini of beta -spectrins are tandem calponin homology domains, which bind actin. High-affinity interaction with actin requires the first two triple helices too (indicated as atypical repeats). At the COOH termini of the subunits are differentially spliced "tails": these can either contain pleckstrin homology domains or short regions of sequence rich on phosphorylation sites. The high molecular mass beta -H spectrins have additional triple helical repeats plus an internal SH3 domain. alpha -Spectrins contain COOH-terminal EF hands in a "calmodulin-like" structure. Interactions between alpha - and beta -subunits lead to the formation of tetramers. Lateral associations between alpha  and beta  occur near the NH2 terminus of beta  and the COOH terminus of alpha , such that the subunits lie anti-parallel to each other, and the EF hands are close to the CH domains. At the NH2 terminus of alpha , the first helical repeat actually only comprises one helix; the most COOH terminal in beta  comprises two helices. These interact "head to tail" to form an intact triple helix bringing two laterally associated alpha beta -dimers together to form an (alpha beta )2-tetramer. Tetramers can form between alpha  and beta -H in the same way.


                              
View this table:
[in this window]
[in a new window]
 
Table 1. Spectrin genes, subunits, and heterotetramers

Metazoan spectrins exhibit 50-60% sequence similarity along the length of the predicted polypeptide chains, when compared between Drosophila, C. elegans, and vertebrates, with some regions with 70-80% identity. Candidates for prototypic spectrins, possibly comprised of a single subunit, have also been characterized biochemically and by electron microscopy in Dictyostelium (16) and Acanthamoeba (336). However, sequence information is not yet available for these presumed spectrin ancestors. Spectrin subunits are absent from completed S. cerevisiae and Arabidopsis thaliana genomes, although individual domains of spectrin are represented. Similarly, no spectrin sequence has yet appeared in genome of Zea mays. Polypeptides cross-reacting with spectrin have been reported in higher plants (118, 284, 364) as well as green algae (176) and Chlamydomonas (252). However, these immunoreactive forms of spectrin have not been characterized in terms of primary sequence or visualized by electron microscopy. Definition of the full scope of the spectrin family awaits completion of genome sequencing. However, the available data demonstrate that spectrins are ancient proteins present in their modern form in simple metazoans.

The spectrin repertoire of the completed C. elegans and D. melanogaster genomes includes one alpha -subunit (105), one beta -subunit (41, 159, 292), and one beta -H subunit (106, 276, 387). Currently characterized spectrins in humans include two alpha -subunits (alpha 1, alpha 2) (353, 419), four beta -subunits (beta 1, beta 2, beta 3, beta 4) (24, 187, 261, 286, 310, 372, 427, 428), and a beta -H subunit (also referred to as beta 5) (371) (Table 1). beta -Spectrins also include isoforms that have not been characterized at a molecular level. beta NM is a beta -type subunit identified at neuromuscular junctions based on immunoreactivity (31). beta Golgi-Spectrin has been discovered by Beck et al. (9) to be an immunoreactive form of beta -spectrin associated with Golgi structures. beta Golgi shares epitopes with beta 1-erythrocyte spectrin, but establishing the relationship of beta Golgi spectrin with other beta -spectrins will require molecular characterization. Recently, beta 3-spectrin has been proposed to function as the Golgi spectrin (372). However, the pattern of expression and cellular localization of beta 3-spectrin do not support a general role in Golgi function (310).

Alternative splicing provides additional diversity among alpha - and beta -spectrins. beta  I, beta  II, and beta  IV spectrins are all differentially spliced. beta  I, beta  II, and beta  IV spectrins have COOH-terminal regions that are subject to differential mRNA splicing to generate "short" or "long" COOH-terminal regions (24, 168, 427). The beta  III polypeptides described to date have a long COOH-terminal region that includes a pleckstrin homology (PH) domain (310, 372). One nomenclature refers to beta -spectrin spliceoforms by the order of their discovery (429): short beta  I is beta  I sigma  I, and long beta  I is beta  I sigma  II. However, this system has become confusing as new family members have been discovered: long beta  IV is beta  IV sigma  1 and short beta  IV is beta  IV sigma  4, while long beta  II is beta  II sigma  1 and short beta  II is beta  II sigma  2. We will refer instead to spliceoforms by molecular weight or in some way to help describe their domain composition.

The long COOH-terminal regions of beta -spectrins have a PH domain (see below) linked by an apparently unstructured region of ~100 amino acid residues to the last (partial) triple helical repeat. The polypeptide chain terminates 50-60 residues after the PH domain. Short COOH-terminal isoforms do not contain a PH domain. About halfway through the linker region after the last (partial) triple helical repeat, the sequences diverge and terminate after 22-28 residues. In both beta  I and beta  II spectrins, the short COOH-terminal region contains multiple Ser or Thr residues that are potential substrate sites for casein kinase II. In the case of the short beta  I COOH-terminal region (i.e., in erythrocyte beta -spectrin), at least six of these residues are substrates for casein kinase II (163, 323). As described more fully in section IIC, the PH domain probably represents a major ligand-binding site in beta -spectrins. Thus differential splicing modulates both the interactive and regulatory properties of the beta -spectrins.

beta II is subject to further differential splicing. A splice variant termed ELF1 represents a truncated beta -spectrin, consisting of little more than a calponin homology domain (the CH1 domain) and the COOH-terminal region of the short beta  II (287).

Combinatorial association of alpha -spectrins with various beta - and beta -H subunits yields alpha /beta and alpha /beta -H heterotetramers with distinct functions and patterns of expression (Fig. 2, Table 1). Human alpha 1/beta 1-spectrins were first characterized in mammalian erythrocytes, and also are expressed in striated muscle and a subset of neurons in the central nervous system (227, 300, 345). Avian erythrocytes, in contrast, have alpha 2/beta 2-spectrin (343). alpha 2/beta 2, alpha 2/beta 3, and alpha 2/beta 4 represent the major forms of spectrin in nonerythroid vertebrate tissues. Terminal web spectrin comprised of alpha 2 and a presumed beta -H spectrin are localized in apical domains of epithelial tissues such as small intestine, while alpha 2/beta 2-spectrins are associated with basolateral domains (147).

1.  Domains

alpha -Spectrins contain 22 domains with the following features: domains 1-9 and 11-21 are comprised of triple helical repeats also found in beta  and beta -H spectrins (see below); domain 10 is an SH3 (src homology domain 3) motif; the COOH-terminal domain 22 is related to calmodulin (393) (Figs. 2 and 3). Domain 11 of vertebrate alpha 2-subunits contains a 35-residue extension with the cleavage site for Ca2+-activated protease and a calmodulin-binding site (162, 235). D. melanogaster spectrin contains a predicted calmodulin-binding site at a different position than vertebrates (105).



View larger version (34K):
[in this window]
[in a new window]
 
Fig. 3. Spectrin domains. A: triple helical repeats. Ribbon representation of two triple helical repeats of chicken alpha -spectrin (from the PDB file 1CUN; Ref. 155). B: calponin homology domains. The figure shows a ribbon representation of the tandem calponin homology domains of utrophin (taken from the PDB file 1QAG; Ref. 291). The equivalent sequence in human beta -G spectrin is 68% identical and is likely to adopt a similar overall conformation, based on the known structures of individual spectrin CH domains (6, 46). Three actin binding sequences (ABS) have been mapped in utrophin and are shown in red (ABS1), purple (ABS2), and cyan (ABS3). ABS1 and ABS2 are in the first calponin homology domain (CH1); ABS3 is in the second (CH2). ABS1 and ABS2 are highly conserved between utrophin and beta -G spectrin (80 and 68% identical, respectively) and probably present the primary site of interaction with filamentous actin. ABS3 is less conserved in sequence between spectrin and utrophin (25% identical), even though the helical conformation of this sequence is preserved in spectrin. C: pleckstrin homology domain. The pleckstrin homology domain of beta -spectrins represents a major binding site for protein and lipid ligands. This figure shows the interaction of the PH domain of mouse beta -G spectrin with inositol 1,4,5-trisphosphate (IP3) (shown as the small molecule in ball and stick, bottom right). The PH domain makes contact with the 4- and 5-phosphate groups through salt bridges and hydrogen bonds; the 1-phosphate group (on the right of the IP3 molecule) is mostly solvent exposed, and the inositol ring has virtually no interactions with the protein. Residues shown likely to interact with the ligand are (from left) Tyr-69, Lys-8, Arg-21, and Ser-22. (from the PDB file 1BTN; Ref. 190). D: SH3 domain. SH3 domains are thought to interact with their targets via hydrophobic interactions with proline-rich sequences. The spectrin SH3 has a "stripe" of hydrophobic residues along one surface that are thought to mediate interactions with targets such as e3B1 (456). The figure shows the residues of this stripe (from left to right: Phe-52, Trp-41, Pro-54, Tyr-57, Tyr-13) (from the PDB file 1SHG; Ref. 298).

beta -Spectrins contain 19 domains beginning with a highly conserved NH2-terminal actin-binding domain comprised of two adjacent calponin homology domains (6, 46), followed by 17 consecutive triple-helical repeat domains and ending with a COOH-terminal domain which includes a PH domain (Figs. 2 and 3). Ankyrin-binding sites are at a site in the midregion of the tetramer (75, 400) and have been assigned to repeat number 15 of beta 1-spectrin (210). Repeat 17 is a partial helical repeat that pairs with the COOH terminus of alpha -spectrins to form a noncovalent triple-helical structure (see below).

beta -H spectrins of D. melanogaster (106, 387), C. elegans (276), and humans (371) have NH2-terminal actin-binding domains and COOH-terminal domains closely related to beta -spectrins but contain 30 triple-helical repeats instead of 17. beta -H spectrins of Drosophila and C. elegans also have an SH3 domain inserted in the fifth triple helical domain. beta -H spectrins lack an ankyrin-binding site (276, 371, 387).

A) TRIPLE-HELICAL DOMAINS. Atomic resolution of the structure of triple-helical repeat domains obtained by X-ray crystallography (100, 155, 434) as well as NMR (319) provides a striking confirmation of the structure originally predicted by Speicher and Marchesi (367). Triple helical repeats are comprised of two parallel and one antiparallel alpha -helices, which are stabilized by interactions between hydrophobic residues spaced in a heptad repeat pattern found in other examples of paired helical structures. Tandem triple helical repeats of spectrin and alpha -actinin are comprised of antiparallel alpha -helices connected by an extended alpha -helix (100, 155) (Fig. 3A). Comparison of hydrodynamic properties of single and multiple domains suggests that serial repeats are flexible and configured such that the average end-end length is reduced compared with values predicted for rigid rods (403). One possible source of flexibility is bending of the alpha -helix interconnecting domains. A novel mechanism for shortening end-end distances by rearrangement of helices has been proposed by Grum et al. (155) based on alternative structures observed by crystallography. An extended series of triple helical repeats may also exhibit a superhelical twist (155, 274).

Spectrin repeats have recently been demonstrated by atomic force microscopy to reversibly unfold and refold when subjected to forces in the range of 35 pN (347). Spectrin and other proteins (see below) with triple helical domains therefore have the potential to function as molecular springs that can store energy and dampen deformations resulting from mechanical stress. The potential role of this elastic behavior in spectrin function is discussed below.

B) ACTIN-BINDING DOMAIN. The NH2-terminal actin-binding domains of the beta -spectrins are comprised of a pair of calponin homology (CH) domains (47). These are similar in sequence to a region of the smooth muscle actin-binding protein calponin; such tandem pairs occur in other proteins that have lateral associations with actin filaments, including dystrophin, utrophin, alpha -actinin, and fimbrin (Fig. 3B). Related calponin-based actin-binding domains have been recently found in the plakin family of proteins involved in connection of actin filaments with intermediate filaments and microtubules (435, 436), and in cortexillins, which bundle actin filaments (116).

X-ray crystallography has resolved the atomic structures of the NH2-terminal (45) and COOH-terminal (6) CH domains of beta -spectrin, and of tandem CH domains of fimbrin (149) and utrophin (291) (Fig. 3B). The tandem pairs of CH domains of fimbrin and utrophin interact with actin, and their binding to actin filaments has been resolved at atomic resolution (149, 161, 208, 291). The beta -spectrin CH domains are also likely to interact with actin. The actin binding activity of beta -spectrin is restricted to the beta -chains (44, 238). A minimal actin-binding fragment of erythrocyte spectrin has been produced by limited trypsin digestion and derives from residues 47-186 (207). These residues represent the NH2-terminal CH domain (known as CH1), which in utrophin and fimbrin is the highest affinity actin binding site (161, 291).

Several considerations suggest that the site of contact with F-actin involves the junction between CH domains, with the first domain providing most of the interactions (6, 161). The second CH domain may contribute by enhancing the affinity for F-actin and/or have a regulatory role (6) (see below). Ironically, the single calponin domain of calponin itself lacks actin-binding activity (145), suggesting the likely possibility that CH domains have additional unresolved functions.

C) PH DOMAIN. beta -Spectrins contain a PH domain located in the COOH-terminal segement, which is deleted in certain alternatively spliced isoforms (see above). These domains extend out from spectrin rods in the midregion of spectrin tetramers and are placed within 10 nm of each other (see Fig. 2). PH domains are ~100-residue folding units first resolved in pleckstrin, which is a major protein kinase C substrate in platelets, and subsequently been found in many proteins (340). A unifying feature of proteins with PH domains is a role in signaling and proximity to plasma membranes. Ligands for PH domains may include polyphosphatidylinositol lipids as well as proteins.

The three-dimensional structures of the PH domains of mouse (190, 262) and D. melanogaster beta -spectrins (447) reveal similar folds to PH domains of other proteins (340) (Fig. 3C). PH domains include a seven-stranded beta -sheet arranged as a beta -barrel with a COOH-terminal alpha -helix. Solution of PH domain structure from other proteins indicates that while the overall folding of PH domains are conserved, variations in loop lengths and composition provide substantial variability in potential interaction surfaces (447). Consistent with structural predictions, binding activities of PH domains of spectrin and other proteins are distinct both with respect to interactions with various phosphatidylinositol lipids and to proteins (340).

D) CALMODULIN-RELATED DOMAIN. alpha -Spectrins contain EF-hand motifs located at the NH2 terminus of that are juxtaposed to the actin-binding domain on the adjacent beta -subunit. The EF-hand domain of alpha -spectrin shares structural homology with calmodulin and also exhibits a Ca2+-dependent conformational change (392, 393). An important distinction between spectrin and calmodulin is that spectrin only contains the two NH2-terminal EF hands and lacks the two COOH-terminal EF hands present in calmodulin. Intact human erythrocyte spectrin or recombinant alpha  I or alpha  II EF hands bind Ca2+ selectively with a stoichiometry corresponding to the number of EF hands but with an unphysiological affinity in the range of hundreds of micromolar (8, 257, 258). However, intact horse spectrin molecules have been reported to bind Ca2+ at many sites of micromolar affinity, which presumably are not related to EF hands (414). Fowler and Taylor (123) reported that low micromolar levels of Ca2+ influenced human erythrocyte spectrin-actin interactions, although spectrin-actin and spectrin-4.1-actin interactions were described as Ca2+ insensitive by Ohanian et al. (307). Clearly much remains to be understood about the significance of Ca2+ binding by spectrins.

E) SH3 domain. SH3 domains, initially observed in the Src protein tyrosine kinase, are present in many proteins involved in cell signaling and mediate interactions with proline-rich stretches in a variety of target proteins (321). SH3 domains are inserted in alpha -spectrins (419) and in invertebrate beta -H spectrins (106, 276) (Fig. 2). The structure of the alpha -spectrin SH3 domain has been resolved at an atomic level by X-ray crystallography (298) and NMR (30, 352) (Fig. 3D). The three-dimensional structure of spectrin SH3 domains is a compact beta -barrel and exhibits the same overall fold as other SH3 domains.

2.  Subunit interactions

Spectrin heterotetramers are assembled through the following interactions between alpha - and beta -subunits: 1) a lateral and antiparallel association between beta -subunits and alpha -subunits; 2) head-head association between laterally associated heterodimers by linkage between partial triple-helical repeats at the COOH-terminal end of the beta -subunits and the NH2-terminal end of alpha -subunits (see Fig. 2). Structural requirements for lateral association between alpha - and beta -spectrins have been analyzed for erythrocyte (14, 368, 403) and D. melanogaster spectrin (409, 411). The minimal domains required for alpha -beta complexes are the first two triple-helical domains of beta -spectrin and the last two triple helical domains of alpha -spectrin (368). The first two triple helical domains of beta -spectrin and last two of alpha -spectrin are closely related to the four triple helical domains of alpha -actinin, which also associate laterally in an antiparallel orientation (100). The atomic structure of tandem alpha -actinin domains reveals a dimer formed stabilized by electrostatic interactions provided by complementary surfaces (100). Association between four triple helical domains of alpha 1- and beta 1-spectrins is of high affinity with a dissociation constant (KD) of 10 nM (403). Further stabilization of alpha -beta complexes is provided by interaction between the calmodulin-related domain of alpha -spectrin and the calponin homology domains of beta -spectrin (409, 411).

The lateral association of alpha - and beta -spectrin subunits is highly conserved and occurs between D. melanogaster and vertebrate spectrins (43). The high affinity of alpha - and beta -subunits implies that spectrin will not exist as independent alpha - or beta -subunits but is an obligatory heterodimer or tetramer. Reports of beta -spectrin unaccompanied by an alpha -subunit in striated muscle and at neuromuscular junctions (31, 338) suggest the possiblity of a heretofore unrecognized alpha -subunit or an immunoreactive but otherwise highly diverged beta -spectrin.

Head-to-head contacts between alpha - and beta -spectrin subunits are believed to occur through contacts resembling pairing between helices in triple helical bundles (89, 211, 221, 366, 395, 433). The NH2 terminus of alpha -spectrin provides one helical segment, and the COOH-terminal repeat of beta -spectrin provides two antiparallel helices, with alpha -beta pairing resulting in a noncovalent triple helical segment. Flanking residues on alpha -spectrin also contribute to alpha -beta association (55).

Defects in spectrin tetramer formation have been established in erythrocytes of patients with hereditary elliptocytosis (315, 395). Mutations in alpha - and beta -spectrin defined in these patients would be predicted to disrupt helical pairing predicted from biochemical studies (89, 396, 434). These mutations include substitution of prolines, which would be expected to disrupt an alpha -helix, as well as mutations in residues predicted to provide contacts between helices. Human mutations in the partial helical domain of alpha -spectrin have been introduced into D. melanogaster alpha -spectrin and result in a temperature-sensitive phenotype (89) (see below).

3.  Spectrin superfamily

Proteins that contain NH2-terminal CH domains, COOH-terminal calmodulin-related domains, and intervening triple helical domains comprise the spectrin superfamily. Currently recognized proteins with these combined features include alpha -actinins and dystrophins. In addition, trabeculin/macrophin/MACF of vertebrates (236) and Kakapo of D. melanogaster (154) are newly recognized members of the plakin family that have CH domains, 23-29 triple helical domains, and a calmodulin-related domain, as well as domains related to plectin and the plakin family (Fig. 4). The COOH termini of these proteins contain a microtubule-binding domain (206, 236). These proteins thus can interact with actin filaments, cadherins, or integrins through the plakin domain and microtubules. Spectrin-like repeats also are present in eight to nine tandem copies in unc 73/kalirin/Trio, which also contain a dbl/pleckstrin homology domain (83). Trio/Unc 73 is required for axon pathfinding in C. elegans and D. melanogaster (259, 375).



View larger version (34K):
[in this window]
[in a new window]
 
Fig. 4. Representatives of the spectrin superfamily. Members of the spectrin superfamily have in common multiple triple helical repeats, a pair of calponin homology domains at the NH2-terminal of one subunit, and a calmodulin-like domain in the COOH-terminal region of one subunit. Specific functions that distinguish each member of the family are conferred by variations in the number of triple helical repeats, and the presence of varying additional ligand-binding domains that include SH3 and PH domains in spectrin, plakin, and GAR22 domains in trabeculin/kakapo and a cysteine-rich domain in dystrophin. In addition, individual helices can contain specific binding activities, for example, the ankyrin binding activity of the 15th repeat in beta -spectrins.

Triple-helical repeats of alpha -actinin are most similar to the first repeats of beta -spectrin (repeats 1 and 2) and the last repeats of alpha -spectrin (domains 20 and 21) (43). alpha -Actinin thus contains within a single polypeptide the COOH-terminal domain of alpha -spectrin (calmodulin-related domain and last two triple helical repeats) and the NH2-terminal domain of beta -spectrin (CH domains and first two triple helical repeats) (Fig. 4). These considerations have led to suggestions that alpha - and beta -spectrins evolved from a homodimeric alpha -actinin-like precursor polypeptide (41, 319, 387, 408). One possible evolutionary scenario is that alpha -actinin became elongated through insertion of seven repeats by an unspecified mechanism, followed by duplication events resulting in a giant alpha -actinin-like protein. Insertion of a transcriptional promoter within a repeat has been proposed to provide the basis for the modern split repeat at the alpha -beta tetramerization site and the origin of separate alpha - and beta -spectrin genes (387, 408).

4.  Spectrin-protein interactions

A) SPECTRIN-ACTIN INTERACTION. The site of contact of F-actin with the actin-binding domains of alpha -actinin (273), fimbrin (161), and utrophin (291) has been mapped to actin subdomains 1 and 2 as well as subdomain 1 of the adjacent actin monomer by image analysis of electron micrographs. These conclusions are supported by genetic mapping of actin contact sites with fimbrin in yeast (175, 177). The fimbrin actin-binding domain induces a conformational change in F-actin (161), suggesting the possibility that beta -spectrin could also perturb F-actin structure.

Comparison of actin-binding activities of the beta -spectrin actin-binding domain alone and with triple-helical repeats suggests that the first triple helical repeat also participates in spectrin-actin complexes (238) (Fig. 1C). These results support a model where beta -spectrin actually lies along the actin filament, thus engaging in contacts involving two actin monomers (238). Interestingly, similar studies of dystrophin-actin interactions have concluded that lateral associations occur between actin and dystrophin triple helical domains (in this case repeat number 11) (351).

There is evidence that different beta -spectrins exhibit varying modes of interaction with actin. It is interesting to note that a very small beta  II-spectrin splice variant ELF1 (a "mini-spectrin") contains a single CH domain that is similar to the CH1 domain of other beta -spectrins. Since beta 1-spectrin CH1, isolated as a tryptic fragment, binds actin avidly in vitro (207), it is likely that ELF1 is a true actin-binding protein, even though some other proteins with single CH domains do not necessarily bind actin (6). Intriguingly, the CH1 tryptic fragment of beta  I-spectrin appears to have a higher affinity interaction with actin than might have been expected: it inhibits interaction of whole erythrocyte spectrin with actin with a half-maximal effect at 5 µM, while the intact erythrocyte dimer binds to actin with a KD of 250 µM (309). This indicates a higher affinity interaction than native erythrocyte alpha  I/beta I-spectrin dimer. One possibility might be that alpha  I-spectrin has a suppressive effect on the interaction of beta 1 CH domains with actin. As we note below, the weak interaction of erythrocyte spectrin with actin is enhanced by proteins 4.1 and adducin.

The tandem CH domains in beta -spectrins may have additional roles in actin binding. CH1, the NH2-terminal CH domain, probably provides the primary interaction with actin (see Ref. 291). CH2, the COOH-terminal of the pair, binds actin only weakly (46). In utrophin, CH2 provides a specificity for actin subtypes: utrophin binds beta -actin (cytoskeletal) with higher affinity than alpha -actin (sarcomeric). The CH domains of beta -spectrin therefore have the potential to target spectrin to particular isoforms of actin, as is the case with utrophin (426). In this context, it is interesting to note that erythrocyte membranes contain only beta -actin, rather than the beta -gamma mixture typical of most cytoskeletal systems (333).

B) SPECTRIN-MEMBRANE INTERACTIONS. Spectrins are coupled to membranes by multiple pathways including direct association with membrane-spanning proteins, interaction with phospholipids, and through interactions with ankyrins (see below). Binding of spectrin to ankyrin-independent protein sites has been measured in brain membranes (80, 251, 373, 374). beta -Spectrin associates with membranes through two distinct classes of sites. One is regulated by calmodulin and is localized in the NH2-terminal region. The other beta -spectrin site is located in the COOH-terminal domain, which includes the PH domain.

Association of the spectrin PH domain with membranes has been demonstrated in living cells using green fluorescent protein-tagged beta -spectrin PH domain (415). One class of spectrin-PH domain interactions is likely to involve PI lipids, since the PH domain of beta 1-spectrin associates with sites in brain membranes stripped of peripheral proteins that are blocked by inositol 1,4,5-trisphosphate (IP3) and presumably represent phosphatidylinositol sites (416).

C) SPECTRIN-ION CHANNEL INTERACTIONS. Candidates for spectrin-binding proteins in brain synaptosomes include the NR2 and NR1 subunits of the NMDA receptor (422). Spectrin binds to the NR2B subunit at sites distinct from those of alpha -actinin-2 and members of the PSD95/SAP90 family. The spectrin-NR2B interactions are inhibited by Ca2+ and fyn-mediated NR2B phosphorylation, but not by Ca2+/calmodulin or by calmodulin kinase II-mediated phosphorylation of NR2B. The spectrin-NR1 interactions are unaffected by Ca2+ but inhibited by Ca2+/calmodulin and by phosphorylation of NR1 by protein kinases A and C. The NR1 subunit thus is a candidate to interact with the Ca2+/calmodulin-regulated site on beta -spectrin (80, 374).

Spectrin associates via the alpha -spectrin SH3 domain with the alpha -subunit of the amiloride-sensitive Na+ channel, EnNaC (349, 457), and with the Na+/H+ exchanger, NHE2 (59). The amiloride-sensitive Na+ channel/spectrin complexes also contain the protein Apx, which is an apically localized protein identified in Xenopus (457). Association with alpha -spectrin may be responsible for apical targeting of NHE2, since deletion of the spectrin-binding loop results in basolateral localization of the channel (59). alpha /beta H (beta TW) is the most likely form of spectrin to associate with the apically targeted NHE2 and amiloride-sensitive Na+ channels since alpha /beta -spectrin generally is localized to the basolateral domains of epithelial cells (438).

The cGMP-gated cation channel of rod photoreceptor plasma membranes copurifies with a 240-kDa polypeptide subsequently identified as spectrin based on immunoreactivity (290). Direct linkage between spectrin and the cation channel is likely since antibodies against each protein coimmunoprecipitates the other from relatively pure preparations of the channel. The 240-kDa polypeptide was localized to the inner surface of the rod outer segment plasma membrane and excluded from the disk membranes, as would be expected for an association of this protein with the cGMP-gated cation channel in vivo.

D) SPECTRIN AS A MEMBRANE ADAPTOR FOR CYTOPLASMIC PROTEINS. Cytoplasmic ligands for spectrin include a protein termed HsSH3bp1 that binds to tyrosine kinases and binds to spectrin through association with the alpha -spectrin SH3 domain (432, 456). HsSH3bp1 is associated with macropinosomes and may couple spectrin to these intracellular organelles (432). Spectrin PH domains are likely to associate with proteins in addition to their interactions with PI lipids (above). An interesting example is RACK1, a protein kinase C-anchoring protein, which associates selectively with the beta -spectrin PH domain and activated protein kinase C to form a ternary complex (348).

A search for annexin VI-binding proteins revealed spectrin as one of ~14 membrane-associated proteins that associate with annexin VI in blot overlays (420). Annexin VI has subsequently been implicated in directing proteolytic degradation of spectrin during receptor-mediated endocytosis (204). The interpretation of these experiments was that annexin VI promoted proteolysis of spectrin, which resulted in relaxation of restraints of budding of a subset of coated pits. Annexin VI, according to this model, utilizes spectrin as an adaptor to direct and possibly activate a protease.

E) SPECTRIN AS A REGULATOR PROTEIN. Spectrin, at nanomolar concentrations, inhibits phospholipase D as well as phospholipases C and A2 in in vitro assays (254, 255). The basis for inhibition was most likely not a direct interaction of spectrin with these enzymes, but rather competition for their phospholipid substrates (255). Spectrin in lymphocytes associates with CD45 (192, 248), which is a member of a family of membrane-spanning glycoproteins with protein-tyrosine phosphatase activity. Spectrin binds to CD45 with a nanomolar affinity and upregulates the tyrosine phosphatase activity of CD45 (248).

B.  Ankyrins

Ankyrin in human erythrocytes provides a high-affinity link between the cytoplasmic domain of the anion exchanger and the spectrin/actin network (Fig. 1). The ankyrin family has a general role as an adapter between a variety of integral membrane proteins and the spectrin skeleton. The C. elegans genome contains a single ankyrin gene, (312), whereas the D. melanogaster genome has two ankyrin genes, Dank1 and Dank2 (35, 110). The ankyrin gene family of mammals currently includes three members: ankyrin-R (R for restricted; also termed ankyrin1) (229, 260), first characterized in erythrocytes, (227); ankyrin-B (B for broadly expressed, also termed ankyrin 2) first characterized in brain (313); and ankyrin-G (G for general or giant; also termed ankyrin 3) independently discovered in searches for components of the node of Ranvier (219) and for epithelial ankyrins (93, 327, 385). Ankyrins are expressed in most tissues, and in many cases all three ankyrins are found in the same cell type.

Diseases of humans attributed to ankyrins include hereditary spherocytosis, which can result from decreased expression and/or mutated forms of ankyrin-R (112). In mice, a similar disorder (the nb/nb mutation) results in a nearly complete deficiency of 210-kDa isoforms of ankyrin-R in erythrocytes, neurons, and striated muscle (452) with a phenotype of severe anemia (33) and degeneration of a subset of Purkinje cell neurons accompanied by cerebellar dysfunction (326). Ankyrin mutations in C. elegans result in the unc44 phenotype, which includes abnormal axon guidance and uncoordinated movements (312).

1.  Domains

Ankyrins are modular proteins comprised of three domains conserved among family members as well as specialized domains found in alternatively spliced isoforms (see Fig. 5). Conserved domains are an NH2-terminal membrane-binding domain, a 62-kDa spectrin-binding domain, and a 12-kDa death domain. The membrane-binding domains are comprised of 24 copies of a 33-residue repeat known as the ANK repeat that is involved in protein recognition in many types of proteins (34, 359) (Fig. 6). The 24 ANK repeats form 4 subdomains, each comprised of the basic folding unit of 6 repeats (280). The role of six-repeat subdomains as protein binding sites is discussed below. Death domains were first reported in proteins such as Fas and the tumor necrosis factor receptor that participate in apoptosis pathways (394). These domains can associate with related death domains in other proteins. The protein interactions of the ankyrin death domain could involve self-association and/or interactions with other proteins and are not yet resolved. The death domain is followed by a regulatory domain subject to alternative splicing that in the case of ankyrin-R modulates both binding of the anion exchanger and of spectrin (81, 157). A regulatory function for this domain has not been demonstrated for ankyrin-B or ankyrin-G. However, the COOH-terminal domains are the most divergent among ankyrin family members and are likely to have distinct functions that are yet to be defined.



View larger version (27K):
[in this window]
[in a new window]
 
Fig. 5. Summary of human ankyrin genes and their alternatively spliced variants. Canonical ankyrins are of 190-220 kDa and have membrane-binding, spectrin-binding, and death domains. Giant ankyrins of 270-480 kDa have insertions of up to 2,400 amino acid residues between the spectrin-binding and death domains and are abundant in axons. Small ankyrins of 26-120 kDa are missing various domains found in canonical ankyrins and are associated with intracellular organelles.



View larger version (31K):
[in this window]
[in a new window]
 
Fig. 6. Schematic view of ankyrin domains and their protein interactions (top) and atomic structure of Ank repeats (bottom). The NH2-terminal membrane-binding domain of ankyrins is composed of 24 Ank repeats folded into 6-repeat subdomains. These domains associate with a variety of membrane proteins as well as tubulin and clathrin. The bottom panel shows a stack of six ankyrin repeats in the protein I-kappa B (PDB file 1NFI; Ref. 193). The two images (a and b) show the same structures rotated by 90°. The sites of protein interactions are likely to be the loops of Ank repeats, based on structures of complexes of I-kappa B and several other Ank repeat proteins with their protein partners (see Ref. 359).

2.  Diversity due to alternative splicing

Ankyrin genes are expressed and processed in a complex tissue-dependent and developmentally regulated fashion, giving rise to a large number of isoforms that utilize different combinations of functional domains. For example, alternative splicing generates ankyrin-G isoforms missing all or portions of their membrane-binding domain (93, 178, 219, 327). Alternate exon usage is also used to generate an unusual isoform of ankyrin-R in striated muscle. This isoform lacks both the membrane-binding and spectrin-binding domains and contains only the COOH-terminal 26 kDa plus a hydrophobic stretch (452). The functions of these small ankyrins are likely to involve intracellular as opposed to plasma membrane roles, since these truncated ankyrins are associated with Golgi, lysosomal, and sarcoplasmic reticulum membranes (11, 88, 92, 452).

Ankyrin-B and ankyrin-G spliceoforms also include polypeptides with insertions of up to 2,500 amino acid residues and molecular mass of up to 480 kDa, which are abundantly expressed in axons (49, 219, 224, 225) (see below). The inserted sequences in both genes are placed between the spectrin-binding and death domains (see Fig. 5). Ankyrin-G polypeptides of 270 and 480 kDa contain inserted sequences beginning with a serine/threonine-rich stretch of ~400 residues, that is followed by sequence with similarity to that of the inserted sequence of 440-kDa ankyrin-B. The 270-kDa ankyrin-G lacks a 190-kDa stretch of this sequence resulting from the use of an alternate splice donor site.

Much of the 220-kDa inserted sequence of 440-kDa ankyrin-B has the configuration of an extended random coil based on physical properties of expressed polypeptides (49). Because the alternatively spliced insert of ankyrin-G has a highly polar hydrophilicity profile similar to that of ankyrin-B, it is likely that the 480-kDa ankyrin-G also contains an extended stretch of random coil inserted between its spectrin-binding and death domains. The properties of the inserted sequences suggest a structural model for 440-kDa ankyrin-B and 480-kDa ankyrin-G where the membrane-associated head domain is separated from the death domain by an extended filamentous tail domain encoded by the inserted sequence (see Fig. 5). The length of the tail domain could be up to 0.5 µm if fully extended, which is a distance that, in principle, could be resolved in the light microscope.

Ankyrin isoforms possessing the tail domain are highly localized to axons, whereas isoforms lacking this domain are localized to the neuron cell body (49, 224). Possible functions of the tail domains include axonal targeting motifs, deregulation of ankyrin membrane-binding domains by physical separation from the regulatory domain, and long-range connections between molecules interacting with the death domain/COOH-terminal domains and membrane-binding domains. Given the potential distance spanned by the inserted sequence, these putative ankyrin-binding molecules could be in distinct membrane domains or even different cellular compartments.

3.  Ankyrin-binding membrane proteins

A defining feature of the ankyrin family is their ability to interact through the membrane-binding domain with structurally diverse proteins with apparently unrelated primary sequences. Currently identified ion channels/pumps that associate with ankyrin and colocalize in cells include anion exchanger isoforms (AE1, AE2, AE3) (22, 23, 196, 293), the Na+-K+-ATPase (216, 297, 304), the voltage-dependent Na+ channel (263, 269), and the Na+/Ca2+ exchanger (240). IP3 receptor and ryanodine receptor Ca2+-release channels also associate with ankyrins (36, 37, 199). Evidence for an in vivo interaction between ankyrin-B and Ca2+ release channels is based on altered targeting of these proteins in striated muscle of ankyrin-B-deficient mice (397) (see below). Finally, ankyrin also associates with cell adhesion molecules (CAMs) including CD44 (203, 249) and the L1 CAM family (L1/neurofascin/NrCAM/CHL1/NgCAM) (76, 79, 107, 182, 450). Evidence for physiologically important interactions between ankyrins and L1 CAMs include downregulation of L1 in axons of ankyrin-B (-/-) mice (358), and reduction of Dank2 in cell bodies of neurons of neuroglian mutant flies (35).

The ankyrin membrane-binding domain also interacts with cytoplasmic proteins including tubulin (19, 75, 82) and clathrin (283). Ankyrin associates with microtubules with a relatively low affinity in the micromolar range, and the physiological significance of this interaction remains to be determined. However, ankyrin association with clathrin occurs with a KD in the nanomolar range and is specific for the fourth subdomain of ankyrin and the terminal knob domain of clathrin. Evidence that ankyrin-clathrin interactions are functionally important is that microinjection of the fourth subdomain inhibits receptor-mediated endocytosis of low-density lipoprotein (283).

The basis for diversity of binding partners for the ankyrin membrane-binding domains is due to special properties of the ankyrin repeats, a motif which mediates protein recognition for a large number of proteins including the transcription factors GABP-beta , Nfkappa /Ikappa B, and SwI 6, p53 binding protein and p16 cyclin inhibitor (reviewed in Ref. 359). Atomic structures for these proteins reveal that ankyrin repeats are folded into a series of antiparallel alpha -helices connected by loops that are arranged perpendicular to the helices (Fig. 6). Residues located at the tips of the loops are the most variable between repeats and contain recognition sites for diverse proteins. The four repeat subdomains of ankyrins each have distinct binding properties, and these subdomains also cooperate with each other to generate a further level of diversity (281, 282). An additional feature of ankyrin is that binding interactions can occur simultaneously with different membrane proteins, resulting in multiprotein complexes (281, 282).

Sites of ankyrin interactions have been evaluated for the erythrocyte anion exchanger (AE1) (78, 96, 424), the Na+-K+-ATPase (197, 453), and the L1 CAM family (181, 450). A general conclusion from these studies is ankyrin is capable of structurally distinct interactions with diverse proteins. This conclusion is reinforced by the fact that ankyrin has independent binding sites for AE1 and L1 CAMs (281, 282). Another conclusion from analysis of ankyrin-binding sites of the Na+-K+-ATPase (450) and L1 CAMs (450) is that ankyrin-binding sites of these proteins share a conformation as a random coil even though they lack obvious sequence similarity. An ankyrin-membrane protein complex has not yet been resolved at an atomic level, but these considerations suggest a model where random coils of at least certain ankyrin-binding proteins associate with loops of ankyrin repeats (see above) (450). Given that ankyrin repeats fold into subdomains, it is likely that loops of ankyrin repeats in different subdomains also could collaborate to create a "binding pocket."

Cytoplasmic domains of the erythrocyte anion exchanger (5) and neurofascin (450) are both dimers in solution. Considered together with the finding that ankyrin has two binding sites for neurofascin as well as for two sites for the anion exchanger, the existence of dimers implies that these proteins and ankyrin are capable of forming oligomeric complexes. One predicted configuration of the anion exchanger/ankyrin complex at low ratios of ankyrin to the anion axchanger is as a pseudo-anion exchanger tetramer with two dimers independently associated with distinct sites on the ankyrin membrane-binding domain (281). Evidence that such an arrangement occurs in erythrocyte membranes is provided by observations that the anion exchanger behaves as a mixture of dimers and tetramers in native membranes and only as a dimer in ankyrin-deficient membranes (439). One could also imagine that at higher ankyrin-to-membrane protein ratios it would be possible to form linear arrays of dimeric membrane proteins cross-linked by the multivalent ankyrin membrane-binding domain. These complexes could be further immobilized by coupling to the spectrin-based membrane skeleton through the spectrin-binding domain of ankyrin. Ability to form such large immobilized complexes between ankyrin and neurofascin could be important for the assembly of specialized membrane domains such as axon initial segments and nodes of Ranvier where these proteins are localized (see below).

A) L1 CAMS AS GENERAL CORECEPTORS FOR ANKYRINS. The major class of ankyrin-binding proteins in mammalian brain is a group of CAMs in the Ig/FnIII superfamily known as L1 CAMs. These molecules together comprise over 1% of the membrane protein in adult brain tissue and are abundantly expressed on axons in the developing nervous system (reviewed in Ref. 181). The L1 CAM family of cell adhesion molecules in the vertebrate nervous system is comprised of L1, NgCAM, NrCAM, CHL1, and neurofascin, in D. melanogaster by neuroglian (181), and in C. elegans by LAD1 (L. Chen and V. Bennett, unpublished data). L1 CAMs possess variable extracellular domains comprised of six Ig and three to five fibronectin type III domains, along with a relatively conserved cytoplasmic domain (181). Extracellular domains of L1 CAMs participate in homophilic interactions as well as a variety of interactions with soluble proteins and other CAMs (39, 121, 350). Extensive diversity in extracellular interactions of L1 CAM family members is provided by divergence between extracellular domains encoded by different genes as well as multiple alternatively spliced variants of each gene (as many as 50 estimated in the case of neurofascin) (165). Consistent with the diverse extracellular domains, a range of functions has been attributed to the L1 CAM family, including axon fasciculation, axonal guidance, neurite extension, a role in long-term potentiation, synaptogenesis, and myelination (39).

Analysis of LAD-1, the single L1 CAM gene in C. elegans, has provided a global view of the pattern of expression in a metazoan and suggests a general expression at sites of cell-cell contact early in embryonic development and in essentially all cell types (Chen and Bennett, unpublished data). LAD-1 binds to GFP-tagged worm ankyrin (unc44) in cultured cells and colocalizes with ankyrin in most cell types. These findings suggest that LAD-1 is the major receptor for ankyrin (unc-44) in the worms. Given that ankyrin is multivalent with respect to neurofascin and the anion exchanger (282), it is possible that ankyrin forms heterocomplexes with LAD-1 and various ion channels (see Fig. 7 for an example of vertebrate L1 CAM/Na+ channel complexes).



View larger version (20K):
[in this window]
[in a new window]
 
Fig. 7. Schematic model for organization of 480/270-kDa ankyrin-G and ankyrin-associated proteins (spectrin, L1 CAMs, voltage-gated Na+ channel) at axon initial segments and nodes of Ranvier. 480/270-kDa ankyrin-G (219), 186-kDa neurofascin and NrCAM (77), and alpha /beta IV spectrin (24) are colocalized with voltage-gated Na+ channels at nodes of Ranvier and axon initial segments. Ankyrins are multivalent in in vitro assays (281, 282) and are proposed in this model to interact with both the channel and adhesion molecules. Neurofascin and possibly NrCAM are palmitoylated at a cysteine residue in the membrane-spanning domain (342), which could contribute to a phospholipid microdomain. The extended tail domain of 480-kDa ankyrin-G could extend up to 0.5 µm into the axoplasm and is shown interacting with a vesicle in a speculative model.

An extrapolation from the results in C. elegans is that additional members and/or alternatively spliced forms of the L1 CAM family in vertebrates are expressed in all tissues and very early in development (the two-cell stage), and function as coreceptors for ankyrin. Precise colocalization of L1 CAMs, ankyrin, and voltage-gated Na+ channels has been demonstrated at nodes of Ranvier and axon initial segments in the vertebrate nervous system (77, 228). It will be of interest to determine if other ion channels reported to associate with ankyrin also are colocalized with CAMs and if these have homology to L1 CAMs. Another variation on the theme of ion channels and CAMs may be provided by the Na+-K+-ATPase which has an alpha -subunit, responsible for ion permeation, associated with a beta -subunit which has properties of a CAM (148).

Residues critical for ankyrin-binding activity of L1 CAM cytoplasmic domains are localized in a 26-residue stretch which includes a sequence, EDGSFIGQY, which is highly conserved in all family members from C. elegans to mammals (one exception is CHL1 which has the sequence EDGSFIGAY) (136, 182, 451; Chen and Bennett, unpublished data). Mutations of the FIGQY tyrosine in the cytoplasmic domain of neurofascin (Y81H/A/E) greatly impair neurofascin-ankyrin interactions (451). Mutation of human L1 at the equivalent tyrosine (Y1229H) is responsible for certain cases of mental retardation (212). Mutations F77A and E73Q greatly diminish ankyrin-binding activity, whereas mutation D74N and a triple mutation of D57N/D58N/D62N result in less loss of ankyrin-binding activity. These results provide evidence for a highly specific interaction between ankyrin and L1 CAM members.

The basis for specificity of association between various L1 CAMs and different ankyrin family members in the context of cells has yet to be determined. However, the ability of neurofascin to participate in high-affinity interactions with both ankyrin-R (282) and ankyrin-B (Chen and Bennett, unpublished data) and the ability of LAD-1 to associate with mammalian ankyrin (Chen and Bennett, unpublished data) suggest that these interactions most likely are not restricted by intrinsic affinity. This raises the interesting question as to how different ankyrins in the same cell are segregated with their respective binding partner and how these interactions are regulated.

B) L1 CAMS AND PHOSPHOTYROSINE-BASED SIGNALING. The association between ankyrin and neurofascin is abolished by phosphorylation of the FIGQY tyrosine, which as noted above is conserved among all L1 CAM family members (136). Phosphorylation of the FIGQY tyrosine inhibits activity of neurofascin in mediating cell adhesion and cell segregation in cultured cells (398). Inhibitory effects of FIGQY phosphorylation on cell-cell interactions of neurofacscin were proposed to result from loss of ankyrin-mediated cross-linking of neurofascin (398).

Antibodies specific for the phosphotyrosine form of the FIGQY peptide resolve members of the L1 CAM family at strategic sites in the nervous system of vertebrates including paranodes of nodes of Ranvier, the AChR domain of the neuromuscular junction, and in zones enriched in migrating neurons (S. Jenkins, A. Sen, N. Cramarcy, R. Sealock, and V. Bennett, unpublished data). Phospho-FIGQY tyrosine forms of LAD-1 are localized in the pharynx and in the vulva of C. elegans in a complementary pattern to the distribution of ankyrin, indicating the conservation of this phosphorylation as well as the potential for its extraneuronal expression (Chen and Bennett, unpublished data). These considerations suggest that L1 CAMs participate in vivo in a phosphotyrosine-based signaling pathway, with one consequence being loss of ankyrin binding. The extracellular ligand(s), kinase(s), and phosphatase(s) involved in determining the phosphorylation state of L1 CAMs remain to be defined. FIGQY-phosphorylated L1 CAMs, by analogy with SH2 and PTB systems, also may associate with yet to be identified phosphotyrosine-dependent adaptors.

C.  Proteins That Promote Spectrin-Actin Interactions

Association of spectrins with F-actin is relatively weak with measured KD values ranging from 6 µM for recombinant beta 2-spectrin (238) to 250 µM for native erythrocyte dimer (309). In fact, spectrin most likely requires accessory proteins in vivo to initiate assembly and to stabilize actin interactions. Advantages of a low-affinity spectrin-actin interaction with the potential for enhancement by accessory proteins include the ability to selectively stabilize spectrin-actin networks in specific locations, as well as providing an additional level of regulation. Protein 4.1 (123, 400, 401) and adducin (23, 134, 135) have been identified in erythrocyte membranes based on their activities in stabilizing spectrin-actin complexes. These proteins have been localized at the spectrin-actin junction in erythrocyte membranes (91), as anticipated from their association with spectrin and actin in vitro.

1.  Protein 4.1

A) PROTEIN 4.1 IN ERYTHROCYTES. Protein 4.1 purified from mammalian erythrocytes associates with beta -spectrin at a site in the NH2-terminal region (12, 399, 400), and it also interacts with F-actin (12, 63, 296). Protein 4.1 can promote a spectrin-4.1-F-actin ternary complex (401). In the presence of 4.1, strong spectrin-actin interaction is observed: the association constant for the ternary complex is 1 × 1012 M-2 (309). The spectrin-4.1 complex also caps the minus end of actin filaments and can sever F-actin filaments (331). Standard preparations of erythrocyte ghosts have minus ends of actin filaments that are capped (330), but it is difficult to be certain of the physiological significance in erythrocytes of the spectrin-4.1 capping activity, since these cells also contain the specific minus end capping protein tropomodulin (reviewed in Ref. 125).

A proportion of protein 4.1 remains membrane-bound after erythrocyte ghosts are extracted with low ionic strength buffers. Several possible membrane associations have been identified including membrane lipids, the anion exchanger band 3, and glycophorin C (e.g., Refs. 3, 137, 138, 169, 195, 266, 267, 320, 341). Protein 4.1 and glycophorin C form a high-affinity ternary complex in vitro with the membrane-associated guanylate kinase (MAGUK) p55 (266). Genetic interactions between human glycophorin C and p55 are indicated by loss of these proteins from membranes of red blood cells from a patient with a 4.1 deficiency (3).

Protein 4.1 interactions in red blood cells are regulated by phosphorylation and by interaction with calmodulin. Protein 4.1 is a substrate for protein kinases A and C, casein kinase II, and an erythrocyte tyrosine kinase. Interestingly, phosphorylation by all these kinases results in downregulation of 4.1 membrane- and/or spectrin-actin binding activities (e.g., Refs. 50, 51, 74, 180, 245, 332, 376). Calmodulin alone (independent of Ca2+) can inhibit spectrin-actin and membrane binding (251, 306, 379).

B) MAMMALIAN GENES FOR PROTEIN 4.1 AND DOMAIN STRUCTURES. The prototypical 4.1 from erythrocytes is now known as 4.1R (R for red blood cell) and is encoded by the EPB41 gene. Three other genes encode close human and mouse homologs of 4.1R; these are EPB41L2, EPB41L3, and EPB41L1 (328). The corresponding proteins are 4.1G, 4.1B, and 4.1N. mRNA encoding 4.1R is most abundant in hematopoietic tissue such as bone marrow and fetal liver, but the mRNA is expressed at lower levels elsewhere (328). 4.1G is so named because of its very general expression as determined by multiple tissue Northern blots (317, 328). 4.1B is expressed most prominently in brain (316), and 4.1N also in brain, most particularly in subpopulations of neurons (412). In Drosophila and C. elegans, single 4.1 genes are present. The D. melanogaster 4.1 protein Coracle has been extensively analyzed, as will be described below, and gives clues to the functions of 4.1 proteins in a genetic background not complicated by multiple potentially redundant 4.1 genes.

Products of all four mammalian genes are modular proteins, with three functional domains linked by regions relatively unconserved between them (see Refs. 65, 316). This appears to be a general vertebrate pattern for 4.1 proteins. The two most conserved modules are a domain that binds erythrocyte membranes and MAGUKs; the other is a domain at the COOH terminus. The membrane binding domain is a FERM domain, a "genetically mobile" module found in ezrin, radixin, merlin, and moesin as well as certain tyrosine phosphatases, talin, and a variety of other metazoan and plant proteins (57). The structure of the human 4.1R FERM domain has recently been solved (Fig. 8) and is revealed to have three lobes (160). Each lobe has a fold recognizable in other proteins. Most NH2-terminal is a ubiquitin-like fold; the central region of sequence is a four helix bundle similar to acyl-CoA binding protein; the COOH-terminal lobe is similar to the PH/phosphotyrosine binding protein superfamily fold. Although the three lobes in 4.1R FERM domain appear to be independent folding units, they have extensive contacts and are suggested not to function independently. Interestingly, this structure reveals that individual lobes are regulated by differential mRNA splicing. Conboy et al. (69) and Huang et al. (188) found that a common differential mRNA splicing event is the excision of exons 4 and 5, especially in brain and endothelial cell mRNAs. This splice is predicted to remove most of the first lobe of the FERM domain. Although the functional consequence of loss of the ubiquitin-like domain has not yet been identified, mutational analysis of the D. melanogaster 4.1 protein Coracle indicates that this eliminates membrane binding activity (418).



View larger version (55K):
[in this window]
[in a new window]
 
Fig. 8. Mammalian 4.1 proteins. Left: the four mammalian proteins are known as 4.1R, 4.1G, 4.1N, and 4.1B. They are modular proteins, assembled from common domains linked by unconserved sequences. The common domains are a FERM domain (a protein and lipid binding module common to ezrin, radixin, moesin, and some other proteins, Ref. 57); a domain that binds spectrin and actin (the SAB domain, found only in vertebrate 4.1s so far); and a COOH-terminal domain (CTD) common to all 4.1 proteins. [Modified from Parra et al. (316).] Right: the structure of the FERM domain of moesin (PDB entry 1EF1A; Ref. 322). The 4.1 proteins have FERM domains homologous to the equivalent domains in the ERM proteins. The figure shows the FERM domain of human moesin. Although the sequences of the human 4.1R and moesin proteins are only ~32% identical, they probably fold very similarly. The FERM domain has three lobes. Lobe 1 (the NH2-terminal lobe) is similar to the fold of ubiquitin; the fold of lobe 2 is similar to that of the acyl-CoA binding protein; and the lobe 3 fold is similar to that of the pleckstrin homology domain (from the PDB file 1EF1; Ref. 322).

The FERM domain is associated with a wide variety of ligand binding activities including membrane proteins (234), membrane lipids (especially acidic lipids and their head groups) (114, 139), calmodulin (306), and 2,3-diphosphoglycerate (295). In cells other than red blood cells, FERM domains interact with numerous transmembrane proteins, including adhesion molecules of the neurexin family, the heparan sulfate proteoglycans CD44 (206) and syndecan (61), and a swelling-induced chloride conductance regulatory protein plCln (380). Neurexins and syndecans are discussed in more detail in section IIIG. The structure of the 4.1R FERM domain and the recent structures of moesin (322) and radixin (158) FERM domains illuminate the nature of the interactions. Band 3 (the anion exchanger AE1) binds at a sequence LEEDY (195) within the most NH2-terminal lobe. A region that binds glycophorin C (and probably NCP neurexins and syndecan 2) is present on the central lobe (307). The binding site for the MAGUK p55 (266) is present in the most COOH-terminal lobe. The major protein binding sites are therefore in separate lobes, so possibly differential splicing gives proteins that can (for example) bind distinct classes of membrane proteins. A mechanism underlying 4.1 binding to a number of small phosphorylated ligands such as inositol phosphates (114) or 2,3-diphosphoglycerate (295) may be indicated by the radixin structure. This contains a binding site for IP3 at the junction of the NH2- and COOH-terminal lobes: this site is composed of several basic residues at the cleft between the two lobes. In 4.1R, a deep cleft between the two lobes is surrounded by basic residues, indicating the possible existence of a ligand-binding site.

The COOH-terminal domain (CTD) is the most diagnostic domain of 4.1 proteins. Whereas the FERM domain is widespread, and the spectrin-actin binding domain not highly conserved, the CTD is preserved among different 4.1 proteins. It is recognizable in D. melanogaster and C. elegans 4.1 homologs, always in association with a FERM domain. The CTD has not yet been found outside metazoa, indicating that like spectrin and ankyrin, 4.1 is an animal protein. The COOH-terminal domain has been reported to bind the nuclear mitotic apparatus protein NuMA and the immunophilin FKBP13 (413). Although a 4.1N-NuMA interaction is indicated to mediate some effects of nerve growth factor on pheochromocytoma (PC12) cells (437), there is no evidence from D. melanogaster genetics of an essential role for 4.1 proteins in neuronal differentiation (119).

The spectrin-actin binding (SAB) domain is well characterized in human 4.1R. A 10-kDa fragment produced in limited chrymotryptic digests of 4.1 promoted spectrin-actin interaction (71, 72). This is encoded by exons 16 and 17 (98, 99, 179). Exon 17 encodes sequence required for the interaction with spectrin and actin, but high-affinity binding is only achieved if sequence encoded by exon 16 is present too. Because exon 16 expression is upregulated during erythroblast differentiation, high-affinity SAB is effectively a gain of function during erythrocyte differentiation. This indicates that SAB may not be a "core" function of the 4.1 proteins, a suggestion supported by the lack of known SAB activity in D. melanogaster Coracle. 4.1G has close conservation of the 4.1R SAB and in vitro promotes spectrin-actin interactions (144). 4.1B also promotes SAB (316). 4.1N does not have an especially well-conserved SAB domain, which is identical to 4.1R in only 26 of 66 residues.

More than one start codon has been identified in 4.1R mRNAs. Erythrocyte 4.1 is predominantly an 80-kDa form. The corresponding mRNA has a 17 nucleotide exon in the 5'-region (exon 2') excised and translation starts at a codon in a 210 nucleotide exon (exon 4) (188). If the 17 nucleotide exon is expressed, translation starts within this exon yielding 135-kDa isoforms typical of nonerythroid 4.1R proteins. The extra NH2-terminal sequence contains a calmodulin-binding site (209, 230). So far, only one translation initiation codon has been identified in 4.1B, 4.1G, and 4.1N, equivalent to the one that yields the 135-kDa form of 4.1R. However, as with 4.1R, these other proteins are encoded by mRNAs that are extensively spliced.

C) CORACLE, THE 4.1 PROTEIN IN D. MELANOGASTER. Fehon et al. (119) have found a FERM domain protein in D. melanogaster they named Coracle. Coracle is distinguished as a 4.1 protein by the presence of a conserved 4.1 CTD, although there is little sequence evidence of a functional SAB. Mutation of the Coracle gene resulted in defects in dorsal closure; homozygotes are embryonic lethal. Coracle does not obviously colocalize with either spectrin or ankyrin in fly epithelial cells. Together with the lack of an obvious SAB sequence, this indicates that coracle is not a SAB protein. However, the sequence relationship of the FERM and CTD regions of Coracle with mammalian 4.1 proteins provides a useful guide to their core functions.

Coracle is selectively localized at pleated septate junctions of ectodermally derived epithelial cells. Smooth septate junctions of, for example, the midgut do not express coracle. This contrasts again with the very wide distribution of spectrin and actin in the fly. It is also clear that there is no Coracle in fly nuclei. Nonerythroid 4.1 proteins of mammals have been found in nuclei, in association with NuMA (271) and spliceosomes (84). Nuclear import requires sequence encoded by exon 16 of mammalian 4.1 (138), which is not present in Coracle. Because exon 16 encodes both a nuclear localization sequence and part of the SAB domain, nuclear functions, like SAB, probably evolved with vertebrates and are not conserved among 4.1 proteins.

Coracle is required for correct functioning of at least two D. melanogaster transmembrane proteins, the epidermal growth factor (EGF) receptor (119) and the cell adhesion molecule neurexin IV (418). Coracle mutations suppress a hypermorphic allele of the EGF receptor ellipse, indicating that full expression of EGF receptor activity requires Coracle. Coracle deficiency results in partial loss of adult cuticular structures. A possible mechanism for this phenotype is that EGF receptor function is compromised in flies with Coracle deficiency, resulting in failure of cell proliferation in imaginal epithelia (226).

Neurexin and Coracle depend on each other for correct localization at the septate junction, and physically interact since they coimmunoprecipitate from fly extracts (7, 418). The coracle FERM domain is both necessary and sufficient for correct localization of neurexin (418). The mechanism underlying this is unclear but may require the MAGUK disks lost (DLT; Ref. 27). DLT is essential for cell polarity and is required for correct localization of neurexin IV at septate junctions. By analogy with the erythrocyte 4.1/p55/glycophorin C complex, it seems possible that a ternary coracle/DLT/neurexin IV complex may form at septate junctions, stabilizing the incorporation the CAM at the junction, but at the time of writing, no published account has tested the existence of such a complex. Correct incorporation of neurexin in these junctions seems to be essential for creation of the transepithelial barrier at the septate junction. In this context a recently described interaction of mammalian 4.1R with the tight junction protein ZO-2 (270) may indicate a general role for 4.1 proteins in barrier functions in vertebrates as well as flies.

D) FUNCTIONS OF MAMMALIAN 4.1R REVEALED BY GENETICS. Deficiency or functional inactivation of erythrocyte 4.1R has been linked for some years with the disease hereditary elliptocytosis (HE). Surprisingly, in view of the widespread expression of 4.1R mRNA, no other tissue in these patients has been reported to be affected, even in patients suffering total loss of 4.1R from their red blood cells. For a more detailed analysis of 4.1R mutations in HE, readers are referred to comprehensive reviews in this speciality, e.g., Reference 87. Characterization of numerous mutations in the 4.1R gene has revealed the importance of the various domains in erythrocyte function. Several mutations have been reported within the SAB domain and confirm that spectrin-4.1-actin interaction is essential for normal erythrocyte function. Loss of one or more exons encoding this domain, or mutation of a critical lysine residue in this domain, gives markedly reduced mechanical stability and deformability (66, 70, 95, 253, 265). These mutations are also typically associated with some spectrin loss from the membrane. These cases of HE are associated with anemia, in contrast to cases where the mutations are in the CTD. A very mild phenotype has been reported in a homozygous HE family in which there are mutations in the CTD (294). In these patients, 4.1R assembles correctly in the membrane skeleton, indicating this domain is not required for any of the classical interactions of 4.1 at the membrane. The relationship of the mutations to the phenotype remains elusive.

So far, the only mouse 4.1 gene to be knocked out is 4.1R (361). Unlike coracle deficiency, loss of 4.1R is not lethal. Indeed, the phenotype is surprisingly mild. However, functional redundancy among the products of the four 4.1 genes could mask potential defects. As would be expected, 4.1R-deficient mice suffer hemolytic anemia. The membranes of erythrocytes are misshapen and frequently fragmented. There is a loss of ~30% of spectrin from the membranes, complete loss of p55, and >80% loss of glycophorin C, i.e., 4.1 is required for stable accumulation of the latter two proteins in erythrocyte membranes. However, platelet function is generally normal, and (at a gross level) the mice are generally unaffected. Nevertheless, subtler defects are manifest in the nervous system. 4.1R null mice exhibit deficits in learning, coordination, balance, and movement (413). The mechanism underlying these defects is unclear, but they fit with the normal pattern of expression of 4.1R mRNA, especially in the dentate gyrus and cerebellum.

Like Coracle and neurexin IV, glycophorin and 4.1 have an interdependent relationship for accumulation at the membrane. Leach elliptocytosis results from mutations in the glycophorin C gene (384) and is associated with loss of both 4.1R and p55 from the erythrocyte membrane (3).

2.  Adducin

Adducin (from the Latin adducere, to draw together) forms ternary complexes between spectrin and actin and promotes association of spectrin with actin filaments (21, 135). Although adducin associates directly with the sides (285, 382) as well as fast-growing ends of actin filaments (223), adducin complexes with the combination of spectrin and actin at 5- to 20-fold lower concentrations than with actin alone (239). Adducin exhibits the highest affinity for complexes between spectrin and the fast-growing ends of actin filaments, which form with an association constant of 15 nM adducin (239). The relative activities of adducin for actin filament ends and sides in the presence and absence of spectrin suggest that the preferred role of adducin in cells is to form a complex with the fast-growing ends of actin filaments that recruits spectrin and prevents addition or loss of actin subunits (Fig. 9). Adducin thus is an actin-capping protein that recruits other proteins to actin filament ends and could represent a new class of assembly factor with the function of integrating actin into other cell structures.



View larger version (28K):
[in this window]
[in a new window]
 
Fig. 9. Schematic models for adducin domain organization (A) and adducin association with spectrin and actin (B). A: folded domains of adducin deduced from limited proteolytic digestion (189, 200); sites are indicated for phosphorylation by protein kinase C and rho-kinase and association with calcium/calmodulin. Amino acid sequences of conserved COOH-terminal MARCKS homology domains of alpha -, beta -, and gamma -adducins are noted. B: conformation of adducin dimers and tetramers (189), and summary of modes of association of adducin with spectrin and actin. Adducin associates with the sides and fast-growing ends of actin filaments both alone and with enhanced affinity in the presence of spectrin. The preferred mode of association of adducin, spectrin, and F-actin occurs in a ternary complex at the fast-growing ends of actin filaments (239).

Adducin interactions with spectrin and actin are mediated by a COOH-terminal basic stretch of residues with homology to the MARCKS family (myristolated alanine rich C kinase substrate; Refs. 29, 298) (Fig. 9). The adducin MARCKS-related domain also contains the site of phosphorylation by protein kinase C at the RTPS-serine (268, 269) as well as for binding of Ca2+/calmodulin (135, 268). Adducin activities involving spectrin and actin are all inhibited by Ca2+/calmodulin (135, 223) and by phosphorylation by protein kinase C (269). Antibodies specific for RTPS-serine phosphorylated adducin reveal that adducin is an in vivo substrate for phorbol ester-activated protein kinases that presumably include members of the protein kinase C family (269). Gelsolin competes for adducin recruitment of spectrin to the fast-growing ends of actin filaments (298) and may provide yet another means of regulating adducin activity.

Adducin has been identified by Kaibuchi and colleagues (213) as a substrate for the Rho-dependent protein kinase at a site distinct from protein kinase C. Experiments with mutated forms of adducin lacking the Rho-phosphorylation site suggest that Rho-dependent phosphorylation of adducin plays an essential role in promoting cell motility (130).

A) ADDUCIN DOMAINS, SUBUNITS, AND QUATERNARY STRUCTURE. Adducin in humans and rodents includes three closely related subunits termed alpha , beta , and gamma  (102, 134, 201). Adducin subunits all contain an NH2-terminal globular domain that participates in subunit interactions, a neck domain that also promotes formation of oligomers, an unstructured tail domain, and finally a COOH-terminal MARCKS-homology stretch containing the spectrin/actin interaction site as well as targets for calmodulin and protein kinase C (Fig. 9). Erythrocyte adducin is comprised of alpha /beta -subunits in a 1:1 ratio, and in other cells include alpha /gamma as well as alpha /beta combinations of subunits (102, 134). Hydrodynamic and cross-linking experiments with erythrocyte and brain adducins (134, 189, 200) support a physical model of adducin as a mixture of dimers and tetramers comprised of ball and chain-shaped subunits associated via their globular domains with tail domains extending into solution (Fig. 9). Adducin is represented by single genes in C. elegans and D. melanogaster (see below) and presumably exists as either homodimer or hometetramer in these organisms.

Sites of interactions between adducin subunits include an oligomerization region within the neck domain (298), as well as undefined sites in the globular head domains (189). Mechanism(s) operate in vertebrate adducins that somehow ensure assembly of adducin heteromers with 1:1 ratios of alpha - and beta -subunits or alpha - and gamma -subunits. One possibility is that one subunit is synthesized in limiting amounts and monomeric subunits in excess of available partners are degraded. However, recombinant adducin constructs can form homodimers, suggesting additional aspects of regulation.

All of the spectrin/actin association activities of the adducin are reproduced with recombinant polypeptides containing the neck, tail, and MARCKS domains (298). Tail/MARCKS and neck/tail domains are inactive. These results and oligomerization activity of the neck domain (see above) suggest that the active form is a parallel dimer with dimerization provided by the neck domain and actin contacts provided by the MARCKS domain (298).

The role of adducin globular domains beyond promoting subunit interactions currently is a mystery. As noted above, the neck and tail domains of adducin are necessary and sufficient for all activities involving spectrin and actin (298). The issue of undiscovered roles for the head domain is particularly relevant in view of the high degree of conservation of this domain and the existence of alternatively spliced variants of adducin lacking the COOH-terminal MARCKS-related domain (see below). A possible clue to the head domain function is a similarity in primary sequence to an E. coli enzyme, aldolphosphofructohydrolase, which requires zinc for catalytic activity. Histidines involved in zinc coordination are conserved in adducin, although an aspartic acid residue required for catalytic activity is missing. These considerations suggest that adducin lacks enzymatic activity but may require zinc for function of the globular domain. A corollary of a requirement for zinc is that adducin may have been at least partially inactive in previous biochemical experiments using adducin isolated with the metal chelator EDTA (134).

B) GENES AND ALTERNATIVELY SPLICED VARIANTS. Adducins, like spectrins, are, so far at least, found only in metazoans, although one of the adducin domains is expressed in E. coli (see above). The C. elegans and D. melanogaster genomes each contains a single adducin gene. Adducin in D. melanogaster was discovered as a transposon-induced mutation in oocyte development termed huli-tai shao or hts (too-little nursing) (423, 444, 445). Adducin of vertebrates is encoded by three closely related genes termed alpha -, beta -, and gamma -adducins (102, 201). alpha -Adducin is expressed in most tissues, while beta -adducin has a more restricted pattern of expression limited to brain and hematopoietic cells (201). gamma -Adducin is a likely companion for alpha -adducin in cells lacking the beta -subunit (102).

Alternative splicing is a general feature of metazoan adducins. The D. melanogaster adducin gene encodes four alternatively spliced forms, including one with a basic COOH-terminal domain, which is expressed in somatic cells (423). Other D. melanogaster adducin transcripts in germ line cells lack the MARCKS-related domain and have distinct 3'-UTR regions resulting in selective targeting of mRNAs within oocytes and nurse cells (423). The C. elegans adducin gene encodes two transcripts, one containing a MARCKS-related domain and the other with a distinct sequence (S. Moorthy and V. Bennett, unpublished data). In vertebrates, alpha - (241), beta - (389, 377) and gamma -adducins (60) also include variant transcripts lacking the COOH-terminal MARCKS-related domains. Other alternatively spliced versions of adducin subunits have predicted internal deletions within the tail as well as the head domain.

    III. PHYSIOLOGICAL FUNCTIONS
Top
Previous
Next
References

A.  Overview

Hypotheses for roles of spectrin and ankyrin-related genes have been generated through the classic maneuvers of determining cellular localization and interacting proteins. Manipulation of gene expression in animal models recently has provided critical tests of these hypotheses and provided new functions as well. The purpose of this section is to briefly summarize proposals for function based on localization and protein neighbors, and then to critically evaluate these ideas in the physiological context of animals.

Initial efforts to explore functions of spectrin in cultured fibroblasts by microinjection of spectrin antibodies resulted in aggregation and collapse of intermediate filaments in cells that otherwise were normal (264). These findings suggested that spectrin was not likely to be required for survival of fibroblasts in culture, and apparently was not essential for fundamental metabolic processes. Subsequently, spectrin and ankyrin were discovered to be localized at basolateral domains of a variety of epithelial tissues (103, 104, 302). These morphological observations were accompanied by Nelson's discovery (304) that ankyrin associated with the Na+-K+-ATPase, which is well known to be localized at basolateral domains of many epithelial tissues. Nelson and colleagues (277) subsequently discovered that expression of E-cadherin in fibroblasts promoted cell-cell contact and recruited spectrin to sites of cell-cell contact. These investigators also characterized a complex of spectrin, cadherin, and ankyrin that formed during assembly of cultured Madin-Darby canine kidney (MDCK) cells into epithelial sheets (301). Moreover, overexpression of ankyrin-binding and actin-binding domains of beta -spectrin resulted in highly abnormal cells lacking polarized distribution of the Na+-K+-ATPase (92, 186). Taken together, these and other observations have led to a widely accepted view that spectrin and ankyrin have a role either in the initial formation of epithelial cell polarity immediately following cadherin-based cell adhesion, or in maintenance of this polarity (438).

Spectrin and ankyrin have also been implicated in intracellular roles involving the Golgi (11, 88). The concept of a Golgi-based spectrin skeleton is based on the observation of immunoreactive forms of beta -spectrin (9, 372) and ankyrin (10, 93, 327) associated with Golgi membranes. The finding that lysosomal membranes contain a 120-kDa ankyrin-G spliced form suggests other organelles also utilize ankyrin and/or spectrin (178). Moreover, spectrin is associated with dynactin, an organelle-based microtubule motor, in cells overexpressing ARP2 (176). Evidence for function of spectrin in post-Golgi targeting is based on disruption of polarized delivery of the Na+-K+-ATPase in cultured MDCK cells overexpressing of the NH2-terminal portion of beta -spectrin (92).

Spectrin has been proposed to participate in axonal transport based on the observation by Willard and colleagues (237) that spectrin (named fodrin by this group) was present in multiple classes of axonally transported proteins and organelles. Spectrin also has been suggested to participate in tethering synaptic vesicles within nerve terminals (363). This hypothesis is based on association of spectrin with synaptic vesicle proteins synapsin (365) and MUNC 13 (354) and observations of filament-shaped structures the size of spectrin associated with synapses (156).

D. melanogaster and C. elegans with their simplified and completely characterized genomes provide model systems to test function in the context of living animals. The spectrin repertoire of both organisms is comprised of three genes encoding one alpha , one generally expressed beta  (beta -G), and one beta -H subunit (Table 1). The pattern of expression of spectrins in these organisms closely parallels their behavior in vertebrates. beta -G spectrin of C. elegans is localized at sites of cell-cell contact beginning at the two-cell embryo and continuing in adult epithelial tissues (292). beta -G spectrin in adult C. elegans, as in vertebrates, is most highly expressed in the nervous system in axons as well as cell bodies and is localized in muscle cells at sites of contact with the extracellular matrix (292). beta -H spectrin of D. melanogaster is localized in apical domains of epithelial cells and is in an equivalent location to beta TW of chickens (85, 108, 147, 388).

Several observations, based on consequences of disruption of expression of spectrin genes in C. elegans and Drosophila, suggest that spectrin, although essential for survival beyond the embryonic stage, actually is not required for initial development of epithelial polarity, Golgi function, axonal transport, or accumulation of synaptic vesicles at presynaptic structures. Normal development of epithelial polarity and normal progression of morphogenesis as well as embryonic viability occurs in C. elegans in the absence of beta -G spectrin (159, 292). Moreover, beta -G spectrin was not required for neuronal migration or axon guidance of dorsal axons, for assembly of synaptic vesicles at nerve endings, or for polarized secretion of collagen. In addition, the plasma membranes of epithelial cells, muscle, and neurons were normal in appearance in electron micrographs, with no evidence for a generalized loss of membrane integrity. Equivalent phenotypes were observed with deficiency of beta -G spectrin as a consequence of either injection of double-stranded RNA (292) or a null allele of unc-70 (159). Normal epithelial polarity in alpha -spectrin null mutants also has been observed in D. melanogaster larvae (89, 232). Interpretation of these findings was complicated by the possible contributions of maternal spectrin (232, 325). However, the principal period of spectrin expression in both organisms occurs during gastrulation, and spectrin synthesized at this time is most likely not of maternal origin. Moreover, double-stranded RNA injection in C. elegans reduces levels of beta -G spectrin to <2% of normal in early embryos.

In summary, direct evaluation of spectrin function in C. elegans and D. melanogaster has raised serious doubts regarding the previously hypothesized roles in maintenance of plasma membrane integrity, establishing cell polarity, Golgi-related roles, axonal transport, and a structural role in the synapse. Nevertheless, all is not well for spectrin mutants, which are lethally affected or subviable as larvae and exhibit multiple defects.

For example, unc-70 worms that do survive under specialized culture conditions (159) are paralyzed and uncoordinated and exhibit loss of sarcomere structure as well as abnormal axon extension. The elucidation of functions for spectrin, ankyrin, as well as their associated proteins in animal models is just beginning, and these results are summarized below.

B.  Stabilization of Cell Surface Membranes at Sites of Cell-Cell Contacts

A unifying role for alpha /beta -G spectrin emerging from results with D. melanogaster and C. elegans is the stabilization of cell-cell and cell-matrix attachments after these structures have formed. The requirement for alpha /beta -G spectrin becomes most apparent in the larval stage when the animals leave the supportive environment of the egg case and presumably generate mechanical stress on their tissues during movement. Evidence for this idea is that defects in muscle and nervous system are reduced in unc-54 worms that exhibit reduced movement due to a myosin mutation (159). Moreover, D. melanogaster alpha -spectrin null larvae that had successfully completed embryonic morphogenesis and established normal cell polarity subsequently exhibited loss of cell-cell contact and cell-substratum contacts (232).

Conditional mutations have allowed evaluation of spectrin function in the developing Drosophila ovary, which is surrounded by a follicular epithelium. This epithelial layer is subjected to stress during oogenesis, especially when yolk formation in the oocyte requires an increase in egg volume. alpha -Spectrin has been eliminated selectively in follicular cells through site-specific recombination by the FLP/FRT system (231) and in both follicular cells and germ cells through rescue of alpha -spectrin null animals with a temperature-sensitive mutation (89). In either case, loss of alpha -spectrin resulted in disruption of the follicular cell monolayer and changes in cell shape (89, 231). The absence of alpha -spectrin would be expected to disrupt both laterally associated alpha /beta -G as well as apical alpha /beta -H complexes. Observations of beta -H-deficient eggs suggest that the loss of alpha /beta -G is responsible for disruption of the monolayer while loss of alpha /beta -H causes changes in cell shape (446) (see below). beta -Spectrin mutations in D. melanogaster have recently been characterized as embryonic lethal, precluding a direct evaluation of alpha /beta contribution to follicular monolayer integrity (109). However, it will be of interest in future work to target beta -spectrin deletion to follicular cells using the FLP/FRT technique.

Activity of alpha /beta and alpha /beta -H spectrin in stabilizing cell-cell contacts and in achieving normal columnar epithelial cell shape requires formation of tetramers. The best evidence for spectrin tetramers as a functional unit is that either a deletion or a point mutation of alpha -spectrin that abolish head-head alpha -beta interactions also prevent rescue of alpha -spectrin null D. melanogaster (89). The requirement for spectrin tetramers suggests that cross-linking of actin filaments is an important aspect of spectrin function and, moreover, suggests an essential role for a spectrin-actin network as resolved in erythrocytes. Coupling of cell adhesion molecules to a spectrin lattice could be anticipated to promote their interaction with molecules on adjacent cells through restricted diffusion and through formation of closely spaced complexes linked to dual sites on spectrin tetramers, thereby increasing the effective local concentration. Also, mechanical coupling of a large number of adhesion molecules on both cytoplasmic surfaces at sites of cell-cell contact into a transcellular and laterally integrated unit would be anticipated to create resistance to deformation in addition to enhanced adhesion.

The molecular composition of the proposed transcellular cell adhesion molecule(s)/spectrin-actin network remains to be established but may involve ankyrin as well as ankyrin-independent interactions. Ankyrin associates with cell adhesion molecules in the L1 CAM family, which are localized at sites of cell-cell contact of all cells in C. elegans (Chen and Bennett, unpublished data) (see above). Another candidate for a spectrin "receptor" is NCAM, a member of the Ig superfamily of cell adhesion molecules which associates directly with spectrin (337).

C.  Cell Sheet Morphogenesis

Creation of tissues and early embryos from ensembles of cells requires mechanisms for coordinating forces generated in individual cells to produce morphogenesis. For example, the developmental processes of embryonic elongation of C. elegans, dorsal closure in Drosophila, formation of enclosed epithelial tissues in metazoans, and neurulation in vertebrates all involve transcellular transmission of forces resulting from constriction of apically associated actin filaments. beta -H spectrin has been implicated in these processes based on the phenotypes of beta -H mutations in C. elegans (276) and in D. melanogaster (388, 446).

beta -H spectrin mutants in C. elegans, termed sma-1 for their small size, are defective in embryonic elongation (276). Normally, the epidermal actin filaments reorganize soon after ventral enclosure to form an array oriented around the circumference of the embryo. Contraction of these actin fibers is accompanied by elongation of the embryo. beta -H mutant worms elongate at only 20% of the rate of wild type and attain only half the final length (276). Moreover, these mutants also exhibit defective morphogenesis of the pharynx and excretory cell. beta -H mutant worms, although mishaped, are viable.

beta -H localization and the phenotype of beta -H mutations in D. melanogaster provide strong evidence for a role in epithelial morphogenesis. beta -H spectrin is expressed in most epithelial tissues and is restricted to apical cell domains where it is present associated with zonula adherens as well as the brush border (231, 386, 388, 446). Mutations of beta -H result in extensive larval lethality as well as defective eye morphology, wing morphogenesis, and tracheal defects resulting in loss of hemolymph (388). In addition, follicular epithelial cells lining egg chambers do not undergo apical constriction but instead remain cuboidal (446).

Adherens junctions are abnormal in beta -H mutant follicular epithelial cells (446). This observation combined with lack of shape change in beta -H deficient epithelial cells suggests that beta -H spectrin physically interacts with adherens junction components and couples these to the actomyosin contractile system. Initial targeting of beta -H spectrin to apical domains requires alpha -spectrin, while targeting of alpha -spectrin requires beta -H spectrin (231, 446). The "receptor" for alpha /beta -H spectrin thus requires both subunits. The identity of molecular partners for beta -H spectrin remains to be determined. DE cadherins or associated proteins are candidates for such an activity based on colocalization (388).

D.  Assembly of Voltage-Gated Na+ Channel-Rich Domains in Excitable Cells

Clustering of voltage-gated Na+ channels (NaCh) at axon initial segments, nodes of Ranvier, and postsynaptic folds of the neuromuscular junction is vital for generating sufficient local current to overwhelm membrane capacitance and resistance and to initiate sufficient depolarization for effective signaling. Several clues point to a role of ankyrin in NaCh clustering. Ankyrin and the NaCh copurify and associate in vitro as well as in cell models (263, 369). Moreover, 480/270-kDa isoforms of ankyrin-G are localized at axon initial segments and nodes of Ranvier (219), sites where the existence of high density of NaCh has been well documented (48, 404, 430). As yet undefined ankyrin-G spliced forms also colocalize with NaCh in postsynaptic folds of mammalian neuromuscular junctions (122, 220, 431). Ankyrin-G also is associated with NaCh clusters in the dystrophic mouse in regions lacking myelination (86), as well as clusters of NaCh induced in cultured retinal ganglion neurons (205). beta  II spectrin, in contrast to ankyrin-G, occurs along the length of axons, does not exhibit increased density at nodes of Ranvier (390) or axon initial segments (449), and thus is not likely to play a role in NaCh localization. However, beta  IV spectrin is colocalized with 480/270-kDa ankyrin-G at nodal and initial axon segments in the central and peripheral nervous system (24). Ankyrin-G and beta  IV spectrin thus define specialized domains within a more general spectrin-actin network.

Evidence that ankyrin is required for localization of both Na+ channels and L1 CAM at axon initial segments is based on targeted knock-out of ankyrin-G expression in the postnatal cerebellum of mice (453). Mutant mice lacking cerebellar 480/270-kDa ankyrin-G developed characteristic cerebellar defects with symptoms of abnormal gait and tremor, and reduced locomotion that became more severe with increasing age. Electrophysiological data from analysis of cerebellar slices demonstrate that Purkinje cell neurons of mutant mice were unable to fire normal action potentials (453). Na+ channels were not concentrated at initial segments of granule cells from mutant mice (453). Neurofascin and NrCAM also exhibited loss of restriction to axon initial segments of Purkinje neurons of ankyrin-G mutant mice (453). It will be of interest to determine if ankyrin-G also is required for targeting of beta  IV spectrin to axon initial segments.

Similarities between nodes of Ranvier and other sites of Na+ channel concentration support the prediction that ankyrin-G also is required for restriction of Na+ channels at these domains. Nodes of Ranvier, the neuromuscular junction, and axon initial segments are each highly specialized, suggesting the likely possibility that Na+ channel/ankyrin-G assemblies will include additional proteins that perform specific functions adapted to each cell domain. Syntrophins, for example, associate with Na+ channels and are concentrated at the neuromuscular junction (140, 357). The beta -subunits of Na+ channels with their extracellular Ig domains may also be candidates to mediate important domain-specific interactions as well as provide a linkage with ankyrin (263).

Ankyrin-G could form heterocomplexes between Na+ channels and neurofascin in vivo by directly binding to both proteins, since the ankyrin membrane-binding domain has distinct binding sites for the Na+ channel, located on subdomains 3 and 4 (370), and for neurofascin, located on subdomains 2 and 3 as well as 3 and 4 (282) (Fig. 7). Possible physiological roles for such Na+ channel/adhesion molecule/ankyrin complexes include directing extracellular interactions with adjacent cells to sites of channel clusters. Another role of coclustering of Na+ channels with neurofascin/NrCAM could be related to the fact that L1 CAM family members are palmitoylated at a conserved cysteine site in their membrane-spanning segments (342). A high density of neurofascin-linked palmitoyl groups (likely to be in the range of 1,000 molecules/µm2) could perturb the local organization of phospholipids. Potential consequences could be recruitment of palmitoylated or lipid-modified signaling proteins and an increased membrane viscosity. It is pertinent in this regard that evidence of a diffusion barrier for glycophosphatidylinositol (GPI)-linked proteins and membrane lipids at axon initial segments has been reported, suggesting some difference in the lipid domain at this site (425).

Ankyrin-G, neurofascin, and the voltage-dependent Na+ channel cosegregate into axon microdomains early in the morphogenesis of the node of Ranvier (228). The 480-kDa ankyrin-G and 440-kDa ankyrin-B are coexpressed in premyelinated dorsal root ganglion axons at early stages of axonal growth during embryonic life. However, at the onset of myelination in the sciatic nerve, 440-kDa ankyrin-B disappears and 480/270-kDa ankyrin-G redistributes from a continuous distribution along premyelinated axons to localized patches adjacent to the ends of myelin-associated glycoprotein (MAG)-staining processes of myelinating Schwann cells. All foci of ankyrin-G also contain neurofascin, NrCAM, and the voltage-dependent Na+ channel. However, neurofascin and NrCAM clusters precede ankyrin-G and are candidates to either recruit or stabilize ankyrin-G at these sites (228). Further observations at later stages of sciatic nerve development suggest pairs of ankyrin/neurofascin/NrCAM/Na+ channel clusters fuse to form the mature node of Ranvier (228). Interestingly, similar clusters of Na+ channels have been reported in remyelinating peripheral nerve (111), which may represent a reversion to an earlier developmental stage of the axon as a response to injury.

Ankyrin-based clusters of Na+ channels persist in Trembler mutant mice with defective myelin (228). These clusters could have partial function in saltatory conduction of the action potential and could explain the relatively mild phenotype of trembler and the related disease of Marie-Charcot-Tooth type 1A in humans.

The molecular events leading to assembly of ankyrin-G and other components at nodes of Ranvier and axon initial segments remain to be deciphered. Neurofascin and NrCAM have been proposed to direct assembly, first, of ankyrin at nodes of Ranvier and other sites, followed by the localization of Na+ channels (228). However, the finding that neurofascin is not distributed normally in the absence of ankyrin-G (453) suggests that ankyrin-G is required for the concentration of neurofascin as well as the Na+ channel, at least at axon initial segments. The domains required for restriction of GFP-tagged 270-kDa ankyrin-G to axon initial segments of cultured dorsal root ganglion neurons have been examined with the conclusion that the membrane-binding domain is not sufficient (449). Moreover, both the spectrin-binding and tail domains of ankyrin-G exhibit activity in targeting GFP constructs to the plasma membrane of neurons. These findings suggest that ankyrin-G functions as an integrated unit requiring all of its domains and imply unidentified ankyrin-binding protein(s) upstream in the pathway to formation of axon initial segments.

E.  Targeting of Ca2-Release Channels to the Ca2+ Compartment of the ER

The ER of metazoan cells is a continuous system of intracellular membranes segregated into subdomains with specialized functions (407). One ER compartment with particular relevance for cell signaling is devoted to Ca2+ homeostasis and is a major determinant of intracellular Ca2+ levels (278). An ER Ca2+ homeostasis compartment is present in many cell types but is morphologically best defined in striated muscle and the nervous system (26, 129, 171). The ER Ca2+ compartment of striated muscle, termed the sarcoplasmic reticulum (SR), is intimately integrated with sarcomeres. In heart muscle, this configuration allows generation of Ca2+ waves that generate periodic cycles of contraction and relaxation by the contractile apparatus. Ryanodine receptors mediate Ca2+ release from SR stores and are localized adjacent to voltage-sensitive Ca2+ channels in t tubules, which are extensions of the plasma membrane (129). The SR/ER Ca2+-ATPase (SERCA) is responsible for subsequent Ca2+ uptake into the SR lumen and is localized over actomyosin in the A-band at sites distinct from ryanodine receptors (198). The specialized neuronal ER involved in Ca2+ homeostasis is located in dendritic spines and growth cones of axons and resembles the SR found in muscle as visualized by electron microscopy (171). The Ca2+ compartment of dendritic spines may have a role in cellular memory (26), while the same compartment in axon growth cones modulates axon pathfinding (378).

Evidence for an essential role of ankyrin-B in targeting Ca2+-release channels to the SR of striated muscle has come from disruption of the ankyrin-B gene in mice (397). Knock-out of the ankyrin-B gene was initially characterized in the nervous system, where the 440-kDa ankyrin-B isoform is required for postnatal survival of premyelinated axons (258) (see below). Ankyrin-B-deficient mice subsesquently were discovered to have musculoskeletal defects, elevated serum creatine kinase levels, as well as localized sites of disorganized sarcomeres in skeletal muscle (397). Ankyrin-B (-/-) cardiomyocytes have highly irregular cytosolic Ca2+ waves, with reduced frequency and rate of uptake of Ca2+. Moreover, ryanodine receptors were no longer distributed in a striated pattern associated with sarcomeres in ankyrin-B (-/-) cardiomyocytes and skeletal muscle. IP3 receptors also exhibited altered localization in cardiomyocytes. The SR and SR/t-tubule junctions are apparently preserved in a normal distribution in ankyrin-B (-/-) skeletal muscle based on electron microscopy and the presence of a normal pattern of triadin and the voltage-gated Ca2+ channel (dyhyropyridine receptor). The abnormal localization of IP3 and ryanodine receptors therefore represents a defect in intracellular sorting of these proteins in striated muscle. Ankyrin-B (-/-) mice also exhibit thymic atrophy as well as reduced expression of IP3 receptors in thymic lymphocytes (397). The requirement for ankyrin-B for proper targeting of Ca2+-release channels therefore is likely to be a feature of other cell types with a specialized Ca2+ compartment.

Several considerations support the hypothesis that ankyrin-B operates at the level of transport and/or segregation of Ca2+-release channels into vesicles. Ankyrin-B is not localized with SERCA or ryanodine receptors in striated muscle (397) but is associated with a novel class of vesicles in striated muscle as well as brain (J. Q. Davis and V. Bennett, unpublished data). Exchange of proteins between ER and Golgi is well known to involve a cellular machinery for recruitment of specific cargo proteins into vesicles and transfer of these vesicles between organelle compartments. A comparable system may also mediate transfer of functionally defined proteins from the ER to specialized sites within the SR. In this case, the basic defect in ankyrin-B (-/-) cells underlying missorting of multiple Ca2+-release channels could be a failure in some step required for segregation of these proteins and/or their transport between the ER and SR.

Ankyrin-B is a multifunctional protein that could participate in ER protein sorting at several levels. The multivalent ankyrin membrane-binding domain could bind to and laterally segregate selected proteins within the plane of the ER membrane (281, 282). Ankyrin-B also could participate in coupling vesicles to transport systems through interactions of the spectrin-binding domain or the microtubule-association site (75, 88, 173). Finally, ankyrin has recently been reported to associate with the terminal domain of clathrin (283) and could therefore interact with the coat proteins of certain vesicles.

F.  Orientation of Mitotic Spindles in Asymmetric Germ Cell Division in Drosophila

Germ line cell division in Drosophila as well as most insects results in a stem cell, which remains undifferentiated, and a daughter cystoblast, which will form the oocyte as well as nurse cells. The cystoblast subsequently experiences four synchronized rounds of mitosis, with the unusual feature of incomplete cytokinesis, resulting in a 16-cell syncytium connected through incompletely closed cleavage furrows. These cells, termed cystocytes, are interconnected by a cytoplasmic structure called the fusome, which was first visualized by light microscopy (85, 275).

Fusomes are comprised of two components: membrane skeletal proteins and membrane vesicles and cisternae proposed to represent a specialized form of the ER (233). Membrane skeletal proteins identified so far in fusomes include adducin (encoded by the huli-tao shao gene), alpha -spectrin, and beta -spectrin (85, 243). beta -H spectrin as well as protein 4.1 and other members of the ERM family are not present in fusomes (85, 272). Fusomes originate from a structure in the stem cell termed the spectrosome, which is enriched in ankyrin as well as alpha /beta -spectrin and adducin (243). The membrane compartment of fusomes includes a fly homolog of the transition ER ATPase (TER94) (233). TER94 is believed to have a role in vesicle fusion in assembly of ER cisternae, and the presence of this protein in the fusome implies that fusome membranes are derived from the ER and undergo fusion events.

Mutations in the huli-tao shao (hts) gene, named from the Chinese for too-little nursing (444), and in alpha -spectrin (85) establish the essential role of these proteins in assembly of fusomes and the spectrosome. Moreover, the phenotypes of these mutants establish that the fusome/spectrosome is required for several steps in successful maturation of oocytes. Hts mutants lack both the membrane and protein components of fusomes (243, 444). Adducin (or more accurately, the alternatively spliced adducin isoform expressed in germ cells; see below) therefore is required for assembly of both membrane skeletal proteins as well as membrane components of fusomes. alpha -Spectrin mutations targeted to germ cells result in loss of fusome-associated beta -spectrin and adducin, but to a lesser extent than the hts mutants (85). alpha -Spectrin mutants were not examined by electron microscopy, and the state of membrane vesicles has not been determined.

Detailed analysis of hts mutants has demonstrated several roles of the fusome in oogenesis (90, 243). A striking observation is that the spectrosome is required for orientation of the mitotic spindle in the first asymmetric cell division that produces the cystoblast and a renewing stem cell. Spindle orientation is a key event in asymmetric cell division events in generation of neuroblasts as well as other examples (reviewed in Ref. 242). It will be of interest to determine if adducin and other fusome components have a broader role in asymmetric cell division events in addition to insect germ cells. Other consequences of the hts mutation that are likely to be specific for germ cells included loss of synchronized cell division in cytocytes and loss of polarized microtubule networks (90).

Repasky and colleagues (28, 344) have discovered an intracellular spectrin-rich structure in lymphocytes that has interesting parallels with the fusome/spectrosome of D. melanogaster germ cells. The lymphoycyte "spectrosome" also contains membrane vesicles (28), as well as ankyrin (153). Other features of the lymphocyte spectrosome include association with a protein kinase C isoform and relocation in response to extracellular signals. Ankyrin-B is expressed in thymocytes, and ankyrin-B (-/-) mice exhibit thymic atrophy (397), although the spectrosome of ankyrin-B-deficient lymphocytes has not been examined. The role of the spectrosome in lymphocyte physiology thus remains to be evalulated.

The relationship between the isoform(s) of adducin expressed in germ cells and spectrin is not clear. Four adducin transcripts are expressed in D. melanogaster ovaries, and only the isoform found in somatic follicular cells contains the COOH-terminal MARCKS-related domain that associates with spectrin and actin, while the isoforms present in spectrosomes lack this domain and presumably cannot interact directly with spectrin (423). All adducin spliced variants contain a conserved globular head domain, which at this point has an unknown function. The observation that vesicle components are missing in hts mutants suggests the possibility that the head domain of adducin participates in organization of intracellular membranes and that spectrin and ankyrin are secondarily recruited via interactions with adducin-associated membranes.

G.  A Role for Protein 4.1 in Selective and Directed Membrane Protein Accumulation

1.  The 4.1 proteins and the neurexin superfamily

A striking common feature of D. melanogaster Coracle and mammalian 4.1 proteins is their requirement for the stable accumulation of proteins related to glycophorin D/C and neurexins in plasma membranes. Both human glycophorin C and D. melanogaster neurexin IV are trapped and essentially immobilized in complexes with 4.1 proteins. The binding site for 4.1 on glycophorin C has been mapped (266) and shows strong sequence similarity to a juxtamembrane sequence in the cytoplasmic domain of neurexin IV (15).

The neurexins are a family of three classes of CAMs (15, 288, 335, 443). One class is the "classical" neurexins I-III, which have roles in neuron-neuron adhesion. The second class is the "NCP" group, which have roles in mammalian brain in axon-glia contact, and in fly epithelia in septate junction formation. The third class is represented so far only by the fly protein axotactin, a secreted form of neurexin with a glia-neuronal signaling function. The 4.1-binding sequence identified in glycophorin C and D. melanogaster neurexin IV is also represented in all the transmembrane members of the neurexin superfamily (335).

In mammals, the junctions of axons and paranodal loops from Schwann cells at the paranodal regions of myelinated axons have been likened to septate junctions (15, 113, 406). During development of myelinated nerves, electron-dense junctions progressively form between the Schwann cell loops and axons; these are incomplete at day 10 of the postnatal life of a rat and may require up to day 31 to assume their final form, substantially after ankyrin-linked Na+ channels are clustered (433). The NCP-group protein CASPR/paranodin is found in these junctions (113, 279) and is localized to the paranodes coincident with their formation (339). CASPR/paranodin associates with protein 4.1 both from red blood cells and brain extracts (279). Given that the neurexin IV/coracle complex seems to be required for the formation of a transepithelial barrier in fly epithelium (417, 418), it seems probable that an analogous function is performed by a paranodin/4.1 complex at the junction of axons with myelinating cells. The paranodal junction makes a partial barrier to the diffusion of small ions and a complete barrier to large molecules, and it will be important to test in the 4.1R null mice whether there is evidence of breakdown of this barrier that might underlie their observed neurological defects. CASPR was identified as a ligand in cis on the neuronal cell surface for the GPI-linked molecule contactin (324); contactin is required for cell surface expression of CASPR (115). Contactin-null mice have a severe ataxic phenotype (25), reminiscent of (but more extreme than) part of the 4.1R-null phenotype (411).

Neighboring to the paranodal regions are the juxtaparanodes, in which another NCP protein CASPR2 (335) is found. Here the Shaker-like K+ channels Kv1.1, Kv1.2, and their beta -subunit Kvbeta 2 are clustered and precisely colocalized with CASPR2. The COOH termini of CASPR2 and these K+ channels contain potential binding sites for the PDZ domains of MAGUK proteins; CASPR2 contains a putative 4.1 binding sequence. It seems likely that these channels and CASPR2 are cross-linked in a complex with MAGUKs and 4.1. These K+ channels are thought to modulate conduction failures at branch points of complex axonal trees and to stabilize transition zones in myelinated axons (58), so it will be important to establish whether these functions are compromised in 4.1R null mice.

The classical neurexins are presynaptic adhesion proteins (38, 288) that retain the conserved 4.1 binding sequence (15). A cytoplasmic interaction of neurexin I with a MAGUK protein, CASK, has been identified in yeast two-hybrid assays (167). CASK is the human homolog of a C. elegans MAGUK, LIN-2, a protein required for vulval differentiation (183). CASK interacts with 4.1R (61), raising the possibility of a three-way neurexin/MAGUK/4.1 complex in presynaptic regions. Although such an idea is not supported by fly genetics (since Coracle has not been reported in presynaptic regions), rat 4.1N has been reported to be abundant in presynaptic terminals (311).

2.  The 4.1 proteins and syndecans

Syndecans are a major class of cell surface heparan sulfate proteoglycan (HSPG), of which syndecan-2 is one of the major neuronal representatives in the forebrain. CASK and syndecan-2 interact in two-hybrid assays, are coexpressed and colocalize in brain development, and can be coimmunoprecipitated from brain extracts (61, 185). 4.1R interacts with CASK in vitro, and so is suggested to generate a tripartite complex (61); however, simultaneous binding of the three proteins to each other has not yet been demonstrated, even though syndecan-2 contains a putative 4.1-binding motif.

Bearing in mind that in flies Coracle is essential for full expression of EGF receptor activity, the interaction with syndecans has added interest in terms of signaling. HSPGs are often considered to be coreceptors for heparin-binding factors: by binding these molecules, with lower affinity and specificity than their cognate high-affinity tyrosine kinase receptors, they are regarded as increasing their effective concentration in the vicinity of the plasma membrane (45). In vertebrates, neuregulin/ARIA is a heparin-binding secreted factor that acts on EGF receptor-like tyrosine kinases ErbB3 and ErbB4 (455). Neuregulin/ARIA is concentrated in synaptic clefts of neuronal-neuronal synapses and in the basal lamina of neuromuscular junctions (150, 355) and has a role in inducing transcription of receptors for acetylcholine, N-methyl-D-aspartate, and GABA (117, 314, 347). Syndecan-2 is concentrated in synapses and has been suggested to be the coreceptor for ARIA/neuregulin (185). Both syndecans and ErbB3/4 bind MAGUK proteins (61, 133, 185) and seem likely to be coclustered in postsynaptic regions by MAGUK interactions. Whether 4.1 has a role in linking this receptor/HSPG complex to the spectrin cytoskeleton and thereby stabilizing the mechanics of synaptic junctions, or whether 4.1 is required for the stable accumulation of either receptor or HSPG at the synapse remains to be seen. CASK has a specific signaling role in brain development (184), thus adding an extra dimension to the potential significance of the 4.1-interactive proteins in brain.

    IV. CLINICAL IMPLICATIONS
Top
Previous
Next
References

A general lesson from results of gene knock-outs in model organisms of spectrin and ankyrin-related proteins is that these genes are not essential for fundamental cellular function, but act at the level of integration of cells into tissues. A corollary is that mutations in these proteins may be compatible with survival but with impaired physiological function, and therefore are candidates to cause disease in humans. Gene knock-outs of ankyrins, protein 4.1 family members, and adducin in mice are now providing clues regarding general classes of phenotypes to be expected as well as specific lesions. Moreover, these studies suggest the presence of pathways that involve additional proteins and potential disease candidates. A summary of currently known disorders due to abnormalities of spectin, ankyrin, and associated proteins are discussed below (see Table 2).


                              
View this table:
[in this window]
[in a new window]
 
Table 2. Metazoan disorders due to abnormalities of spectrin, ankyrin, and associated proteins

A.  Functional Channelopathies Due to Defects in Ankyrin-Dependent Targeting

Ankyrin-G- and ankyrin-B-deficient mice described above both suffer from missorting of ion channels that are the equivalent in phenotype to mutations in the channels themselves. For example, mice missing cerebellar ankyrin-G exhibited severe ataxia associated with loss of ability of Purkinje neurons to fire action potentials (453). Moreover, ankyrin-G (-/-) mice and mice with a mutation in the SNC6 Na+ channel subunit both exhibited progressive degeneration of Purkinje neurons (32, 215).

Ankyrin-G is encoded by a complex set of tissue and developmentally specific transcripts (93, 178, 219, 327). Mutations could occur that would target specific tissues as in the case of the cerebellar-restricted gene knock-out. The potential channels targeted by ankyrin-G may include the Na+-K+-ATPase (297, 304, 385), the Na+/Ca2+ exchanger (240), as well as others. The potential phenotypes of ankyrin-G mutations therefore could range from abnormal Na+ absorption, defective Ca2+ dynamics, and abnormal heart rhythms to name a few. Moreover, the cellular pathway utilized by ankyrin-G for Na+ channel targeting is not known, but presumably involves additional proteins that are candidates to contribute to a functional channelopathy.

Disruption of ankyrin-B in mice results in abnormal targeting of Ca2+ signaling proteins including ryanodine receptors and IP3 receptors (397). Ankyrin-B-deficient mice exhibit multisystem dysfunction including severe disorders in nervous system development, myopathy, megacolon, atrophy of the thymus, and abnormal kidney development and do not survive the neonatal period (358, 397). Complete ankyrin-B deficiency in humans therefore would be anticipated to involve defective development of the nervous system as well as severe dysfunction of striated muscle and immune system that would not be compatible with prolonged postnatal life. However, individuals with weak alleles or partial deficiency of ankyrin-B may be viable and exhibit clinical disease.

Ankyrin-B (+/-) mice have reduced expression of ankyrin-B but survive to adulthood (P. Mohler, A. Gramolini, and V. Bennett, unpublished data). These animals may provide models for certain autosomal dominant human "channelopathies" involving Ca2+ release channels, with loss of function due to missorting rather than direct mutations in these proteins. A candidate disease involving ankyrin-B is long Q-T syndrome type 4, an autosomal dominant cardiac arrhythmia associated with sudden death, that maps to the same chromosomal region of 4q25-27 as the ANK2 gene encoding ankyrin-B (356). In further support of a connection between ankyrin-B and heart disease, ankyrin-B (+/-) mice exhibit abnormalities in heart conduction and bradycardia, as well as an increased Q-T interval (Mohler et al., unpublished data).

Ankyrin-B mutations also are likely to result in abnormalities in the immune and nervous systems. Coordinated assembly and spatial organization of Ca2+ release channels within the ER is essential in cells of the immune system as well as in striated muscle. Lymphocytes encode information in the amplitude and frequency of intracellular waves of Ca2+ (101). Unlike the highly organized SR of striated muscle, lymphocytes are likely to have variable states of organization of IP3 receptors that depend on their differentiation state. As a consequence of such plasticity, signals that elevate Ca2+ can have opposite effects in naïve and differentiated cells (101). Ankyrin-B deficiency has profound consequences for survival of neonatal thymic lymphocytes as expected if signals promoting differentiation are interrupted (397).

The specialized neuronal ER involved in Ca2+ homeostasis is located in dendritic spines and growth cones of axons and resembles the SR found in muscle as visualized by electron microscopy (171). The 220-kDa ankyrin-B is expressed in neuron cell bodies and dendrites in the postnatal brain in a time frame that approximates development of the dendritic spine apparatus of hippocampal and Purkinje neurons (225), whereas 440-kDa ankyrin-B is targeted to axons early in development (49, 224). These results suggest that 220-kDa ankyrin-B is a good candidate to participate in targeting Ca2+-release channels to their physiological sites in dendrites of neurons, whereas 440-kDa ankyrin-B may have a similar function in axons.

B.  Use-Dependent Dystrophies of Muscle and Nerves Due to Defects in the Spectrin-Based Transcellular Mechanical Coupling Pathway

Consequences of spectrin deficiency in C. elegans (159, 292) include degeneration of muscles and abnormalities in the nervous system that could be attributed to mechanical stresses. Prediction of the phenotype in vertebrates resulting from defects in spectrin are complicated by the multiple closely related genes that may overlap in function. However, truncations of beta -spectrin can act in a dominant-negative fashion by poisoning alpha /beta -spectrin dimers and preventing formation of tetramers (186). Such mutations conceivably could exhibit penetrance even in the presence of other normal beta -spectrin genes.

Examples of acquired disorders due to loss of mechanical support include unexplained myopathies and peripheral neuropathies. Demyelinated peripheral axons would be particularly vulnerable to trauma if axo-glia contacts were weakened. It is of interest in this regard that a major defect in multiple sclerosis is severing of axons at sites where myelin is interrupted (391). A potential therapeutic strategy in this case would be to restore expression of 440-kDa ankyrin-B and of L1, which are normally lost with myelination, and may play a role in stabilizing premyelinated axons.

C.  Abnormal Nervous System Development Due to L1 CAM Defects

The L1 CAM family comprises a major class of cell adhesion molecules in the adult mammalian nervous system and has been implicated in diverse functions ranging from axon fasciculation to synaptogenesis (39). Disorders related to defects in L1 have provided initial insight into the clinical implications of these functions. Mutations in the human L1 gene, located on the X chromosome, are responsible for a syndrome termed CRASH for corpus callosum agenesis, mental retardation, adducted thumbs, spastic paraplegia, and hydrocephalus (128, 212). Over 35 mutations in L1 have currently been characterized, and these are distributed in all domains including several in the cytoplasmic domain. Disruption of the L1 gene in mice results in abnormal axon guidance in the corticospinal tract, brain malformations including dilated ventricles, and behavioral deficits (61, 73).

Several considerations implicate ankyrin and/or phospho-FIGQY signaling in the pathophysiology of L1 defects. L1 and 440-kDa ankyrin-B are colocalized in premyelinated axon tracts in the developing nervous system and are both downregulated after myelination (358). Ankyrin-B (-/-) mice exhibit a phenotype similar to, but more severe than, L1 (-/-) mice and share features of human patients with L1 mutations (358). For example, ankyrin-B (-/-) mice exhibit hypoplasia of the corpus callosum and pyramidal tracts, dilated ventricles, all features of the CRASH syndrome associated with L1 mutations. One missense mutation in the L1 cytoplasmic domain results in conversion of FIGQY 1229 to H and clinical disease (405). The Y1229H mutation of the FIGQY tyrosine would abolish both ankyrin-binding activity (450) as well as phospho-FIGQY tyrosine signaling. One or both of these activities thus is essential for L1 function in nervous system development.

Diseases have not yet been attributed to other L1 CAM family members. These genes are autosomal, in contrast to L1, and presumably would exhibit a recessive pattern of inheritance. It also is possible that mutations could result in expression of dominant/negative forms of polypeptides, as has been oberved with LAD-1 in C. elegans (Chen and Bennett, unpublished data). It is conceivable that mutations in L1 CAM family members may have subtle consequences at the level of complex neural function resulting in problems such as learning disabilities, thinking disorders, and overall mental retardation. These activities are difficult to assess in mice, but could be significant in a human context.

    V. SUMMARY AND PERSPECTIVES
Top
Previous
Next
References

Molecular dissection of the spectrin-based membrane skeleton of the humble mammalian erythrocyte has provided biologists with a set of proteins with diverse roles in organization and survival of cells in metazoan organisms. The lack of an essential function for membrane skeletal proteins in generic cells grown in culture and the absence of their genes in the yeast genome have, until recently, limited advances in understanding roles of these proteins outside of erythrocytes. However, characterization of genes and alternatively spliced variants combined with completion of the genomes of simple metazoans and application of homologous recombination in mice now are providing the first glimpses of the full scope of physiological roles for spectrin, ankyrin, and their associated proteins. These functions now promise to include organization of specialized compartments within the plasma membrane and endoplasmic reticulum, mechanical stabilization at the tissue level based on transcellular protein assemblies, participation in epithelial morphogenesis, and orientation of mitotic spindles in asymmetric cell divisions.

These studies, in addition to stretching the erythrocyte paradigm beyond recognition, also are revealing new pathways essential for metazoan life that may not be present in fungi or plants. Examples include ankyrin-dependent targeting of proteins to the specialized compartments within the plasma membrane and ER, and components and function of the phospho-FIGQY tyrosine pathway of L1 CAMs. A broader issue is the evolution of these pathways, beginning with spectrin and ankyrin themselves, and continuing with their legion of interacting partners and the cellular structures dependent on these proteins. More immediate questions relate to the roles of these pathways in a clinical context, either as the basis for disease, or more positively as therapeutic targets. The newly recognized role of ankyrin-B in targeting proteins to the Ca2+ compartment, for example, suggests the potential for modulating functions of immune system, the heart, and nervous system. These pathways could also be influenced in a negative fashion by teratogens and other toxic chemicals and have not yet been evaluated due to lack of appropriate assays. These considerations suggest that we have arrived at the end of the beginning in terms of understanding basic roles of spectrin and ankyrin and in applying this information.

    ACKNOWLEDGMENTS

V. Bennett was supported in part by grants from the National Institutes of Health and the Muscular Dystrophy Association and by the Howard Hughes Medical Institute. A. J. Baines was suported in part by the Biotechnology and Biological Science Research Council, the Wellcome Trust, and the British Council Alliance. A travel grant from North American Treaty Organization to the authors is acknowledged.

    FOOTNOTES

Address for reprint requests and other correspondence: V. Bennett, Howard Hughes Medical Institute and Depts. of Cell Biology and Biochemistry, Duke University Medical Center, Durham, NC 27710 (E-mail: benne012{at}mc.duke.edu).

    REFERENCES
Top
Previous

1. Agre P, Casella JF, Zinkham WH, McMillan C, and Bennett V. Partial deficiency of erythrocyte spectrin in hereditary spherocytosis. Nature 314: 380-383, 1985[Web of Science][Medline].
2. Agre P, Orringer EP, and Bennett V. Deficient red-cell spectrin in severe, recessively inherited spherocytosis. N Engl J Med 306: 1155-1161, 1982[Web of Science][Medline].
3. Alloisio N, Dalla Venezia N, Rana A, Andrabi K, Texier P, Gilsanz F, Cartron JP, Delaunay J, and Chishti AH. Evidence that red blood cell protein p55 may participate in the skeleton-membrane linkage that involves protein 4.1 and glycophorin C. Blood 82: 1323-1327, 1993[Abstract/Free Full Text].
4. Anstee DJ, Hemming NJ, and Tanner MJ. Functional factors in the red cell membrane: interactions between the membrane and its underlying skeleton. Immunol Invest 24: 187-198, 1995[Web of Science][Medline].
5. Appell KC, and Low PS. Partial structural characterization of the cytoplasmic domain of the erythrocyte membrane protein, band 3. J Biol Chem 256: 11104-11111, 1981[Abstract/Free Full Text].
6. Banuelos S, Saraste M, and Carugo KD. Structural comparisons of calponin homology domains: implications for actin binding. Structure 6: 1419-1431, 1998[Medline].
7. Baumgartner S, Littleton JT, Broadie K, Bhat MA, Harbecke R, Lengyel JA, Chiquetehrismann R, Prokop A, and Bellen HJ. A Drosophila neurexin is required for septate junction and blood-nerve barrier formation and function. Cell 87: 1059-1068, 1996[Web of Science][Medline].
8. Beaven GH, and Gratzer WB. Interaction of divalent cations with human red cell cytoskeletons. Biochim Biophys Acta 600: 140-149, 1980[Medline].
9. Beck KA, Buchanan JA, Malhotra V, and Nelson WJ. Golgi spectrin: identification of an erythroid beta -spectrin homolog associated with the Golgi complex. J Cell Biol 127: 707-723, 1994[Abstract/Free Full Text].
10. Beck KA, Buchanan JA, and Nelson WJ. Golgi membrane skeleton: identification, localization and oligomerization of a 195 kDa ankyrin isoform associated with the Golgi complex. J Cell Sci 110: 1239-1249, 1997[Abstract].
11. Beck KA, and Nelson WJ. A spectrin membrane skeleton of the Golgi complex. Biochim Biophys Acta 1404: 153-160, 1998[Medline].
12. Becker PS, Schwartz MA, Morrow JS, and Lux SE. Radiolabel-transfer cross-linking demonstrates that protein 4.1 binds to the NH2-terminal region of beta  spectrin and to actin in binary interactions. Eur J Biochem 193: 827-836, 1990[Web of Science][Medline].
13. Becker PS, Tse WT, Lux SE, and Forget BG. Beta spectrin kissimmee: a spectrin variant associated with autosomal dominant hereditary spherocytosis and defective binding to protein 4.1 xJ Clin Invest 92: 612-616, 1993.
14. Begg GE, Harper SL, Morris MB, and Speicher DW. Initiation of spectrin dimerization involves complementary electrostatic interactions between paired triple-helical bundles. J Biol Chem 275: 3279-3287, 2000[Abstract/Free Full Text].
15. Bellen HJ, Lu Y, Beckstead R, and Bhat MA. Neurexin IV, caspr and paranodin---novel members of the neurexin family: encounters of axons and glia. Trends Neurosci 21: 444-449, 1998[Web of Science][Medline].
16. Bennett H, and Condeelis J. Isolation of an immunoreactive analog of brain fodrin that is associated with the cell cortex of Dictyostelium amoebae. Cell Motil Cytoskeleton 11: 303-317, 1988[Web of Science][Medline].
17. Bennett V. Purification of an active proteolytic fragment of the membrane attachment site for human erythrocyte spectrin. J Biol Chem 253: 2292-2299, 1978[Free Full Text].
18. Bennett V. Immunoreactive forms of human erythrocyte ankyrin are present in diverse cells and tissues. Nature 281: 597-599, 1979[Web of Science][Medline].
19. Bennett V, and Davis J. Erythrocyte ankyrin: immunoreactive analogs are associated with mitotic structures in cultured cells and with microtubules in brain. Proc Natl Acad Sci USA 78: 7550-7554, 1981[Abstract/Free Full Text].
20. Bennett V, Davis J, and Fowler WE. Brain spectrin, a membrane-associated protein related in structure and function to erythrocyte spectrin. Nature 299: 126-131, 1982[Medline].
21. Bennett V, Gardner K, and Steiner JP. Brain adducin: a protein kinase C substrate that may mediate site-directed assembly at the spectrin-actin junction. J Biol Chem 263: 5860-5869, 1988[Abstract/Free Full Text].
22. Bennett V, and Stenbuck PJ. The membrane attachment protein for spectrin is associated with band 3 in human erythrocyte membranes. Nature 280: 468-473, 1979[Medline].
23. Bennett V, and Stenbuck PJ. Identification and partial purification of ankyrin, the high affinity membrane attachment site for human erythrocyte spectrin. J Biol Chem 254: 2533-2541, 1979[Free Full Text].
24. Berghs S, Agguajaro D, Dirkx R Jr, Maksimova E, Stabach P, Hermel JM, Zhang JP, Philbrick W, Slepnev V, Ort T, and Solimena M. BetaIV spectrin, a new spectrin localized at axon initial segments and nodes of Ranvier in the central and peripheral nervous system. J Cell Biol 151: 985-1002, 2000[Abstract/Free Full Text].
25. Berglund EO, Murai KK, Fredette B, Sekerkova G, Marturano B, Weber L, Mugnaini E, and Ranscht B. Ataxia and abnormal cerebellar microorganization in mice with ablated contactin gene expression. Neuron 24: 739-750, 1999[Web of Science][Medline].
26. Berridge M. Neuronal calcium signaling. Neuron 21: 13-26, 1998[Web of Science][Medline].
27. Bhat MA, Izaddoost S, Lu Y, Cho KO, Choi KW, and Bellen HJ. Discs lost, a novel multi-PDZ domain protein, establishes and maintains epithelial polarity. Cell 96: 833-845, 1999[Web of Science][Medline].
28. Black JD, Koury ST, Bankert RB, and Repasky EA. Heterogeneity in lymphocyte spectrin distribution: ultrastructural identification of a new spectrin-rich cytoplasmic structure. J Cell Biol 106: 97-109, 1988[Abstract/Free Full Text].
29. Blackshear PJ. The MARCKS family of cellular protein kinase C substrates. J Biol Chem 268: 1501-1504, 1993[Free Full Text].
30. Blanco FJ, Ortiz AR, and Serrano L. 1H and 15N NMR assignment and solution structure of the SH3 domain of spectrin: comparison of unrefined and refined structure sets with the crystal structure. J Biomol NMR 9: 347-357, 1997[Web of Science][Medline].
31. Bloch RJ, and Morrow JS. An unusual beta-spectrin associated with clustered acetylcholine receptors. J Cell Biol 108: 481-493, 1989[Abstract/Free Full Text].
32. Boakes RJ, Candy JM, Dick DJ, Harris JB, Pollard S, and Thompson J. Abnormal electrophysiological and anatomical characteristics of cerebellar Purkinje cells in the mutant mouse jolting (Abstract). J Physiol (Lond) 346: 27P, 1984.
33. Bodine DM IV, Birkenmeier CS, and Barker JE. Spectrin deficient inherited hemolytic anemias in the mouse: characterization by spectrin synthesis and mRNA activity in reticulocytes. Cell 37: 721-729, 1984[Web of Science][Medline].
34. Bork P. Hundreds of ankyrin-like repeats in functionally diverse proteins: mobile modules that cross phyla horizontally? Proteins 17: 363-374, 1993[Web of Science][Medline].
35. Bouley M, Tian MZ, Paisley K, Shen YC, Malhotra JD, and Hortsch MJ. The L1-type cell adhesion molecule neuroglian influences the stability of neural ankyrin in the Drosophila embryo but not it axonal localization. J Neurosci 20: 4515-4523, 2000[Abstract/Free Full Text].
36. Bourguignon LY, Chu A, Jin H, and Brandt NR. Ryanodine receptor-ankyrin interaction regulates internal Ca2+ release in mouse T-lymphoma cells. J Biol Chem 270: 17917-17922, 1995[Abstract/Free Full Text].
37. Bourguignon LY, Jin H, Iida N, Brandt NR, and Zhang SH. The involvement of ankyrin in the regulation of inositol 1,4,5-trisphosphate receptor-mediated internal Ca2+ release from Ca2+ storage vesicles in mouse T-lymphoma cells. J Biol Chem 268: 7290-7297, 1993[Abstract/Free Full Text].
38. Brose N. Synaptic cell adhesion proteins and synaptogenesis in the mammalian central nervous system. Naturwissenschaften 86: 516-524, 1999[Web of Science][Medline].
39. Brummendorf T, and Rathjen FG. Molecular interactions involving immunoglobulin superfamily adhesion molecules. In: Ig Superfamily Molecules in the Nervous System, edited by Sonderegger P. Amsterdam: Harwood Academic, 1998, p. 23-56.
40. Burridge K, Kelly T, and Mangeat P. Nonerythrocyte spectrins: actin-membrane attachment proteins occurring in many cell types. J Cell Biol 95: 478-486, 1982[Abstract/Free Full Text].
41. Byers TJ, Brandin E, Lue RA, Winograd E, and Branton D. The complete sequence of Drosophila beta-spectrin reveals supra-motifs comprising eight 106-residue segments. Proc Natl Acad Sci USA 89: 6187-6191, 1992[Abstract/Free Full Text].
42. Byers TJ, and Branton D. Visualization of the protein associations in the erythrocyte membrane skeleton. Proc Natl Acad Sci USA 82: 6153-6157, 1985[Abstract/Free Full Text].
43. Byers TJ, Husain-Chishti A, Dubreuil RR, Branton D, and Goldstein LS. Sequence similarity of the amino-terminal domain of Drosophila beta spectrin to alpha  actinin and dystrophin. J Cell Biol 109: 1633-1641, 1989[Abstract/Free Full Text].
44. Calvert R, Bennett P, and Gratzer W. Properties and structural role of the subunits of human spectrin. Eur J Biochem 107: 355-361, 1980[Web of Science][Medline].
45. Carey DJ. Syndecans: multifunctional cell-surface co-receptors. Biochem J 327: 1-16, 1997.
46. Carugo KD, Banuelos S, and Saraste M. Crystal structure of a calponin homology domain. Nat Struct Biol 4: 175-179, 1997[Web of Science][Medline].
47. Castresana J, and Saraste M. Does Vav bind to F-actin through a CH domain? FEBS Lett 374: 149-151, 1995[Web of Science][Medline].
48. Catterall WA. Localization of sodium channels in cultured neural cells. J Neurosci 1: 777-783, 1981[Abstract].
49. Chan W, Kordeli E, and Bennett V. 440-kD ankyrinB: structure of the major developmentally regulated domain and selective localization in unmyelinated axons. J Cell Biol 123: 1463-1473, 1993[Abstract/Free Full Text].
50. Chao TS, and Tao M. Effect of 2,3-diphosphoglycerate on the phosphorylation of protein 4.1 by protein kinase C. Arch Biochem Biophys 285: 221-226, 1991[Web of Science][Medline].
51. Chao TS, and Tao M. Modulation of protein 4.1 binding to inside-out membrane vesicles by phosphorylation. Biochemistry 30: 10529-10535, 1991[Medline].
52. Chasis JA, Agre P, and Mohandas N. Decreased membrane mechanical stability and in vivo loss of surface area reflect spectrin deficiencies in hereditary spherocytosis. J Clin Invest 82: 617-623, 1988.
53. Che A, Morrison IE, Pan R, and Cherry RJ. Restriction by ankyrin of band 3 rotational mobility in human erythrocyte membranes and reconstituted lipid vesicles. Biochemistry 36: 9588-9595, 1997[Medline].
55. Cherry L, Menhart N, and Fung LW. Interactions of the alpha -spectrin N-terminal region with beta-spectrin. Implications for the spectrin tetramerization reaction. J Biol Chem 274: 2077-2084, 1999[Abstract/Free Full Text].
56. Chishti AH. Function of p55 and its nonerythroid homologues. Curr Opin Hematol 5: 116-121, 1998[Medline].
57. Chishti AH, Kim AC, Marfatia SM, Lutchman M, Hanspal M, Jindal H, Liu SC, Low PS, Rouleau GA, Mohandas N, Chasis JA, Conboy JG, Gascard P, Takakuwa Y, Huang SC, Benz EJ, Bretscher A, Fehon RG, Gusella AF, Ramesh V, Solomon F, Marchesi VT, Tsukita S, Arpin M, Louvard D, Tonks NK, Anderson JM, Fanning AS, Bryant PJ, Woods DF, and Hoover KB. The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane. Trends Biochem Sci 23: 281-282, 1998[Web of Science][Medline].
58. Chiu SY, Zhou L, Zhang CL, and Messing A. Analysis of potassium channel functions in mammalian axons by gene knockouts. J Neurocytol 28: 349-364, 1999[Web of Science][Medline].
59. Chow CW. Regulation and intracellular localization of the epithelial isoforms of the Na+/H+ exchangers NHE2 and NHE3. Clin Invest Med 22: 195-206, 1999[Web of Science][Medline].
60. Citterio L, Azzani T, Duga S, and Bianchi G. Genomic organization of the human gamma adducin gene. Biochem Biophys Res Commun 266: 110-114, 1999[Web of Science][Medline].
61. Cohen AR, Woods DF, Marfatia SM, Walther Z, Chishti AH, Anderson JM, and Wood DF. Human CASK/LIN-2 binds syndecan-2 and protein 4.1 and localizes to the basolateral membrane of epithelial cells. J Cell Biol 142: 129-138, 1998[Abstract/Free Full Text].
62. Cohen CM, Dotimas E, and Korsgren C. Human erythrocyte membrane protein band 4.2 (pallidin). Semin Hematol 30: 119-137, 1993[Web of Science][Medline].
63. Cohen CM, and Langley RC Jr. Functional characterization of human erythrocyte spectrin alpha and beta chains: association with actin and erythrocyte protein 4.1. Biochemistry 23: 4488-4495, 1984[Medline].
64. Cohen NR, Taylor JS, Scott LB, Guillery RW, Soriano P, and Furley AJ. Errors in corticospinal axon guidance in mice lacking the neural cell adhesion molecule L1. Curr Biol 8: 26-33, 1997.
65. Conboy J. The role of alternative premRNA splicing in regulating the structure and function of skeletal protein 4.1. Proc Soc Exp Biol Med 220: 73-78, 1999[Medline].
66. Conboy J, Marchesi S, Kim R, Agre P, Kan YW, and Mohandas N. Molecular analysis of insertion deletion mutations in protein-4.1 in elliptocytosis. 2. Determination of molecular genetic origins of rearrangements. J Clin Invest 86: 524-530, 1990.
67. Conboy J, Mohandas N, Tchernia GY, and Kan W. Molecular basis of hereditary elliptocytosis due to protein 4.1 deficiency. N Engl J Med 315: 680-685, 1986[Abstract].
68. Conboy JG. Structure, function, and molecular genetics of erythroid membrane skeletal protein 4.1 in normal and abnormal red blood cells. Semin Hematol 30: 58-73, 1993[Web of Science][Medline].
69. Conboy JG, Chan JY, Chasis JA, Kan YW, and Mohandas N. Tissue-specific and development-specific alternative RNA splicing regulates expression of multiple isoforms of erythroid membrane protein 4.1. J Biol Chem 266: 8273-8280, 1991[Abstract/Free Full Text].
70. Conboy JG, Shitamoto R, Parra M, Winardi R, Kabra A, Smith J, and Mohandas N. Hereditary elliptocytosis due to both qualitative and quantitative defects in membrane skeletal protein 4.1. Blood 78: 2438-2443, 1991[Abstract/Free Full Text].
71. Correas I, Leto TL, Speicher DW, and Marchesi VT. Identification of the functional site of erythrocyte protein 4.1 involved in spectrin-actin associations. J Biol Chem 261: 3310-3315, 1986[Abstract/Free Full Text].
72. Correas I, Speicher DW, and Marchesi VT. Structure of the spectrin-actin binding-site of erythrocyte protein 4.1. J Biol Chem 261: 3362-3366, 1986[Web of Science].
73. Dahme M, Bartsch U, Martini R, Anliker B, Schachner M, and Mantei N. Disruption of the mouse L1 gene leads to malformations of the nervous system. Nat Genet 17: 346-349, 1997[Web of Science][Medline].
74. Danilov YN, Fennell R, Ling E, and Cohen CM. Selective modulation of band 4.1 binding to erythrocyte membranes by protein kinase C. J Biol Chem 265: 2556-2562, 1990[Abstract/Free Full Text].
75. Davis JQ, and Bennett V. Brain ankyrin. A membrane-associated protein with binding sites for spectrin, tubulin, and the cytoplasmic domain of the erythrocyte anion channel. J Biol Chem 259: 13550-13559, 1984[Abstract/Free Full Text].
76. Davis JQ, and Bennett V. Ankyrin binding activity shared by the neurofascin/L1/NrCAM family of nervous system cell adhesion molecules. J Biol Chem 269: 27163-27166, 1994[Abstract/Free Full Text].
77. Davis JQ, Lambert S, and Bennett V. Molecular composition of the node of Ranvier: identification of ankyrin-binding cell adhesion molecules neurofascin (mucin+/third FNIII domain-) and NrCAM at nodal axon segments. J Cell Biol 135: 1355-1367, 1996[Abstract/Free Full Text].
78. Davis L, Lux SE, and Bennett V. Mapping the ankyrin-binding site of the human erythrocyte anion exchanger. J Biol Chem 264: 9665-9672, 1989[Abstract/Free Full Text].
79. Davis JQ, McLaughlin T, and Bennett V. Ankyrin-binding proteins related to nervous system cell adhesion molecules: candidates to provide transmembrane and intercellular connections in adult brain. J Cell Biol 121: 121-133, 1993[Abstract/Free Full Text].
80. Davis LH, and Bennett V. Identification of two regions of beta G spectrin that bind to distinct sites in brain membranes. J Biol Chem 269: 4409-4416, 1994[Abstract/Free Full Text].
81. Davis LH, Davis JQ, and Bennett V. Ankyrin regulation: an alternatively spliced segment of the regulatory domain functions as an intramolecular modulator. J Biol Chem 267: 18966-18972, 1992[Abstract/Free Full Text].
82. Davis LH, Otto E, and Bennett V. Specific 33-residue repeat(s) of erythrocyte ankyrin associate with the anion exchanger. J Biol Chem 266: 11163-11169, 1991[Abstract/Free Full Text].
83. Debant A, Serra-Pages C, Seipel K, O'Brien S, Tang M, Park SH, and Streuli M. The multidomain protein Trio binds the LAR transmembrane tyrosine phosphatase, contains a protein kinase domain, and has separate rac-specific and rho-specific guanine nucleotide exchange factor. Proc Natl Acad Sci USA 93: 5466-5471, 1996[Abstract/Free Full Text].
84. Decarcer G, Lallena WJ, and Correas I. Protein 4.1 is a component of the nuclear matrix of mammalian cells. Biochem J 312: 871-877, 1995.
85. De Cuevas M, Lee JK, and Spradling AC. Alpha-spectrin is required for germline cell division and differentiation in the Drosophila ovary. Development 122: 3959-3968, 1996[Abstract].
86. Deerinck TJ, Levinson SR, Bennett GV, and Ellisman EH. Clustering of voltage-sensitive sodium channels on axons is independent of direct Schwann cell contact in the dystrophic mouse. J Neurosci 17: 5080-5088, 1997[Abstract/Free Full Text].
87. Delaunay J, Alloisio N, Morle L, Baklouti F, Dallavenezia N, Maillet P, and Wilmotte R. Molecular genetics of hereditary elliptocytosis and hereditary spherocytosis. Ann Genet 39: 209-221, 1996[Web of Science][Medline].
88. De Matteis MA, and Morrow JS. The role of ankyrin and spectrin in membrane transport and domain formation. Curr Opin Cell Biol 10: 542-549, 1998[Web of Science][Medline].
89. Deng H, Lee JK, Goldstein LS, and Branton D. Drosophila development requires spectrin network formation. J Cell Biol 128: 71-79, 1995[Abstract/Free Full Text].
90. Deng W, and Lin H. Spectrosomes and fusomes anchor mitotic spindles during asymmetric germ cell divisions and facilitate the formation of apolarized microtubule array for oocyte specification in Drosophila. Dev Biol 189: 79-94, 1997[Web of Science][Medline].
91. Derick LH, Liu SC, Chishti AH, and Palek J. Protein immunolocalization in the spread erythrocyte membrane skeleton. Eur J Cell Biol 57: 317-320, 1992[Web of Science][Medline].
92. Devarajan P, Stabach PR, De Matteis MA, and Morrow JS. DevNa,K-ATPase transport from endoplasmic reticulum to Golgi requires the Golgi spectrin-ankyrin G119 skeleton in Madin-Darby canine kidney cells. Proc Natl Acad Sci USA 94: 10711-10716, 1997[Abstract/Free Full Text].
93. Devarajan P, Stabach PR, Mann AS, Ardito T, Kashgarian M, and Morrow JS. Identification of a small cytoplasmic ankyrin (AnkG119) in the kidney and muscle that binds beta I sigma spectrin and associates with the Golgi apparatus. J Cell Biol 133: 819-830, 1996[Abstract/Free Full Text].
94. Dhermy D, Galand C, Bournier O, Cynober T, Mechinaud F, Tchemia G, and Garbarz M. Hereditary spherocytosis with spectrin deficiency related to null mutations of the beta-spectrin gene. Blood Cells Mol Dis 24: 251-261, 1998[Web of Science][Medline].
95. Dhermy D, Garbarz M, Lecomte MC, Feo C, Bournier O, Chaveroche I, Gautero H, Galand C, and Boivin P. Hereditary elliptocytosis: clinical, morphological and biochemical studies of 38 cases. Nouv Rev Fr Hematol 28: 129-140, 1986.
96. Ding Y, Kobayashi S, and Kopito R. Mapping of ankyrin binding determinants on the erythroid anion exchanger, AE1. J Biol Chem 271: 22494-22498, 1996[Abstract/Free Full Text].
97. Discher DE. New insights into erythrocyte membrane organization and microelasticity. Curr Opin Hematol 7: 117-122, 2000[Web of Science][Medline].
98. Discher DE, Parra M, Conboy JG, and Mohandas N. Mechanochemistry of the alternatively spliced spectrin-actin binding domain in membrane skeletal protein-4.1. J Biol Chem 268: 7186-7195, 1993[Abstract/Free Full Text].
99. Discher DE, Winardi R, Schischmanoff PO, Parra M, Conboy JG, and Mohandas N. Mechanochemistry of protein 4.1s spectrin-actin-binding domain: ternary complex interactions, membrane-binding, network integration, structural strengthening. J Cell Biol 130: 897-907, 1995[Abstract/Free Full Text].
100. Djinovic-Carugo K, Young P, Gautel M, and Saraste M. Structure of the alpha-actinin rod: molecular basis for cross-linking of actin filaments. Cell 98: 537-546, 1999[Web of Science][Medline].
101. Dolmetsch R, Lewis RS, Goodnow CG, and Healy JI. Differential activation of transcription factors induced by calcium response amplitude and duration. Nature 386: 855-858, 1997[Medline].
102. Dong L, Chapline C, Mousseau B, Fowler L, Ramsay K, Stevens JL, and Jaken S. 35h, a sequence isolated as a protein kinase C binding protein, is a novel member of the adducin family. J Biol Chem 270: 25534-25540, 1995[Abstract/Free Full Text].
103. Drenckhahn D, and Bennett V. Polarized distribution of Mr 210,000 and 190,000 analogs of erythrocyte ankyrin along the plasma membrane of transporting epithelia, neurons and photoreceptors. Eur J Cell Biol 43: 479-486, 1987[Web of Science][Medline].
104. Drenckhahn D, Schluter K, Allen DP, and Bennet V. Colocalization of band 3 with ankyrin and spectrin at the basal membrane of intercalated cells in the rat kidney. Science 230: 1287-1289, 1985[Abstract/Free Full Text].
105. Dubreuil RR, Byers TJ, Sillman AL, Bar-Zvi D, Goldstein LS, and Branton D. The complete sequence of Drosophila alpha-spectrin: conservation of structural domains between alpha-spectrins and alpha-actinin. J Cell Biol 109: 2197-2205, 1989[Abstract/Free Full Text].
106. Dubreuil RR, Byers TJ, Stewart CT, and Kiehart DP. A beta-spectrin isoform from Drosophila (beta H) is similar in size to vertebrate dystrophin. J Cell Biol 111: 1849-1858, 1990[Abstract/Free Full Text].
107. Dubreuil RR, Macvicar G, Dissanayake S, Liu C, Homer D, and Hortsch M. Neuroglian-mediated cell adhesion induces assembly of the membrane skeleton at cell contact sites. J Cell Biol 133: 647-655, 1996[Abstract/Free Full Text].
108. Dubreuil RR, Maddux PB, Grushko TA, and MacVicar GR. Segregation of two spectrin isoforms: polarized membrane-binding sites direct polarized membrane skeleton assembly. Mol Biol Cell 8: 1933-1942, 1997[Abstract/Free Full Text].
109. Dubreuil RR, Wang P, Dahl S, Lee J, and Goldstein LS. Drosophila beta spectrin functions independently of alpha spectrin to polarize the Na,K ATPase in epithelial cells. J Cell Biol 149: 647-656, 2000[Abstract/Free Full Text].
110. Dubreuil RR, and Yu J. Ankyrin and beta-spectrin accumulate independently of alpha-spectrin in Drosophila. Proc Natl Acad Sci USA 91: 10285-10289, 1994[Abstract/Free Full Text].
111. Dugandzija-Novakovic S, Koszowski AG, Levinson SR, and Shrager P. Clustering of Na+ channels and node of Ranvier formation in remyelinating axons. J Neurosci 15: 492-503, 1995[Abstract].
112. Eber SW, Gonzalez JM, Lux ML, Scarpa AL, Tse WT, Dornwell M, Herbers J, Kugler W, Ozcan R, Pekrun A, Gallagher PG, Schroter W, Forget BG, and Lux SE. Ankyrin-1 mutations are a major cause of dominant and recessive hereditary spherocytosis. Nat Genet 13: 214-218, 1996[Web of Science][Medline].
113. Einheber S, Zanazzi G, Ching W, Scherer S, Milner TA, Peles E, and Salzer JL. The axonal membrane protein Caspr, a homologue of neurexin IV, is a component of the septate-like paranodal junctions that assemble during myelination. J Cell Biol 139: 1495-1506, 1997[Abstract/Free Full Text].
114. El Ouggouti S, Bournier O, Boivin P, Bertrand O, and Dhermy D. Purification of erythrocyte protein 4.1 by selective interaction with inositol hexaphosphate. Protein Exp Purif 3: 488-496, 1992[Web of Science][Medline].
115. Faivre-Sarrailh C, Gauthier F, Denisenko-Nehrbass N, Le Bivic A, Rougon G, and Girault JA. The glycosylphosphatidyl inositol-anchored adhesion molecule F3/contactin is required for surface transport of paranodin/contactin-associated protein (caspr). J Cell Biol 149: 491-502, 2000[Abstract/Free Full Text].
116. Faix J, Steinmetz M, Boves H, Kammerer RA, Lottspeich F, Mintert U, Murphy J, Stock A, Aebi U, and Gerisch G. Cortexillins, major determinants of cell shape and size, are actin-bundling proteins with a parallel coiled-coil tail. Cell 86: 631-642, 1996[Web of Science][Medline].
117. Falls DL, Rosen KM, Corfas G, Lane WS, and Fischbach GD. Aria, a protein that stimulates acetylcholine receptor synthesis, is a member of the neu ligand family. Cell 72: 801-815, 1993[Web of Science][Medline].
118. Faraday CD, and Spanswick RM. Evidence for a membrane skeleton in higher plants. A spectrin-like polypeptide co-isolates with rice root plasma membranes. FEBS Lett 318: 313-316, 1993[Web of Science][Medline].
119. Fehon RG, Dawson IA, and Artavanistsakonas S. A Drosophila homolog of membrane-skeleton protein-4.1 is associated with septate junctions and is encoded by the coracle gene. Development 120: 545-557, 1994[Abstract].
120. Feo CJ, Fischer S, Piau JP, Grange MJ, and Tchernia G. First instance of the absence of an erythrocyte membrane protein [band 4(1)] in a case of familial elliptocytic anemia. Nouv Rev Fr Hematol 22: 315-325, 1980.
121. Fitzli D, Stoeckli ET, Kunz S, Siribour K, Rader C, Kunz B, Kozlov SV, Buchstaller A, Lane RP, Suter DM, Dreyer WJ, and Sonderegger P. A direct interaction of axonin-1 with NgCAM-related cell adhesion molecule (NrCAM) results in guidance, but not growth of commissural axons. J Cell Biol 149: 951-968, 2000[Abstract/Free Full Text].
122. Flucher BE, and Daniels MP. Distribution of Na+ channels and ankyrin in neuromuscular junctions is complementary to that of acetylcholine receptors and the 43 kD protein. Neuron 3: 163-175, 1989[Web of Science][Medline].
123. Fowler V, and Taylor DL. Spectrin plus band 4.1 cross-link actin. Regulation by micromolar calcium. J Cell Biol 85: 361-376, 1980[Abstract/Free Full Text].
124. Fowler VM. Tropomodulin: a cytoskeletal protein that binds to the end of erythrocyte tropomyosin and inhibits tropomyosin binding to actin. J Cell Biol 111: 471-481, 1990[Abstract/Free Full Text].
125. Fowler VM. Regulation of actin filament length in erythrocytes and striated muscle. Curr Opin Cell Biol 8: 86-96, 1996[Web of Science][Medline].
126. Fowler VM. Capping actin filament growth: tropomodulin in muscle and nonmuscle cells. Soc Gen Physiol Ser 52: 79-89, 1997[Medline].
127. Fowler VM, and Bennett V. Erythrocyte membrane tropomyosin. Purification and properties. J Biol Chem 259: 5978-5989, 1984[Abstract/Free Full Text].
128. Fransen E, Lemmon V, Van Camp G, Vits L, Coucke P, and Willems PJ. Crash syndrome: clinical spectrum of corpus callosum hypoplasia, retardation, adducted thumbs, spastic paraparesis and hydrocephalus due to mutations in one single gene, L1. Eur J Hum Genet 3: 273-284, 1995[Web of Science][Medline].
129. Franzini-Armstrong C, and Protasi F. Ryanodine receptors of striated muscles: a complex channel capable of multiple interactions. Physiol Rev 77: 699-729, 1997[Abstract/Free Full Text].
130. Fukata Y, Oshiro N, Kinoshita N, Kawano Y, Matsuoka Y, Bennett V, Matsuura Y, and Kaibuchi K. Phosphorylation of adducin by Rho-kinase plays a crucial role in cell motility. J Cell Biol 145: 347-361, 1999[Abstract/Free Full Text].
131. Gallagher PG, and Ferriera JD. Molecular basis of erythrocyte membrane disorders. Curr Opin Hematol 4: 128-135, 1997[Medline].
132. Gallagher PG, Tse WT, Scarpa AL, Lux SE, and Forget BG. Structure and organization of the human ankyrin-1 gene. Basis for complexity of premRNA processing. J Biol Chem 272: 19220-19228, 1997[Abstract/Free Full Text].
133. Garcia RA, Vasudevan K, and Buonanno A. The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses. Proc Natl Acad Sci USA 97: 3596-3601, 2000[Abstract/Free Full Text].
134. Gardner K, and Bennett V. A new erythrocyte membrane-associated protein with calmodulin binding activity. Identification and purification. J Biol Chem 261: 1339-1348, 1986[Abstract/Free Full Text].
135. Gardner K, and Bennett V. Modulation of spectrin-actin assembly by erythrocyte adducin. Nature 328: 359-362, 1987[Medline].
136. Garver TD, Ren Q, Tuvia S, and Bennett V. Tyrosine phosphorylation at a site highly conserved in the L1 family of cell adhesion molecules abolishes ankyrin binding and increases lateral mobility of neurofascin. J Cell Biol 137: 703-714, 1997[Abstract/Free Full Text].
137. Gascard P, and Cohen CM. Absence of high-affinity band 4.1 binding sites from membranes of glycophorin C- and D-deficient (Leach phenotype) erythrocytes. Blood 83: 1102-1108, 1994[Abstract/Free Full Text].
138. Gascard P, Nunomura W, Lee G, Walensky LD, Krauss SW, Takakuwa Y, Chasis JA, Mohandas N, and Conboy JG. Deciphering the nuclear import pathway for the cytoskeletal red cell protein 4.1R. Mol Biol Cell 10: 1783-1798, 1999[Abstract/Free Full Text].
139. Gascard P, Pawelczyk T, Lowenstein JM, and Cohen CM. The role of inositol phospholipids in the association of band 4.1 with the human erythrocyte-membrane. Eur J Biochem 211: 671-681, 1993[Web of Science][Medline].
140. Gee SH, Madhavan R, Levinson SR, Caldwell JH, Sealock R, and Froehner SC. Interaction of muscle and brain sodium channels with multiple members of the syntrophin family of dystrophin-associated proteins. J Neurosci 18: 128-137, 1998[Abstract/Free Full Text].
141. Georgatos SD, and Marchesi VT. The binding of vimentin to human erythrocyte membranes: a model system for the study of intermediate filament-membrane interactions. J Cell Biol 100: 1955-1961, 1985[Abstract/Free Full Text].
142. Gilligan DM, Lieman J, and Bennett V. Assignment of the human beta-adducin gene (ADD2) to 2p13-p14 by in situ hybridization. Genomics 28: 610-612, 1995[Web of Science][Medline].
143. Gilligan DM, Lozovatsky L, Gwynn B, Brugnara C, Mohandas N, and Peters LL. Targeted disruption of the beta adducin gene (Add2) causes red blood cell spherocytosis in mice. Proc Natl Acad Sci USA 96: 10717-10722, 1999[Abstract/Free Full Text].
144. Gimm JA, and Mohandas N. Actin-binding motif of protien 4.1, a novel sequence. Mol Biol Cell 10: 776, 1999.
145. Gimona M, and Mital R. The single CH domain of calponin is neither sufficient nor necessary for F-actin binding. J Cell Sci 111: 1813-1821, 1998[Abstract].
146. Glenney JR Jr, Glenney P, Osborn M, and Weber K. An F-actin- and calmodulin-binding protein from isolated intestinal brush borders has a morphology related to spectrin. Cell 28: 843-854, 1982[Web of Science][Medline].
147. Glenney JR Jr, Glenney P, and Weber K. The spectrin-related molecule, TW-260/240, cross-links the actin bundles of the microvillus rootlets in the brush borders of intestinal epithelial cells. J Cell Biol 96: 1491-1496, 1983[Abstract/Free Full Text].
148. Gloor S, Antonicek H, Sweadner KJ, Pagliusi S, Frank R, Moos M, and Schachner M. The adhesion molecule on glia (AMOG) is a homologue of the beta subunit of the Na,K-ATPase. J Cell Biol 110: 165-174, 1990[Abstract/Free Full Text].
149. Goldsmith SC, Pokala N, Shen W, Fedorov AA, Matsudaira P, and Almo SC. The structure of an actin-crosslinking domain from human fimbrin. Nat Struct Biol 4: 708-712, 1997[Web of Science][Medline].
150. Goodearl AD, Yee AG, Sandrock AW Jr, Corfas G, and Fischbach GD. Aria is concentrated in the synaptic basal lamina of the developing chick neuromuscular junction. J Cell Biol 130: 1423-1434, 1995[Abstract/Free Full Text].
151. Goodman SR, Zagon IS, and Kulikowski RR. Identification of a spectrin-like protein in nonerythroid cells. Proc Natl Acad Sci USA 78: 7570-7574, 1981[Abstract/Free Full Text].
152. Greenquist AC, Shohet SB, and Bernstein SE. Marked reduction of spectrinin hereditary spherocytosis in the common house mouse. Blood 51: 1149-1155, 1978[Abstract/Free Full Text].
153. Gregorio CC, Repasky EA, Fowler VM, and Black JD. Dynamic properties of ankyrin in T lymphocytes: colocalization with spectrin and protein kinase C beta. J Cell Biol 125: 345-358, 1994[Abstract/Free Full Text].
154. Gregory SL, and Brown NH. Kakapo, a gene required for adhesion between and within cell layers in Drosophila, encodes a large cytoskeletal linker protein related to plectin and dystrophin. J Cell Biol 143: 1271-1282, 1998[Abstract/Free Full Text].
155. Grum VL, Li D, MacDonald RI, and Mondragon A. Structures of two repeats of spectrin suggest models of flexibility. Cell 98: 523-535, 1999[Web of Science][Medline].
156. Gulley RL, and Reese TS. Cytoskeletal organization at the postsynaptic complex. J Cell Biol 91: 298-302, 1981[Abstract/Free Full Text].
157. Hall TG, and Bennett V. Regulatory domains of erythrocyte ankyrin. J Biol Chem 262: 10537-10545, 1987[Abstract/Free Full Text].
158. Hamada K, Shimizu T, Matsui T, Tsukita S, and Hakoshima T. Structural basis of the membrane-targeting and unmasking mechanisms of the radixin FERM domain. EMBO J 19: 4449-4462, 2000[Web of Science][Medline].
159. Hammarlund M, Davis WS, and Jorgensen EM. Mutations in beta-spectrin disrupt axon outgrowth and sarcomere structure. J Cell Biol 149: 931-942, 2000[Abstract/Free Full Text].
160. Han BG, Nunomura W, Takakuwa Y, Mohandas N, and Jap BK. Protein 4.1R core domain structure and insights into regulation of cytoskeletal organization. Nat Struct Biol 7: 871-875, 2000[Web of Science][Medline].
161. Hanein D, Volkmann N, Goldsmith S, Michon AM, Lehman W, Craig R, Derosier D, Almo S, and Matsudaira P. An atomic model of fimbrin binding to F-actin and its implications for filament crosslinking and regulation. Nat Struct Biol 5: 787-792, 1998[Web of Science][Medline].
162. Harris AS, Croall DE, and Morrow JS. The calmodulin-binding site in alpha-fodrin is near the calcium-dependent protease-I cleavage site. J Biol Chem 263: 15754-15761, 1988[Abstract/Free Full Text].
163. Harris HW Jr, and Lux SE. Structural characterization of the phosphorylation sites of human erythrocyte spectrin. J Biol Chem 255: 11512-11520, 1980[Abstract/Free Full Text].
164. Hartwig JH. Actin-binding proteins. 1. Spectrin super family. Protein Profile 2: 703-800, 1995[Web of Science][Medline].
165. Hassel B, Rathjen FG, and Volkmer H. Organization of the neurofascin gene and analysis of developmentally regulated alternative splicing. J Biol Chem 272: 28742-28749, 1997[Abstract/Free Full Text].
166. Hassoun H, and Palek J. Hereditary spherocytosis: a review of the clinical and molecular aspects of the disease. Blood Rev 10: 129-147, 1996[Web of Science][Medline].
167. Hata Y, Butz S, and Sudhof TC. Cask, a novel DLG/PSD95 homolog with an N-terminal calmodulin-dependent protein-kinase domain identified by interaction with neurexins. J Neurosci 16: 2488-2494, 1996[Abstract/Free Full Text].
168. Hayes NV, Scott C, Heerkens E, Ohanian V, Maggs AM, Pinder JC, Kordeli E, and Baines AJ. Identification of a novel C-terminal variant of betaII spectrin: two isoforms of betaII spectrin have distinct intracellular locations and activities. J Cell Sci 113: 2023-2034, 2000[Abstract].
169. Hemming NJ, Anstee DJ, Mawby WJ, Reid ME, and Tanner MJ. Localization of the protein 4.1-binding site on human erythrocyte glycophorins C and D. Biochem J 299: 191-196, 1994.
170. Hemming NJ, Anstee DJ, Staricoff MA, Tanner MJ, and Mohandas N. Identification of the membrane attachment sites for protein 4.1 in the human erythrocyte. J Biol Chem 270: 5360-5366, 1995[Abstract/Free Full Text].
171. Henkart M, Landis DM, and Reese TS. Similarity of junctions between plasma membranes and endoplasmic reticulum in muscle and neurons. J Cell Biol 70: 338-347, 1976[Abstract/Free Full Text].
172. Herrmann JM, Malkus P, and Schekman R. Out of the ER-outfitters, escorts and guides. Trends Cell Biol 9: 5-7, 1999[Web of Science][Medline].
173. Holleran EA, and Holzbaur EL. Speculating about spectrin: new insights into the Golgi-associated cytoskeleton. Trends Cell Biol 8: 26-29, 1998[Web of Science][Medline].
174. Holleran EA, Tokito MK, Karki S, and Holzbaur EL. Centractin (ARP1) associates with spectrin revealing a potential mechanism to link dynactin to intracellular organelles. J Cell Biol 135: 1815-1829, 1996[Abstract/Free Full Text].
175. Holtzman DA, Wertman KF, and Drubin DG. Mapping actin surfaces required for functional interactions in vivo. J Cell Biol 126: 423-432, 1994[Abstract/Free Full Text].
176. Holzinger A, De Ruijter N, Emons AM, and Lutz-Meindl U. Spectrin-like proteins in green algae (Desmidiaceae). Cell Biol Int 23: 335-344, 1999[Web of Science][Medline].
177. Honts JE, Sandrock TS, Brower SM, O'Dell JL, and Adams AE. Actin mutations that show suppression with fimbrin mutations identify a likely fimbrin-binding site on actin. J Cell Biol 126: 413-422, 1994[Abstract/Free Full Text].
178. Hoock TC, Peters LL, and Lux SE. Isoforms of ankyrin-3 that lack the NH2-terminal repeats associate with mouse macrophage lysosomes. J Cell Biol 136: 1059-1070, 1997[Abstract/Free Full Text].
179. Horne WC, Huang SC, Becker PS, Tang TK, and Benz E Jr. Tissue-specific alternative splicing of protein 4.1 inserts an exon necessary for formation of the ternary complex with erythrocyte spectrin and F-actin. Blood 82: 2558-2563, 1993[Abstract/Free Full Text].
180. Horne WC, Leto TL, and Marchesi VT. Differential phosphorylation of multiple sites in protein 4.1 and protein 4 9 by phorbol ester-activated and cyclic AMP-dependent protein-kinases. J Biol Chem 260: 9073-9076, 1985[Abstract/Free Full Text].
181. Hortsch M. Structural and functional evolution of the L1 family: are four adhesion molecules better than one? Mol Cell Neurosci 15: 1-10, 2000[Web of Science][Medline].
182. Hortsch M, Homer D, Malhotra JD, Chang S, Frankel J, Jefford G, and Dubreuil RR. Structural requirements for outside-in and inside-out signaling by Drosophila neuroglian, a member of the L1 family of cell adhesion molecules. J Cell Biol 142: 251-261, 1998[Abstract/Free Full Text].
183. Hoskins R, Hajnal AF, Harp SA, and Kim SK. The C. elegans vulvar induction gene lin-2 encodes a member of the MAGUK family of cell junction proteins. Development 122: 97-111, 1996[Abstract].
184. Hsueh YP, Wang TF, Yang FC, and Sheng M. Nuclear translocation and transcription regulation by the membrane-associated guanylate kinase CASK/LIN-2. Nature 404: 298-302, 2000[Medline].
185. Hsueh YP, Yang FC, Kharazia V, Naisbitt S, Cohen AR, Weinberg RJ, and Sheng M. Direct interaction of CASK/LIN-2 and syndecan heparan sulfate proteoglycan and their overlapping distribution in neuronal synapses. J Cell Biol 142: 139-151, 1998[Abstract/Free Full Text].
186. Hu J, Moorthy S, and Bennett V. Expression of functional domains of beta G-spectrin disrupts epithelial morphology in cultured cells. J Cell Biol 128: 1069-1080, 1995[Abstract/Free Full Text].
187. Hu J, Watanabe M, and Bennett V. Characterization of human brain cDNA encoding the general isoform of beta-spectrin. J Biol Chem 267: 18715-18722, 1992[Abstract/Free Full Text].
188. Huang JP, Tang CJ, Kou GH, Marchesi VT, Benz E Jr, and Tang TK. Genomic structure of the locus encoding protein 4.1. Structural basis for complex combinational patterns of tissue-specific alternative RNA splicing. J Biol Chem 268: 3758-3766, 1993[Abstract/Free Full Text].
189. Hughes CA, and Bennett V. Adducin: a physical model with implications for function in assembly of spectrin-actin complexes. J Biol Chem 270: 18990-18996, 1995[Abstract/Free Full Text].
190. Hyvonen M, Macias MJ, Nilges M, Oschkinat H, Saraste M, and Wilmanns M. Structure of the binding-site for inositol phosphates in a PH domain. EMBO J 14: 4676-4685, 1995[Web of Science][Medline].
191. Ichimura T, and Ellisman MH. Three-dimensional fine structure of cytoskeletal-membrane interactions at nodes of Ranvier. J Neurocytol 20: 667-681, 1991[Web of Science][Medline].
192. Iida N, Lokeshwar VB, and Bourguignon LY. Mapping the fodrin binding domain in CD45, a leukocyte membrane-associated tyrosine phosphatase. J Biol Chem 269: 28576-28583, 1994[Abstract/Free Full Text].
193. Jacobs MD, and Harrison SC. Structure of an IkappaBalpha/NF-kappaB complex. Cell 95: 749-758, 1998[Web of Science][Medline].
195. Jons T, and Drenckhahn D. Identification of the binding interface involved in linkage of cytoskeletal protein 4.1 to the erythrocyte anion exchanger. EMBO J 11: 2863-2867, 1992[Web of Science][Medline].
196. Jons T, and Drenckhahn D. Anion exchanger 2 (AE2) binds to erythrocyte ankyrin and is colocalized with ankyrin along the basolateral plasma membrane of human gastric parietal cells. Eur J Cell Biol 75: 232-236, 1998[Web of Science][Medline].
197. Jordan C, Puschel B, Koob R, and Drenckhahn D. Identification of a binding motif for ankyrin on the alpha-subunit of Na+,K+- ATPase. J Biol Chem 270: 29971-29975, 1995[Abstract/Free Full Text].
198. Jorgensen AO, Shen AC, Arnold W, McPherson PS, and Campbell KP. The Ca2+-release channel/ryanodine receptor is localized in junctional and corbular sarcoplasmic reticulum in cardiac muscle. J Cell Biol 120: 969-980, 1993[Abstract/Free Full Text].
199. Joseph SK, and Samanta S. Detergent solubility of the inositol trisphosphate receptor in rat brain membranes. Evidence for association of the receptor with ankyrin. J Biol Chem 268: 6477-6486, 1993[Abstract/Free Full Text].
200. Joshi R, and Bennett V. Mapping the domain structure of human erythrocyte adducin. J Biol Chem 265: 13130-13136, 1990[Abstract/Free Full Text].
201. Joshi R, Gilligan DM, Otto E, McLaughlin T, and Bennett V. Primary structure and domain organization of human alpha and beta adducin. J Cell Biol 115: 665-675, 1991[Abstract/Free Full Text].
202. Kaiser HW, O'Keefe E, and Bennett V. Adducin: Ca2+-dependent association with sites of cell-cell contact. J Cell Biol 109: 557-569, 1989[Abstract/Free Full Text].
203. Kalomiris EL, and Bourguignon LY. Mouse T lymphoma cells contain a transmembrane glycoprotein (GP85) that binds ankyrin. J Cell Biol 106: 319-327, 1988[Abstract/Free Full Text].
204. Kamal A, Ying Y, and Anderson RG. Annexin VI-mediated loss of spectrin during coated pit budding is coupled to delivery of LDL to lysosomes. J Cell Biol 142: 937-947, 1998[Abstract/Free Full Text].
205. Kaplan MR, Meyer-Franke A, Lambert S, Bennett V, Duncan ID, Levinson SR, and Barres BA. Induction of sodium channel clustering by oligodendrocytes. Nature 386: 724-728, 1997[Medline].
206. Karakesisoglou I, Yang Y, and Fuchs E. An epidermal plakin that integrates actin and microtubule networks at cellular junctions. J Cell Biol 149: 195-208, 2000[Abstract/Free Full Text].
207. Karinch AM, Zimmer WE, and Goodman SR. The identification and sequence of the actin-binding domain of human red blood cell beta-spectrin. J Biol Chem 265: 11833-11840, 1990[Abstract/Free Full Text].
208. Keep NH, Winder SJ, Moores CA, Walke S, Norwood FL, and Kendrick-Jones JJ. Crystal structure of the actin-binding region of utrophin reveals a head-to-tail dimer. Struct Fold Des 7: 1539-1546, 1999[Medline].
209. Kelly GM, Zelus BD, and Moon RT. Identification of a calcium-dependent calmodulin-binding domain in Xenopus membrane skeleton protein 4.1. J Biol Chem 266: 12469-12473, 1991[Abstract/Free Full Text].
210. Kennedy SP, Warren SL, Forget BG, and Morrow JS. Ankyrin binds to the 15th repetitive unit of erythroid and nonerythroid beta-spectrin. J Cell Biol 115: 267-277, 1991[Abstract/Free Full Text].
211. Kennedy SP, Weed SA, Forget BG, and Morrow JS. A partial structural repeat forms the heterodimer self-association site of all beta-spectrins. J Biol Chem 269: 11400-11408, 1994[Abstract/Free Full Text].
212. Kenwrick S, Watkins A, and Angelis ED. Neural cell recognition molecule L1: relating biological complexity to human disease mutations. Hum Mol Genet 9: 879-886, 2000[Abstract/Free Full Text].
213. Kimura K, Fukata Y, Matsuoka Y, Bennett V, Matsuura Y, Okawa K, Iwamatsu A, and Kaibuchi K. Regulation of the association of adducin with actin filaments by Rho-associated kinase (Rho-kinase) and myosin phosphatase. J Biol Chem 273: 5542-5548, 1998[Abstract/Free Full Text].
214. Koenig E, and Repasky E. A regional analysis of alpha-spectrin in the isolated Mauthner neuron and in isolated axons of the goldfish and rabbit. J Neurosci 5: 705-714, 1985[Abstract].
215. Kohrman DC, Smith AL, Goldin J, Harris MR, and Meisler MH. A missense mutation in the sodium channel Scn8a is responsible for cerebellar ataxia in the mouse mutant jolting. J Neurosci 16: 5993-5999, 1996[Abstract/Free Full Text].
216. Koob R, Zimmermann M, Schoner W, and Drenckhahn D. Colocalization and coprecipitation of ankyrin and Na+,K+-ATPase in kidney epithelial cells. Eur J Cell Biol 45: 230-237, 1988[Web of Science][Medline].
217. Kordeli E, and Bennett V. Distinct ankyrin isoforms at neuron cell bodies and nodes of Ranvier resolved using erythrocyte ankyrin-deficient mice. J Cell Biol 114: 1243-1259, 1991[Abstract/Free Full Text].
218. Kordeli E, Davis J, Trapp B, and Bennett V. An isoform of ankyrin is localized at nodes of Ranvier in myelinated axons of central and peripheral nerves. J Cell Biol 110: 1341-1352, 1990[Abstract/Free Full Text].
219. Kordeli E, Lambert S, and Bennett V. AnkyrinG. A new ankyrin gene with neural-specific isoforms localized at the axonal initial segment and node of Ranvier. J Biol Chem 270: 2352-2359, 1995[Abstract/Free Full Text].
220. Kordeli E, Ludosky MA, Deprette C, Frappier T, and Cartaud J. AnkyrinG is associated with the postsynaptic membrane and the sarcoplasmic reticulum in the skeletal muscle fiber. J Cell Sci 111: 2197-2207, 1998[Abstract].
221. Kotula L, Desilva TM, Speicher DW, and Curtis PJ. Functional characterization of recombinant human red cell alpha-spectrin polypeptides containing the tetramer binding site. J Biol Chem 268: 14788-14793, 1993[Abstract/Free Full Text].
222. Kuhlman PA, and Fowler VM. Purification and characterization of an alpha 1 beta 2 isoform of CapZ from human erythrocytes: cytosolic location and inability to bind to Mg2+ ghosts suggest that erythrocyte actin filaments are capped by adducin. Biochemistry 36: 13461-13472, 1997[Medline].
223. Kuhlman PA, Hughes CA, Bennett V, and Fowler VM. A new function for adducin. Calcium/calmodulin-regulated capping of the barbed ends of actin filaments. J Biol Chem 271: 7986-7991, 1996[Abstract/Free Full Text].
224. Kunimoto M. A neuron-specific isoform of brain ankyrin, 440-kD ankyrinB, is targeted to the axons of rat cerebellar neurons. J Cell Biol 131: 1821-1829, 1995[Abstract/Free Full Text].
225. Kunimoto M, Otto E, and Bennett V. A new 440-kD isoform is the major ankyrin in neonatal rat brain. J Cell Biol 115: 1319-1331, 1991[Abstract/Free Full Text].
226. Lamb RS, Ward RE, Schweizer L, and Fehon RG. Drosophila coracle, a member of the protein 4.1 superfamily, has essential structural functions in the septate junctions and developmental functions in embryonic and adult epithelial cells. Mol Biol Cell 9: 3505-3519, 1998[Abstract/Free Full Text].
227. Lambert S, and Bennett V. Postmitotic expression of ankyrinR and beta R-spectrin in discrete neuronal populations of the rat brain. J Neurosci 13: 3725-3735, 1993[Abstract].
228. Lambert S, Davis JQ, and Bennett V. Morphogenesis of the node of Ranvier: co-clusters of ankyrin and ankyrin-binding integral proteins define early developmental intermediates. J Neurosci 17: 7025-7036, 1997[Abstract/Free Full Text].
229. Lambert S, Yu H, Prchal JT, Lawler J, Ruff P, Speicher D, Cheung MC, Kan YW, and Palek J. cDNA sequence for human erythrocyte ankyrin. Proc Natl Acad Sci USA 87: 1730-1734, 1990[Abstract/Free Full Text].
230. Leclerc E, and Vetter S. Characterization of a calcium-dependent calmodulin-binding domain in the 135-kD human protein 4.1 isoform. Eur J Biochem 258: 567-571, 1998[Web of Science][Medline].
231. Lee JK, Brandin E, Branton D, and Goldstein LS. alpha-Spectrin is required for ovarian follicle monolayer integrity in Drosophila melanogaster. Development 124: 353-362, 1997[Abstract].
232. Lee JK, Coyne RS, Dubreuil RR, Goldstein LS, and Branton D. Cell shape and interaction defects in alpha-spectrin mutants of Drosophila melanogaster. J Cell Biol 123: 1797-1809, 1993[Abstract/Free Full Text].
233. Leon A, and McKearin D. Identification of TER94, an AAA ATPase protein, as a Bam-dependent component of the Drosophila fusome. Mol Biol Cell 10: 3825-3834, 1999[Abstract/Free Full Text].
234. Leto TL, and Marchesi VT. A structural model of human-erythrocyte protein-4.1. J Biol Chem 259: 4603-4608, 1984[Abstract/Free Full Text].
235. Leto TL, Pleasic S, Forget BG, Benz EJ Jr, and Marchesi VT. Characterization of the calmodulin-binding site of nonerythroid alpha-spectrin. Recombinant protein and model peptide studies. J Biol Chem 264: 5826-5830, 1989[Abstract/Free Full Text].
236. Leung CL, Sun D, Zheng M, Knowles DR, and Liem RK. Microtubule actin cross-linking factor (MACF): a hybrid of dystonin and dystrophin that can interact with the actin and microtubule cytoskeletons. J Cell Biol 147: 1275-1286, 2001[Abstract/Free Full Text].
237. Levine J, and Willard M. Fodrin: axonally transported polypeptides associated with the internal periphery of many cells. J Cell Biol 90: 631-642, 1981[Abstract/Free Full Text].
238. Li X, and Bennett V. Identification of the spectrin subunit and domains required for formation of spectrin/adducin/actin complexes. J Biol Chem 271: 15695-15702, 1996[Abstract/Free Full Text].
239. Li X, Matsuoka Y, and Bennett V. Adducin preferentially recruits spectrin to the fast growing ends of actin filaments in a complex requiring the MARCKS-related domain and a newly defined oligomerization domain. J Biol Chem 273: 19329-19338, 1998[Abstract/Free Full Text].
240. Li ZP, Burke EP, Frank JS, Bennett V, and Philipson KD. The cardiac Na+-Ca2+ exchanger binds to the cytoskeletal protein ankyrin. J Biol Chem 268: 11489-11491, 1993[Abstract/Free Full Text].
241. Lin B, Nasir J, McDonald H, Graham R, Rommens JM, Goldberg YP, and Hayden MR. Genomic organization of the human alpha-adducin gene and its alternately spliced isoforms. Genomics 25: 93-99, 1995[Web of Science][Medline].
242. Lin H, and Schagat T. Neuroblasts: a model for the asymmetric division of stem cells. Trends Genet 13: 33-39, 1997[Web of Science][Medline].
243. Lin H, and Spradling AC. The Drosophila fusome, a germline-specific organelle, contains membrane skeletal proteins and functions in cyst formation. Development 120: 947-956, 1994[Abstract].
244. Lin H, and Spradling AC. Fusome asymmetry and oocyte determination in Drosophila. Dev Genet 16: 6-12, 1995[Web of Science][Medline].
245. Ling E, Danilov YN, and Cohen CM. Modulation of red cell band 4.1 function by cAMP-dependent kinase and protein kinase C phosphorylation. J Biol Chem 263: 2209-2216, 1988[Abstract/Free Full Text].
246. Ling E, Gardner K, and Bennett V. Protein kinase C phosphorylates a recently identified membrane skeleton-associated calmodulin-binding protein in human erythrocytes. J Biol Chem 261: 13875-13878, 1986[Abstract/Free Full Text].
247. Liu C, Derick LH, and Palek J. Visualization of the hexagonal lattice in the erythrocyte membrane skeleton. J Cell Biol 104: 527-536, 1987[Abstract/Free Full Text].
248. Lokeshwar VB, and Bourguignon LY. Tyrosine phosphatase activity of lymphoma CD45 (GP180) is regulated by a direct interaction with the cytoskeleton. J Biol Chem 267: 21551-21557, 1992[Abstract/Free Full Text].
249. Lokeshwar VB, Fregien N, and Bourguignon LY. Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function. J Cell Biol 126: 1099-1109, 1994[Abstract/Free Full Text].
250. Lombardo CR, and Low PS. Calmodulin modulates protein-4.1 binding to human erythrocyte membranes. Arch Biochem Biophys 1196: 139-144, 1994.
251. Lombardo CR, Weed SA, Kennedy SP, Forget BG, and Morrow JS. Beta II-spectrin (fodrin) and beta I epsilon 2-spectrin (muscle) contain NH2- and COOH-terminal membrane association domains (MAD1 and MAD2). J Biol Chem 269: 29212-29219, 1994[Abstract/Free Full Text].
252. Lorenz M, Bisikirska B, Hanus-Lorenz B, Strzalka K, and Sikorski AF. Proteins reacting with anti-spectrin antibodies are present in Chlamydomonas cells. Cell Biol Int 19: 83-90, 1995[Web of Science][Medline].
253. Lorenzo F, Dallavenezia N, Morle L, Baklouti F, Alloisio N, Ducluzeau MT, Roda L, Lefrancois P, and Delaunay J. Protein 4.1 deficiency associated with an altered binding to the spectrin-actin complex of the red-cell membrane skeleton. J Clin Invest 94: 1651-1656, 1994.
254. Lukowski S, Lecomte MC, Mira JP, Marin P, Gautero H, Russo-Marie F, and Geny B. Inhibition of phospholipase D activity by fodrin. An active role for the cytoskeleton. J Biol Chem 271: 24164-24171, 1996[Abstract/Free Full Text].
255. Lukowski S, Mira JP, Zachowski A, and Geny B. Fodrin inhibits phospholipases A2, C, and D by decreasing polyphosphoinositide cell content. Biochem Biophys Res Commun 248: 278-284, 1998[Web of Science][Medline].
256. Luna EJ, Kidd GH, and Branton D. Identification by peptide analysis of the spectrin-binding protein in human erythrocytes. J Biol Chem 254: 2526-2532, 1979[Abstract/Free Full Text].
257. Lundberg S, Buevich AV, Sethson I, Edlund U, and Backman L. Calcium-binding mechanism of human nonerythroid alpha-spectrin EF-structures. Biochemistry 36: 7199-7208, 1997[Medline].
258. Lundberg S, Lehto VP, and Backman L. Characterization of calcium-binding to spectrins. Biochemistry 31: 5665-5671, 1992[Medline].
259. Luo L. Trio quartet in D. Neuron 26: 1-2, 2000[Web of Science][Medline].
260. Lux SE, John KM, and Bennett V. Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue-differentiation and cell-cycle control proteins. Nature 344: 36-42, 1990[Medline].
261. Ma Y, Zimmer WE, Riederer BM, Bloom ML, Barker JE, Goodman SR, and Goodman SM. The complete amino acid sequence for brain beta spectrin (beta fodrin): relationship to globin sequences. Brain Res Mol Brain Res 18: 87-99, 1993[Medline].
262. Macias MJ, Musacchio A, Ponstingl H, Nilges M, Saraste M, and Oschkinat H. Structure of the pleckstrin homology domain from beta-spectrin. Nature 369: 675-677, 1994[Medline].
263. Malhotra JD, Kazen-Gillespie K, Hortsch M, and Isom LL. Sodium channel beta subunits mediate homophilic cell adhesion and recruit ankyrin to points of cell-cell contact. J Biol Chem 275: 11383-11388, 2000[Abstract/Free Full Text].
264. Mangeat PH, and Burridge K. Immunoprecipitation of nonerythrocyte spectrin within live cells following microinjection of specific antibodies: relation to cytoskeletal structures. J Cell Biol 98: 1363-1377, 1984[Abstract/Free Full Text].
265. Marchesi SL, Conboy J, Agre P, Letsinger JT, Marchesi VT, Speicher DW, and Mohandas N. Molecular analysis of insertion deletion mutations in protein-4.1 in elliptocytosis. I. Biochemical identification of rearrangements in the spectrin actin binding domain and functional characterizations. J Clin Invest 86: 516-523, 1990.
266. Marfatia SM, Leu RA, Branton D, and Chishti AH. Identification of the protein 4.1 binding interface on glycophorin C and p55, a homologue of the Drosophila discs-large tumor suppressor protein. J Biol Chem 270: 715-719, 1995[Abstract/Free Full Text].
267. Marfatia SM, Lue RA, Branton D, and Chishti AH. In vitro binding-studies suggest a membrane-associated complex between erythroid P55, protein-4.1, and glycophorin-C. J Biol Chem 269: 8631-8634, 1994[Abstract/Free Full Text].
268. Matsuoka Y, Hughes CA, and Bennett V. Adducin regulation. Definition of the calmodulin-binding domain and sites of phosphorylation by protein kinases A and C. J Biol Chem 271: 25157-25166, 1996[Abstract/Free Full Text].
269. Matsuoka Y, Li X, and Bennett V. Adducin is an in vivo substrate for protein kinase C: phosphorylation in the MARCKS-related domain inhibits activity in promoting spectrin-actin complexes and occurs in many cells, including dendritic spines of neurons. J Cell Biol 142: 485-497, 1998[Abstract/Free Full Text].
270. Mattagajasingh SN, Huang SC, Hartenstein JS, and Benz EJ Jr. Characterization of the interaction between protein 4.1R and ZO-2: a possible link between the tight junction and the actin cytoskeleton. J Biol Chem. In press.
271. Mattagajasingh SN, Huang SC, Hartenstein JS, Snyder M, Marchesi VT, and Benz EJ. A nonerythroid isoform of protein 4.1R interacts with the nuclear mitotic apparatus (NuMA) protein. J Cell Biol 145: 29-43, 1999[Abstract/Free Full Text].
272. McCartney BM, and Fehon RG. Distinct cellular and subcellular patterns of expression imply distinct functions for the Drosophila homologues of moesin and the neurofibromatosis 2 tumor suppressor, merlin. J Cell Biol 133: 843-852, 1996[Abstract/Free Full Text].
273. McGough A, Way M, and Derosier D. Determination of the alpha-actinin-binding site on actin filaments by cryoelectron microscopy and image analysis. J Cell Biol 126: 433-443, 1994[Abstract/Free Full Text].
274. McGough AM, and Josephs R. On the structure of erythrocyte spectrin in partially expanded membrane skeletons. Proc Natl Acad Sci USA 7: 5208-5212, 1990.
275. McKearin D. The Drosophila fusome, organelle biogenesis and germ cell differentiation: if you build it. Bioessays 19: 147-152, 1997[Web of Science][Medline].
276. McKeown C, Praitis V, and Austin J. sma-1 encodes a betaH-spectrin homolog required for Caenorhabditis elegans morphogenesis. Development 125: 2087-2098, 1998[Abstract].
277. McNeill H, Ozawa M, Kemler R, and Nelson WJ. Novel function of the cell adhesion molecule uvomorulin as an inducer of cell surface polarity. Cell 62: 309-316, 1990[Web of Science][Medline].
278. Meldolesi J, and Pozzan T. The heterogeneity of ER calcium stores has a key role in nonmuscle cell signaling and function. J Cell Biol 142: 1395-1398, 1998[Free Full Text].
279. Menegoz M, Gaspar P, Lebert M, Galvez T, Burgaya F, Palfrey C, Ezan P, Amos F, and Girault JA. Paranodin, a glycoprotein of neuronal paranodal membranes. Neuron 19: 319-331, 1997[Web of Science][Medline].
280. Michaely P, and Bennett V. The membrane-binding domain of ankyrin contains four independently folded subdomains, each comprised of six ankyrin repeats. J Biol Chem 268: 22703-22709, 1993[Abstract/Free Full Text].
281. Michaely P, and Bennett V. The ANK repeats of erythrocyte ankyrin form two distinct but cooperative binding sites for the erythrocyte anion exchanger. J Biol Chem 270: 22050-22057, 1995[Abstract/Free Full Text].
282. Michaely P, and Bennett V. Mechanism for binding site diversity on ankyrin. Comparison of binding sites on ankyrin for neurofascin and the Cl-/HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> anion exchanger. J Biol Chem 270: 31298-31302, 1995[Abstract/Free Full Text].
283. Michaely P, Kamal A, Anderson RG, and Bennett V. A requirement for ankyrin binding to clathrin during coated pit budding. J Biol Chem 274: 35908-35913, 1999[Abstract/Free Full Text].
284. Michaud D, Guillet G, Rogers PA, and Charest PM. Identification of a 220 kDa membrane-associated plant cell protein immunologically related to human beta-spectrin. FEBS Lett 294: 77-80, 1991[Web of Science][Medline].
285. Mische SM, Mooseker MS, and Morrow JS. Erythrocyte adducin: a calmodulin-regulated actin-bundling protein that stimulates spectrin-actin binding. J Cell Biol 105: 2837-2845, 1987[Abstract/Free Full Text].
286. Mishra L, Cai T, Levine A, Weng D, Mezey E, Mishra B, and Gearhart JJ. Identification of elf1, a beta-spectrin, in early mouse liver development. Int J Dev Biol 42: 221-224, 1998[Web of Science][Medline].
287. Mishra L, Cai T, Yu P, Monga SP, and Mishra B. Elf3 encodes a novel 200-kD beta-spectrin: role in liver development. Oncogene 18: 353-364, 1999[Web of Science][Medline].
288. Missler M, and Sudhof TC. Neurexins: three genes and 1001 products. Trends Genet 14: 20-26, 1998[Web of Science][Medline].
289. Mohandas N, and Evans E. Mechanical properties of the red cell membrane in relation to molecular structure and genetic defects. Annu Rev Biophys Biomol Struct 23: 787-818, 1994[Web of Science][Medline].
290. Molday LL, Cook NJ, Kaupp UB, and Molday RS. The cGMP-gated cation channel of bovine rod photoreceptor cells is associated with a 240-kDa protein exhibiting immunochemical cross-reactivity with spectrin. J Biol Chem 265: 18690-18695, 1990[Abstract/Free Full Text].
291. Moores NH, Keep CA, and Kendrick-Jones J. Structure of the Utrophin actin-binding domain bound to F-actin reveals binding by an induced fit mechanism. J Mol Biol 297: 465-480, 2000[Web of Science][Medline].
292. Moorthy S, Chen L, and Bennett V. Caenorhabditis elegans beta-G spectrin is dispensable for establishment of epithelial polarity, but essential for muscular and neuronal function. J Cell Biol 149: 915-930, 2000[Abstract/Free Full Text].
293. Morgans CW, and Kopito RR. Association of the brain anion exchanger, AE3, with the repeat domain of ankyrin. J Cell Sci 105: 1137-1142, 1993[Abstract].
294. Moriniere M, Ribeiro L, Dalla Venezia N, Deguillien M, Maillet P, Cynober T, Delhommeau F, Almeida H, Tamagnini G, Delaunay J, and Baklouti F. Elliptocytosis in patients with C-terminal domain mutations of protein 4.1 correlates with encoded messenger RNA levels rather than with alterations in primary protein structure. Blood 95: 1834-1841, 2000[Abstract/Free Full Text].
295. Moriyama R, Lombardo CR, Workman RF, and Low PS. Regulation of linkages between the erythrocyte membrane and its skeleton by 2,3-diphosphoglycerate. J Biol Chem 268: 10990-10996, 1993[Abstract/Free Full Text].
296. Morris MB, and Lux SE. Characterization of the binary interaction between human erythrocyte protein-4.1 and actin. Eur J Biochem 231: 644-650, 1995[Web of Science][Medline].
297. Morrow JS, Cianci CD, Ardito T, Mann AS, and Kashgarian M. Ankyrin links fodrin to the alpha subunit of Na,K-ATPase in Madin-Darby canine kidney cells and in intact renal tubule cells. J Cell Biol 108: 455-465, 1989[Abstract/Free Full Text].
298. Musacchio A, Noble M, Pauptit R, Wierenga R, and Saraste M. Crystal structure of a Src-homology 3 (SH3) domain. Nature 359: 851-855, 1992[Medline].
299. Nehls V, Drenckhahn D, Joshi R, and Bennett V. Adducin in erythrocyte precursor cells of rats and humans: expression and compartmentalization. Blood 78: 1692-1696, 1991[Abstract/Free Full Text].
300. Nelson WJ, and Lazarides E. Switching of subunit composition of muscle spectrin during myogenesis in vitro. Nature 304: 364-368, 1983[Medline].
301. Nelson WJ, Shore EM, Wang AZ, and Hammerton RW. Identification of a membrane-cytoskeletal complex containing the cell adhesion molecule uvomorulin (E-cadherin), ankyrin, and fodrin in Madin-Darby canine kidney epithelial cells. J Cell Biol 11: 349-357, 1990.
302. Nelson WJ, and Veshnock PJ. Dynamics of membrane-skeleton (fodrin) organization during development of polarity in Madin-Darby canine kidney epithelial cells. J Cell Biol 103: 1751-1765, 1986[Abstract/Free Full Text].
303. Nelson WJ, and Veshnock PJ. Modulation of fodrin (membrane skeleton) stability by cell-cell contact in Madin-Darby canine kidney epithelial cells. J Cell Biol 104: 1527-1537, 1987[Abstract/Free Full Text].
304. Nelson WJ, and Veshnock PJ. Ankyrin binding to (Na+ + K+)ATPase and implications for the organization of membrane domains in polarized cells. Nature 328: 533-536, 1987[Medline].
305. Nigg E, and Cherry RJ. Dimeric association of band 3 in the erythrocyte membrane demonstrated by protein diffusion measurements. Nature 277: 493-494, 1979[Medline].
306. Nunomura W, Takakuwa Y, Parra M, Conboy JG, and Mohandas N. Ca(2+)-dependent and Ca(2+)-independent calmodulin binding sites in erythrocyte protein 4.1. Implications for regulation of protein 4 1 interactions with transmembrane proteins. J Biol Chem 275: 6360-6367, 2000[Abstract/Free Full Text].
307. Nunomura Takakuwa WY, Parra M, Conboy J, and Mohandas N. Regulation of protein 4.1R, p55, and glycophorin C ternary complex in human erythrocyte membrane. J Biol Chem 275: 24540-24546, 2000[Abstract/Free Full Text].
308. Nunomura W, Takakuwa Y, Tokimitsu R, Krauss SW, Kawashima M, and Mohandas N. Regulation of CD44-protein 4.1 interaction by Ca2+ and calmodulin: implications for modulation of CD44-ankyrin interaction. J Biol Chem 272: 30322-30328, 1997[Abstract/Free Full Text].
309. Ohanian V, Wolfe LC, John KM, Pinder JC, Lux SE, and Gratzer WB. Analysis of the ternary interaction of the red cell membrane skeletal proteins spectrin, actin, and 4.1. Biochemistry 23: 4416-4420, 1984[Medline].
310. Ohara O, Ohara R, Yamakawa H, Nakajima D, and Nakayama M. Characterization of a new beta-spectrin gene which is predominantly expressed in brain. Mol Brain Res 57: 181-192, 1998[Medline].
311. Ohara R, Yamakawa H, Nakayama M, Yuasa S, and Ohara O. Cellular and subcellular localization of a newly identified member of the protein 4.1 family, brain 4 1, in the cerebellum of adult and postnatally developing rats. Brain Res 117: 127-138, 1999.
312. Otsuka AJ, Franco R, Yang B, Shim KH, Tang LZ, Zhang YY, Boontrakulpoontawee P, Jeyaprakash A, Hedgecock E, Wheaton VI, and Sobery A. An ankyrin-related gene (unc-44) is necessary for proper axonal guidance in Caenorhabditis elegans. J Cell Biol 129: 1081-1092, 1995[Abstract/Free Full Text].
313. Otto E, Kunimoto M, McLaughlin T, and Bennett V. Isolation and characterization of cDNAs encoding human brain ankyrins reveal a family of alternatively spliced genes. J Cell Biol 114: 241-253, 1991[Abstract/Free Full Text].
314. Ozaki M, Sasner M, Yano R, Lu HS, and Buonanno A. Neuregulin-beta induces expression of an NMDA-receptor subunit. Nature 390: 691-694, 1997[Medline].
315. Palek J, and Lambert S. Genetics of the red cell membrane skeleton. Semin Hematol 27: 290-332, 1990[Web of Science][Medline].
316. Parra M, Gascard P, Walensky LD, Gimm JA, Blackshaw S, Chan N, Takakuwa Y, Berger T, Lee G, Chasis JA, Snyder SH, Mohandas N, and Conboy JG. Molecular and functional characterization of protein 4.1B, a novel member of the protein 4 1 family with high level, focal expression in brain. J Biol Chem 275: 3247-3255, 2000[Abstract/Free Full Text].
317. Parra M, Gascard P, Walensky LD, Snyder SH, Mohandas N, and Conboy JG. Cloning and characterization of 4.1G (EPB41L2), a new member of the skeletal protein 4 1 (EPB41) gene family. Genomics 49: 298-306, 1998[Web of Science][Medline].
318. Pascua J, Castresana J, and Saraste M. Evolution of the spectrin repeat. Bioessays 19: 811-817, 1997[Web of Science][Medline].
319. Pascual J, Pfuhl M, Walther D, Saraste M, and Nilges M. Solution structure of the spectrin repeat: a left-handed antiparallel triple-helical coiled-coil. J Mol Biol 273: 740-751, 1997[Web of Science][Medline].
320. Pasternack G, Anderson R, Leto TL, and Marchesi VT. Interactions between protein 4.1 and Band 3. J Biol Chem 260: 3676-3683, 1985[Abstract/Free Full Text].
321. Pawson T, and Scott JD. Signaling through scaffold, anchoring, and adaptor proteins. Science 278: 2075-2080, 1997[Abstract/Free Full Text].
322. Pearson MA, Reczek D, Bretscher A, and Karplus PA. Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain. Cell 101: 259-270, 2000[Web of Science][Medline].
323. Pedroni S, Lecomte MC, Gautero H, and Speicher DW. Characterization of the phosphorylation sites of human erythrocyte spectrin. Mol Biol Cell 6: 1569-1569, 1995[Web of Science].
324. Peles E, Nativ M, Lustig M, Grumet M, Schilling J, Martinez R, Plowman GD, and Schlessinger J. Identification of a novel contactin-associated transmembrane receptor with multiple domains implicated in protein-protein interactions. EMBO J 16: 978-988, 1997[Web of Science][Medline].
325. Pesacreta TC, Byers TJ, Dubreuil R, Kiehart DP, and Branton D. Drosophila spectrin: the membrane skeleton during embryogenesis. J Cell Biol 108: 1697-1709, 1989[Abstract/Free Full Text].
326. Peters LL, Birkenmeier CS, Bronson RT, White RA, Lux SE, Otto E, Bennett V, Higgins A, and Barker JE. Purkinje cell degeneration associated with erythroid ankyrin deficiency in nb/nb mice. J Cell Biol 114: 1233-1241, 1991[Abstract/Free Full Text].
327. Peters LL, John KM, Lu FM, Eicher EM, Higgins A, Yialamas M, Turtzo LC, Otsuka AJ, and Lux SE. Ank3 (epithelial ankyrin), a widely distributed new member of the ankyrin gene family and the major ankyrin in kidney, is expressed in alternatively spliced forms, including forms that lack the repeat domain. J Cell Biol 130: 313-330, 1995[Abstract/Free Full Text].
328. Peters LL, Weier HU, Walensky LD, Snyder SH, Parra M, Mohandas N, and Conboy JG. Four paralogous protein 4.1 genes map to distinct chromosomes in mouse and human. Genomics 54: 348-350, 1998[Web of Science][Medline].
329. Pinder JC, Gardner B, and Gratzer WB. Interaction of protein-4.1 with the red-cell membrane: effects of phosphorylation by protein-kinase-C. Biochem Biophys Res Commun 210: 478-482, 1995[Web of Science][Medline].
330. Pinder JC, and Gratzer WB. Structural and dynamic states of actin in the erythrocyte. J Cell Biol 96: 768-775, 1983[Abstract/Free Full Text].
331. Pinder JC, Ohanian V, and Gratzer WB. Spectrin and protein 4.1 as an actin filament capping complex. FEBS Lett 169: 161-164, 1984[Web of Science][Medline].
332. Pinder JC, Pekrun A, Maggs AM, Brain AP, and Gratzer WB. Association state of human red blood cell band 3 and its interaction with ankyrin. Blood 85: 2951-2961, 1995[Abstract/Free Full Text].
333. Pinder JC, Ungewickell E, Bray D, and Gratzer WB. The spectrin-actin complex and erythrocyte shape. J Supramol Struct 8: 439-445, 1978[Web of Science][Medline].
334. Pinto-Correia C, Goldstein EG, Bennett V, and Sobel JS. Immunofluorescence localization of an adducin-like protein in the chromosomes of mouse oocytes. Dev Biol 146: 301-311, 1991[Web of Science][Medline].
335. Poliak S, Gollan L, Martinez R, Custer A, Einheber S, Salzer JL, Trimmer JS, Shrager P, and Peles E. Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channels. Neuron 24: 1037-1047, 1999[Web of Science][Medline].
336. Pollard TD. Purification of a high molecular weight actin filament gelation protein from Acanthamoeba that shares antigenic determinants with vertebrate spectrins. J Cell Biol 99: 1970-1980, 1984[Abstract/Free Full Text].
337. Pollerberg GE, Burridge K, Krebs KE, Goodman SR, and Schachner M. The 180-kD component of the neural cell adhesion molecule N-CAM is involved in a cell-cell contacts and cytoskeleton-membrane interactions. Cell Tissue Res 250: 227-236, 1987[Web of Science][Medline].
338. Porter GA, Scher MG, Resneck WG, Porter NC, Fowler VM, and Bloch RJ. Two populations of beta-spectrin in rat skeletal muscle. Cell Motil Cytoskeleton 37: 7-19, 1997[Web of Science][Medline].
339. Rasband MN, Trimmer JS, Peles E, Levinson SR, and Shrager P. K+ channel distribution and clustering in developing and hypomyelinated axons of the optic nerve. J Neurocytol 28: 319-331, 1999[Web of Science][Medline].
340. Rebecchi MJ, and Scarlata S. Pleckstrin homology domains: a common fold with diverse functions. Annu Rev Biophys Biomol Struct 27: 503-528, 1998[Web of Science][Medline].
341. Reid ME, Takakuwa Y, Conboy J, Tchernia G, and Mohandas N. Glycophorin C content of human erythrocyte membrane is regulated by protein 4.1. Blood 75: 2229-2234, 1990[Abstract/Free Full Text].
342. Ren Q, and Bennett V. Palmitoylation of neurofascin at a site in the membrane-spanning domain highly conserved among the L1 family of cell adhesion molecules. J Neurochem 70: 1839-1849, 1998[Web of Science][Medline].
343. Repasky EA, Granger BL, and Lazarides E. Widespread occurrence of avian spectrin in nonerythroid cells. Cell 29: 821-833, 1982[Web of Science][Medline].
344. Repasky EA, Symer DE, and Bankert RB. Spectrin immunofluorescence distinguishes a population of naturally capped lymphocytes in situ. J Cell Biol 99: 350-355, 1984[Abstract/Free Full Text].
345. Riederer BM, Zagon IS, and Goodman SR. Brain spectrin(240/235) and brain spectrin(240/235E): two distinct spectrin subtypes with different locations within mammalian neural cells. J Cell Biol 102: 2088-2097, 1986[Abstract/Free Full Text].
346. Rief M, Pascual J, Saraste M, and Gaub HE. Single molecule force spectroscopy of spectrin repeats: low unfolding forces in helix bundles. J Mol Biol 286: 553-561, 1999[Web of Science][Medline].
347. Rieff HI, Raetzman LT, Sapp DW, Yeh HH, Siegel RE, and Corfas G. Neuregulin induces GABA(A) receptor subunit expression and neurite outgrowth in cerebellar granule cells. J Neurosci 19: 10757-10766, 1999[Abstract/Free Full Text].
348. Rodriguez MM, Ron D, Touhara K, Chen CH, and Mochly-Rosen D. Rack1, a protein kinase C anchoring protein, coordinates the binding of activated protein kinase C and select pleckstrin homology domains in vitro. Biochemistry 38: 13787-13794, 1999[Medline].
349. Rotin D, Bar-Sagi D, O'Brodovich H, Merilainen J, Lehto VP, Canessa CM, Rossier BC, and Downey GP. An SH3 binding region in the epithelial Na+ channel (alpha rENaC) mediates its localization at the apical membrane. EMBO J 13: 4440-4450, 1994[Web of Science][Medline].
350. Rutishauser U. Defining a role and mechanism for IgCAM function in vertebrate axon guidance. J Cell Biol 149: 757-760, 2000[Abstract/Free Full Text].
351. Rybakova IN, Amann KJ, and Ervasti JM. A new model for the interaction of dystrophin with F-actin. J Cell Biol 135: 661-672, 1996[Abstract/Free Full Text].
352. Sadqi M, Casares S, Abril MA, Lopez-Mayorga O, Conejero-Lara F, and Freire E. The native state conformational ensemble of the SH3 domain from alpha-spectrin. Biochemistry 38: 8899-8906, 1999[Medline].
353. Sahr KE, Laurila P, Kotula L, Scarpa AL, Coupal E, Leto TL, Linnenbach AJ, Winkelmann JC, Speicher DW, and Marchesi VT. The complete cDNA and polypeptide sequences of human erythroid alpha-spectrin. J Biol Chem 265: 4434-4443, 1990[Abstract/Free Full Text].
354. Sakaguchi G, Orita S, Naito A, Maeda M, Igarashi H, Sasaki T, and Takai Y. A novel brain-specific isoform of beta spectrin: isolation and its interaction with Munc13. Biochem Biophys Res Commun 248: 846-851, 1998[Web of Science][Medline].
355. Sandrock AW Jr, Goodearl AD, Yin QW, Chang D, and Fischbach GD. Aria is concentrated in nerve terminals at neuromuscular junctions and at other synapses. J Neurosci 15: 6124-6136, 1995[Abstract].
356. Schott JJ, Charpentier F, Peltier S, Foley P, Drouin E, Bouhour JB, Marec HL, Pascal O, Donnelly P, Vergnaud G, Bachner L, and Moisan JP. Mapping of a gene for long QT syndrome to chromosome 4q25-27. Am J Hum Genet 57: 1114-1122, 1995[Web of Science][Medline].
357. Schultz J, Hoffmuller U, Krause G, Ashurst J, Macias PMJ, Schmieder P, Schneider-Mergener J, and Oschkinat H. Specific interactions between the syntrophin PDZ domain and voltage-gated sodium channels. Nat Struct Biol 5: 19-24, 1998[Web of Science][Medline].
358. Scotland P, Zhou D, Benveniste H, and Bennett V. Nervous system defects of AnkyrinB (-/-) mice suggest functional overlap between the cell adhesion molecule L1 and 440-kDAnkyrinB in premyelinated axons. J Cell Biol 143: 1305-1315, 1998[Abstract/Free Full Text].
359. Sedgwick SG, and Smerdon SJ. The ankyrin repeat: a diversity of interactions on a common structural framework. Trends Biochem Sci 24: 311-316, 1999[Web of Science][Medline].
360. Shen BW, Josephs R, and Steck TL. Ultrastructure of the intact skeleton of the human erythrocyte membrane. J Cell Biol 102: 997-1006, 1986[Abstract/Free Full Text].
361. Shi ZT, Afzal V, Coller B, Patel D, Chasis JA, Parra M, Lee G, Paszty C, Stevens M, Walensky L, Peters LL, Mohandas N, Rubin E, and Conboy JG. Protein 4.1R-deficient mice are viable but have erythroid membrane skeleton abnormalities. J Clin Invest 103: 331-340, 1999[Web of Science][Medline].
362. Shotton DM, Burke BE, and Branton D. The molecular structure of human erythrocyte spectrin. Biophysical and electron microscopic studies. J Mol Biol 131: 303-329, 1979[Web of Science][Medline].
363. Sikorski AF, Sangerman J, Goodman SR, and Critz SD. Spectrin (betaSpIIsigma1) is an essential component of synaptic transmission. Brain Res 852: 161-166, 2000[Web of Science][Medline].
364. Sikorski AF, Swat W, Brzezinska M, Wroblewski Z, and Bisikirska B. A protein cross-reacting with anti-spectrin antibodies is present in higher plant cells. Z Naturforsch 48: 580-583, 1993.
365. Sikorski AF, Terlecki G, Zagon IS, and Goodman SR. Synapsin I-mediated interaction of brain spectrin with synaptic vesicles. J Cell Biol 114: 313-318, 1991[Abstract/Free Full Text].
366. Speicher DW, Desilva TM, Speicher KD, Ursitti JA, Hembach P, and Weglarz L. Location of the human red cell spectrin tetramer binding site and detection of a related "closed" hairpin loop dimer using proteolytic footprinting. J Biol Chem 268: 4227-4235, 1993[Abstract/Free Full Text].
367. Speicher DW, and Marchesi VT. Erythrocyte spectrin is comprised of many homologous triple helical segments. Nature 311: 177-180, 1984[Medline].
368. Speicher DW, Weglarz L, and Desilva TM. Properties of human red cell spectrin heterodimer (side-to-side) assembly and identification of an essential nucleation site. J Biol Chem 267: 14775-14782, 1992[Abstract/Free Full Text].
369. Srinivasan Y, Elmer L, Davis J, Bennett V, and Angelides K. Ankyrin and spectrin associate with voltage-dependent sodium channels in brain. Nature 333: 177-180, 1988[Medline].
370. Srinivasan Y, Lewallen M, and Angelides K. Mapping the binding site on ankyrin for the voltage-dependent sodium channel from brain. J Biol Chem 267: 7483-7489, 1992[Abstract/Free Full Text].
371. Stabach PR, and Morrow JS. Identification and characterization of beta V spectrin, a mammalian ortholog of Drosophila beta H spectrin. J Biol Chem 275: 21385-21395, 2000[Abstract/Free Full Text].
372. Stankewich MC, Tse WT, Peters LL, Ch'ng Y, John KM, Stabach PR, Devarajan P, Morrow JS, and Lux SE. A widely expressed betaIII spectrin associated with Golgi and cytoplasmic vesicles. Proc Natl Acad Sci USA 95: 14158-14163, 1998[Abstract/Free Full Text].
373. Steiner JP, and Bennett V. Ankyrin-independent membrane protein-binding sites for brain and erythrocyte spectrin. J Biol Chem 263: 14417-14425, 1988[Abstract/Free Full Text].
374. Steiner JP, Walke HT Jr, and Bennett V. Calcium/calmodulin inhibits direct binding of spectrin to synaptosomal membranes. J Biol Chem 264: 2783-2791, 1989[Abstract/Free Full Text].
375. Steven R, Kubiseski TJ, Zheng H, Kulkarni S, Mancillas J, Ruiz Morales A, Hogue CW, Pawson T, and Culotti J. Unc-73 activates the Rac GTPase and is required for cell and growth cone migrations in C. elegans. Cell 92: 785-795, 1998[Web of Science][Medline].
376. Subrahmanyam G, Berticsand PJ, and Anderson RA. Phosphorylation of protein 4.1 on tyrosine-418 modulates its function in vitro. Proc Natl Acad Sci USA 88: 5222-5226, 1991[Abstract/Free Full Text].
377. Suriyapperuma SP, Lozovatsky L, Ciciotte SL, Peters LL, and Gilligan DM. The mouse adducin gene family: alternative splicing and chromosomal localization. Mamm Genome 11: 16-23, 2000[Web of Science][Medline].
378. Takei K, Shin RM, Inoue T, Kato K, and Mikoshiba K. Regulation of nerve growth mediated by inositol 1,4,5-trisphosphate receptors in growth cones. Science 282: 1705-1708, 1998[Abstract/Free Full Text].
379. Tanaka T, Kadowaki K, Lazarides E, and Sobue K. Ca2+-dependent regulation of the spectrin actin interaction by calmodulin and protein 4.1. J Biol Chem 266: 1134-1140, 1991[Abstract/Free Full Text].
380. Tang CJC, and Tang TK. The 30-kD domain of protein 4.1 mediates its binding to the carboxyl terminus of pICln, a protein involved in cellular volume regulation. Blood 92: 1442-1447, 1998[Abstract/Free Full Text].
381. Tanner MJ. The structure and function of band 3 (AE1): recent developments (review). Mol Membr Biol 14: 155-165, 1997[Web of Science][Medline].
382. Taylor KA, and Taylor DW. Formation of two-dimensional complexes of F-actin and crosslinking proteins on lipid monolayers: demonstration of unipolar alpha-actinin-F-actin crosslinking. Biophys J 67: 1976-1983, 1994[Web of Science][Medline].
383. Tchernia G, Mohandas N, and Shohet SB. Deficiency of skeletal membrane protein band 4.1 in homozygous hereditary elliptocytosis. Implications for erythrocyte membrane stability. J Clin Invest 68: 454-460, 1981.
384. Telen MJ, Le Van Kim C, Chung A, Cartron JP, and Colin Y. Molecular basis for elliptocytosis associated with glycophorin C and D deficiency in the Leach phenotype. Blood 78: 1603-1606, 1991[Abstract/Free Full Text].
385. Thevananther S, Kolli AH, and Devarajan P. Identification of a novel ankyrin isoform (AnkG190) in kidney and lung that associates with the plasma membrane and binds alpha-Na,K-ATPase. J Biol Chem 273: 23952-23058, 1998[Abstract/Free Full Text].
386. Thomas GH, and Kiehart DP. Beta heavy-spectrin has a restricted tissue and subcellular distribution during Drosophila embryogenesis. Development 120: 2039-2050, 1994[Abstract].
387. Thomas GH, Newbern EC, Korte CC, Bales MA, Muse SV, Clark AG, and Kiehart DP. Intragenic duplication and divergence in the spectrin superfamily of proteins. Mol Biol Evol 14: 1285-1295, 1997[Abstract].
388. Thomas GH, Zarnescu DC, Juedes AE, Bales MA, Londergan A, Korte CC, and Kiehart DP. Drosophila beta heavy-spectrin is essential for development and contributes to specific cell fates in the eye. Development 125: 2125-2134, 1998[Abstract].
389. Tisminetzky S, Devescovi G, Tripodi G, Muro A, Bianchi G, Colombi M, Moro L, Barlati S, Tuteja R, and Baralle FE. Genomic organisation and chromosomal localisation of the gene encoding human beta adducin. Gene 167: 313-316, 1995[Web of Science][Medline].
390. Trapp BD, Andrews SB, Wong A, O'Connell M, and Griffin JW. Co-localization of the myelin-associated glycoprotein and the microfilament components, F-actin and spectrin, in Schwann cells of myelinated nerve fibres. J Neurocytol 18: 47-60, 1989[Web of Science][Medline].
391. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, and Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338: 278-285, 1998[Abstract/Free Full Text].
392. Trave G, Lacombe PJ, Pfuhl M, Saraste M, and Pastore A. Molecular mechanism of the calcium-induced conformational change in the spectrin EF-hands. EMBO J 14: 4922-4931, 1995[Web of Science][Medline].
393. Trave G, Pastore A, Hyvonen M, and Saraste M. The C-terminal domain of alpha-spectrin is structurally related to calmodulin. Eur J Biochem 227: 35-42, 1995[Web of Science][Medline].
394. Tschopp J, Martinon F, and Hofmann K. Apoptosis: silencing the death receptors. Curr Biol 9: R381-R384, 1999[Web of Science][Medline].
395. Tse WT, Lecomte MC, Costa FF, Garbarz M, Feo C, Boivin P, Dhermy D, and Forget BG. Point mutation in the beta-spectrin gene associated with alpha I/74 hereditary elliptocytosis. Implications for the mechanism of spectrin dimer self-association. J Clin Invest 86: 909-916, 1990.
396. Tse WT, and Lux SE. Red blood cell membrane disorders. Br J Hematol 104: 2-13, 1999[Web of Science][Medline].
397. Tuvia S, Buhusi M, Davis L, Reedy M, and Bennett V. Ankyrin-B is required for intracellular sorting of structurally diverse Ca2+ homeostasis proteins. J Cell Biol 147: 995-1008, 1999[Abstract/Free Full Text].
398. Tuvia S, Garver TD, and Bennett V. The phosphorylation state of the FIGQY tyrosine of neurofascin determines ankyrin-binding activity and patterns of cellsegregation. Proc Natl Acad Sci USA 94: 12957-12962, 1997[Abstract/Free Full Text].
399. Tyler JM, Hargreaves DR, and Branton D. Purification of two spectrin-binding proteins: biochemical and electron microscopic evidence for site-specific reassociation between spectrin and bands 2.1 and 4.1. Proc Natl Acad Sci USA 76: 5192-5196, 1979[Abstract/Free Full Text].
400. Tyler JM, Reinhardt BN, and Branton D. Associations of erythrocyte membrane proteins. Binding of purified bands 2.1 and 4.1 to spectrin. J Biol Chem 255: 7034-7039, 1980[Abstract/Free Full Text].
401. Ungewickell E, Bennett PM, Calvert R, Ohanian V, and Gratzer WB. In vitro formation of a complex between cytoskeleton proteins of the human erythrocyte. Nature 280: 811-814, 1979[Medline].
402. Ursitti JA, and Fowler VM. Immunolocalization of tropomodulin, tropomyosin and actin in spread human erythrocyte skeletons. J Cell Sci 107: 1633-1639, 1994[Abstract].
403. Ursitti JA, Kotula L, Desilva TM, Curtis PJ, and Speicher DW. Mapping the human erythrocyte beta-spectrin dimer initiation site using recombinant peptides and correlation of its phasing with the alpha-actinin dimer site. J Biol Chem 271: 6636-6644, 1996[Abstract/Free Full Text].
404. Vabnick I, Novakovic SD, Levinson SR, Schachner M, and Shrager P. The clustering of axonal sodium channels during development of the peripheral nervous system. J Neurosci 16: 4914-4922, 1996[Abstract/Free Full Text].
405. Van Camp G, Fransen E, Vits L, Raes G, and Willems PJ. A locus-specific mutation database for the neural cell adhesion molecule L1CAM (Xq28). Hum Mutat 8: 391, 1996[Web of Science][Medline].
406. Vasilescu V, and Filip DA. The Ranvier node as a chemo-electric pulsatory unit: a study of its structure-functions relations. Physiologie 16: 83-91, 1979[Medline].
407. Vertel BM, Walters LM, and Mills D. Subcompartments of the endoplasmic reticulum. Semin Cell Biol 3: 325-341, 1992[Medline].
408. Viel A. Alpha-actinin and spectrin structures: an unfolding family story. FEBS Lett 460: 391-394, 1999[Web of Science][Medline].
409. Viel A, and Branton D. Interchain binding at the tail end of the Drosophila spectrin molecule. Proc Natl Acad Sci USA 91: 10839-10843, 1994[Abstract/Free Full Text].
410. Viel A, and Branton D. Spectrin: on the path from structure to function. Curr Opin Cell Biol 8: 49-55, 1996[Web of Science][Medline].
411. Viel A, Gee MS, Tomooka L, and Branton D. Motifs involved in interchain binding at the tail-end of spectrin. Biochim Biophys Acta 1384: 396-404, 1998[Medline].
412. Walensky LD, Blackshaw S, Liao D, Watkins CC, Weier HU, Parra M, Huganir RL, Conboy JG, Mohandas N, and Snyder SH. A novel neuron-enriched homolog of the erythrocyte membrane cytoskeletal protein 4.1. J Neurosci 19: 6457-6467, 1999[Abstract/Free Full Text].
413. Walensky LD, Shi ZT, Blackshaw S, Devries AC, Demas GE, Gascard P, Nelson RJ, Conboy JG, Rubin EM, Snyder SH, and Mohandas N. Neurobehavioral deficits in mice lacking the erythrocyte membrane cytoskeletal protein 4.1. Curr Biol 8: 1269-1272, 1998[Web of Science][Medline].
414. Wallis C, Wenegieme E, and Babitch J. Characterization of calcium binding to brain spectrin. J Biol Chem 267: 4333-4337, 1992[Abstract/Free Full Text].
415. Wang DS, Miller R, Shaw R, and Shaw G. The pleckstrin homology domain of human beta I sigma II spectrin is targeted to the plasma membrane in vivo. Biochem Biophys Res Commun 225: 420-426, 1996[Web of Science][Medline].
416. Wang DS, and Shaw G. The association of the C-terminal region of beta I sigma II spectrin to brain membranes is mediated by a PH domain, does not require membrane proteins, and coincides with a inositol-1,4,5 triphosphate binding site. Biochem Biophys Res Commun 217: 608-615, 1995[Web of Science][Medline].
417. Ward RE, and Fehon RG. Structure/function analysis of Drosophila coracle, a protein 4.1 homologue required for morphogenesis and cell proliferation. Mol Biol Cell 7: 3521-3521, 1996[Web of Science].
418. Ward RE, Lamb RS, and Fehon RG. A conserved functional domain of Drosophila coracle is required for localization at the septate junction and has membrane-organizing activity. J Cell Biol 140: 1463-1473, 1998[Abstract/Free Full Text].
419. Wasenius VM, Saraste M, Salven P, Eramaa M, Holm L, and Lehto VP. Primary structure of the brain alpha-spectrin. J Cell Biol 108: 79-93, 1989[Abstract/Free Full Text].
420. Watanabe T, Inui M, Chen BY, Iga M, and Sobue K. Annexin VI-binding proteins in brain. Interaction of annexin VI with a membrane skeletal protein, calspectin (brain spectrin or fodrin). J Biol Chem 269: 17656-17662, 1994[Abstract/Free Full Text].
421. Weber A, Pennise CR, Babcock GG, and Fowler VM. Tropomodulin caps the pointed ends of actin filaments. J Cell Biol 127: 1627-1635, 1994[Abstract/Free Full Text].
422. Wechsler A, and Teichberg VI. Brain spectrin binding to the NMDA receptor is regulated by phosphorylation, calcium and calmodulin. EMBO J 17: 3931-3939, 1998[Web of Science][Medline].
423. Whittaker KL, Ding D, Fisher WW, and Lipshitz HD. Different 3'-untranslated regions target alternatively processed hu-li tai shao (hts) transcripts to distinct cytoplasmic locations during Drosophila oogenesis. J Cell Sci 112: 3385-3398, 1999[Abstract].
424. Willardson BM, Thevenin BJ, Harrison ML, Benson WB, Low MD, and Low PS. Localization of the ankyrin-binding site on erythrocyte membrane protein, band 3. J Biol Chem 264: 15893-15899, 1989[Abstract/Free Full Text].
425. Winckler B, Forscher P, and Mellman I. A diffusion barrier maintains distribution of membrane proteins in polarized neurons. Nature 397: 698-701, 1999[Medline].
426. Winder SJ, Hemmings L, Maciver SK, Bolton SJ, Tinsley JM, Davies KE, Critchley DR, and Kendrick-Jones J. Utrophin actin binding domain: analysis of actin binding and cellular targeting. J Cell Sci 108: 63-71, 1995[Abstract].
427. Winkelmann JC, Chang JG, Tse WT, Scarpa AL, Marchesi VT, and Forget BG. Full-length sequence of the cDNA for human erythroid beta-spectrin. J Biol Chem 265: 11827-11832, 1990[Abstract/Free Full Text].
428. Winkelmann JC, Costa FF, Linzie BL, and Forget BG. Beta spectrin in human skeletal muscle. Tissue-specific differential processing of 3' beta spectrin premRNA generates a beta spectrin isoform with a unique carboxyl terminus. J Biol Chem 265: 20449-20454, 1990[Abstract/Free Full Text].
429. Winkelmann JC, and Forget BG. Erythroid and nonerythroid. Blood 81: 3173-3185, 1993[Abstract/Free Full Text].
430. Wollner DA, and Catterall WA. Localization of sodium channels in axon hillocks and initial segments of retinal ganglion cells. Proc Natl Acad Sci USA 83: 8424-8428, 1986[Abstract/Free Full Text].
431. Wood SJ, and Slater CR. Beta-spectrin is colocalized with voltage-gated sodium channels and ankyrinG at the adult rat neuromuscular junction. J Cell Biol 140: 675-684, 1998[Abstract/Free Full Text].
432. Xu J, Ziemnicka D, Merz GS, and Kotula L. Human spectrin src homology 3 domain binding protein 1 regulates macropinocytosis in NIH 3T3 cells. J Cell Sci 113: 3805-3814, 2000[Abstract].
433. Yamamoto K, Merry AC, and Sima AA. An orderly development of paranodal axoglial junctions and bracelets of Nageotte in the rat sural nerve. Brain Res 96: 36-45, 1996.
434. Yan Y, Winograd E, Viel A, Cronin T, Harrison SC, and Branton D. Crystal structure of the repetitive segments of spectrin. Science 262: 2027-2030, 1993[Abstract/Free Full Text].
435. Yang Y, Bauer C, Strasser G, Wollman R, Julien JP, and Fuchs E. Integrators of the cytoskeleton that stabilize microtubules. Cell 98: 229-238, 1999[Web of Science][Medline].
436. Yang Y, Dowling J, Yu QC, Kouklis P, Cleveland DW, and Fuchs E. An essential cytoskeletal linker protein connecting actin microfilaments to intermediate filaments. Cell 86: 655-665, 1996[Web of Science][Medline].
437. Ye K, Compton DA, Lai MM, Walensky LD, and Snyder SH. Protein 4.1N binding to nuclear mitotic apparatus protein in PC12 cells mediates the antiproliferative actions of nerve growth factor. J Neurosci 19: 10747-10756, 1999[Abstract/Free Full Text].
438. Yeaman C, Grindstaff KK, and Nelson WJ. New perspectives on mechanisms involved in generating epithelial cell polarity. Physiol Rev 79: 73-98, 1999[Abstract/Free Full Text].
439. Yi SJ, Liu SC, Derick LH, Murray J, Barker JE, Cho MR, Palek J, and Golan DE. Red cell membranes of ankyrin-deficient nb/nb mice lack band 3 tetramers but contain normal membrane skeletons. Biochemistry 36: 9596-9604, 1997[Medline].
440. Yu J, Fischman DA, and Steck TL. Selection solubilization of proteins and phospholipids from red blood cell membranes by nonionic detergents. J Supramol Struct 1: 233-248, 1973[Medline].
441. Yu J, and Goodman SR. Syndeins: the spectrin-binding protein(s) of the human erythrocyte membrane. Proc Natl Acad Sci USA 76: 2340-2344, 1979[Abstract/Free Full Text].
442. Yu J, and Steck TL. Isolation and characterization of band 3, the predominant polypeptide of the human erythrocyte membrane. J Biol Chem 250: 9170-9175, 1975[Abstract/Free Full Text].
443. Yuan LL, and Ganetzky B. A glial-neuronal signaling pathway revealed by mutations in a neurexin-related protein. Science 283: 1343-1345, 1999[Abstract/Free Full Text].
444. Yue L, and Spradling AC. Hu-li tai shao, a gene required for ring canal formation during Drosophila oogenesis, encodes a homolog of adducin. Genes Dev 6: 2443-2454, 1992[Abstract/Free Full Text].
445. Zaccai M, and Lipshitz HD. Role of Adducin-like (hu-li tai shao) mRNA and protein localization in regulating cytoskeletal structure and function during Drosophila oogenesis and early embryogenesis. Dev Genet 19: 249-257, 1996[Web of Science][Medline].
446. Zarnescu DC, and Thomas GH. Apical spectrin is essential for epithelial morphogenesis but not apicobasal polarity in Drosophila. J Cell Biol 146: 1075-1086, 1999[Abstract/Free Full Text].
447. Zhang P, Talluri S, Deng H, Branton D, and Wagner G. Solution structure of the pleckstrin homology domain of Drosophila beta-spectrin. Structure 3: 1185-1195, 1995[Medline].
448. Zhang X, and Bennett V. Identification of O-linked N-acetylglucosamine modification of ankyrinG isoforms targeted to nodes of Ranvier. J Biol Chem 271: 31391-31398, 1996[Abstract/Free Full Text].
449. Zhang X, and Bennett V. Restriction of 480/270 kD ankyrin-G to axon proximal segments requires multiple ankyrin-G-specific domains. J Cell Biol 142: 1571-1581, 1998[Abstract/Free Full Text].
450. Zhang X, Davis JQ, Carpenter S, and Bennett V. Structural requirements for association of neurofascin with ankyrin. J Biol Chem 273: 30785-30794, 1998[Abstract/Free Full Text].
451. Zhang Z, Devarajan P, Dorfman AL, and Morrow JS. Structure of the ankyrin-binding domain of alpha-Na,K-ATPase. J Biol Chem 273: 18681-18684, 1998[Abstract/Free Full Text].
452. Zhou D, Birkenmeier CS, Williams MW, Sharp JJ, Barker JE, and Bloch RJ. Small, membrane-bound, alternatively spliced forms of ankyrin 1 associated with the sarcoplasmic reticulum of mammalian skeletal muscle. J Cell Biol 136: 621-631, 1997[Abstract/Free Full Text].
453. Zhou D, Lambert S, Malen PL, Carpenter S, Boland LM, and Bennett V. AnkyrinG is required for clustering of voltage-gated Na channels at axon initial segments and for normal action potential. J Cell Biol 143: 1295-1304, 1998[Abstract/Free Full Text].
454. Zhou D, Ursitti JA, and Bloch RJ. Developmental expression of spectrins in rat skeletal muscle. Mol Biol Cell 9: 47-61, 1998[Abstract/Free Full Text].
455. Zhu X, Lai C, Thomas S, and Burden SJ. Neuregulin receptors, erbB3 and erbB4, are localized at neuromuscular synapses. EMBO J 14: 5842-5848, 1995[Web of Science][Medline].
456. Ziemnicka-Kotula D, Xu J, Gu H, Potempska A, Kim KS, Jenkins EC, Trenkner E, and Kotula L. Identification of a candidate human spectrin Src homology 3 domain-binding protein suggests a general mechanism of association of tyrosine kinases with the spectrin-based membrane skeleton. J Biol Chem 273: 13681-13692, 1998[Abstract/Free Full Text].
457. Zuckerman JB, Chen X, Jacobs JD, Hu B, Kleyman TR, and Smith PR. Association of the epithelial sodium channel with Apx and alpha-spectrin in A6 renal epithelial cells. J Biol Chem 274: 23286-23295, 1999[Abstract/Free Full Text].
0031-9333/01 $15.00 Copyright © 2001 The American Physiological Society



This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
J.-M. Sobotzik, J. M. Sie, C. Politi, D. Del Turco, V. Bennett, T. Deller, and C. Schultz
AnkyrinG is required to maintain axo-dendritic polarity in vivo
PNAS, October 13, 2009; 106(41): 17564 - 17569.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Chen, J. Liu, S. Heck, J. A. Chasis, X. An, and N. Mohandas
Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesis
PNAS, October 13, 2009; 106(41): 17413 - 17418.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. F. Kline, H. T. Kurata, T. J. Hund, S. R. Cunha, O. M. Koval, P. J. Wright, M. Christensen, M. E. Anderson, C. G. Nichols, and P. J. Mohler
Dual role of KATP channel C-terminal motif in membrane targeting and metabolic regulation
PNAS, September 29, 2009; 106(39): 16669 - 16674.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
R. B. Nowak, R. S. Fischer, R. K. Zoltoski, J. R. Kuszak, and V. M. Fowler
Tropomodulin1 is required for membrane skeleton organization and hexagonal geometry of fiber cells in the mouse lens
J. Cell Biol., September 21, 2009; 186(6): 915 - 928.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Betz, M. Lenz, J.-F. Joanny, and C. Sykes
ATP-dependent mechanics of red blood cells
PNAS, September 8, 2009; 106(36): 15320 - 15325.
[Abstract] [Full Text] [PDF]


Home page
Mol Biol EvolHome page
A. J. Baines, P. A. Bignone, M. D.A. King, A. M. Maggs, P. M. Bennett, J. C. Pinder, and G. W. Phillips
The CKK Domain (DUF1781) Binds Microtubules and Defines the CAMSAP/ssp4 Family of Animal Proteins
Mol. Biol. Evol., September 1, 2009; 26(9): 2005 - 2014.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Davis, K. Abdi, M. Machius, C. Brautigam, D. R. Tomchick, V. Bennett, and P. Michaely
Localization and Structure of the Ankyrin-binding Site on {beta}2-Spectrin
J. Biol. Chem., March 13, 2009; 284(11): 6982 - 6987.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Metral, B. Machnicka, S. Bigot, Y. Colin, D. Dhermy, and M.-C. Lecomte
{alpha}II-Spectrin Is Critical for Cell Adhesion and Cell Cycle
J. Biol. Chem., January 23, 2009; 284(4): 2409 - 2418.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Mohandas and P. G. Gallagher
Red cell membrane: past, present, and future
Blood, November 15, 2008; 112(10): 3939 - 3948.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. F. Robledo, S. L. Ciciotte, B. Gwynn, K. E. Sahr, D. M. Gilligan, N. Mohandas, and L. L. Peters
Targeted deletion of {alpha}-adducin results in absent {beta}- and {gamma}-adducin, compensated hemolytic anemia, and lethal hydrocephalus in mice
Blood, November 15, 2008; 112(10): 4298 - 4307.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Wu and W. D. Bowen
Role of Sigma-1 Receptor C-terminal Segment in Inositol 1,4,5-Trisphosphate Receptor Activation: CONSTITUTIVE ENHANCEMENT OF CALCIUM SIGNALING IN MCF-7 TUMOR CELLS
J. Biol. Chem., October 17, 2008; 283(42): 28198 - 28215.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. R. Cunha and P. J. Mohler
Cardiac Cytoskeleton and Arrhythmia: An Unexpected Role for Protein 4.1R in Cardiac Excitability
Circ. Res., October 10, 2008; 103(8): 779 - 781.
[Full Text] [PDF]


Home page
Circ. Res.Home page
M. A. Stagg, E. Carter, N. Sohrabi, U. Siedlecka, G. K. Soppa, F. Mead, N. Mohandas, P. Taylor-Harris, A. Baines, P. Bennett, et al.
Cytoskeletal Protein 4.1R Affects Repolarization and Regulates Calcium Handling in the Heart
Circ. Res., October 10, 2008; 103(8): 855 - 863.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Le Scouarnec, N. Bhasin, C. Vieyres, T. J. Hund, S. R. Cunha, O. Koval, C. Marionneau, B. Chen, Y. Wu, S. Demolombe, et al.
Dysfunction in ankyrin-B-dependent ion channel and transporter targeting causes human sinus node disease
PNAS, October 7, 2008; 105(40): 15617 - 15622.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Sohet, Y. Colin, S. Genetet, P. Ripoche, S. Metral, C. Le Van Kim, and C. Lopez
Phosphorylation and Ankyrin-G Binding of the C-terminal Domain Regulate Targeting and Function of the Ammonium Transporter RhBG
J. Biol. Chem., September 26, 2008; 283(39): 26557 - 26567.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. D. Werbeck, P. J. E. Rowling, V. R. Chellamuthu, and L. S. Itzhaki
From the Cover: Shifting transition states in the unfolding of a large ankyrin repeat protein
PNAS, July 22, 2008; 105(29): 9982 - 9987.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Y. W. Bourguignon, K. Peyrollier, W. Xia, and E. Gilad
Hyaluronan-CD44 Interaction Activates Stem Cell Marker Nanog, Stat-3-mediated MDR1 Gene Expression, and Ankyrin-regulated Multidrug Efflux in Breast and Ovarian Tumor Cells
J. Biol. Chem., June 20, 2008; 283(25): 17635 - 17651.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Salomao, X. Zhang, Y. Yang, S. Lee, J. H. Hartwig, J. A. Chasis, N. Mohandas, and X. An
Protein 4.1R-dependent multiprotein complex: New insights into the structural organization of the red blood cell membrane
PNAS, June 10, 2008; 105(23): 8026 - 8031.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Das, C. Base, D. Manna, W. Cho, and R. R. Dubreuil
Unexpected Complexity in the Mechanisms That Target Assembly of the Spectrin Cytoskeleton
J. Biol. Chem., May 2, 2008; 283(18): 12643 - 12653.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
K. Susuki and M. N. Rasband
Spectrin and Ankyrin-Based Cytoskeletons at Polarized Domains in Myelinated Axons
Experimental Biology and Medicine, April 1, 2008; 233(4): 394 - 400.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. F. Odell, D. F. Van Helden, and J. L. Scott
The Spectrin Cytoskeleton Influences the Surface Expression and Activation of Human Transient Receptor Potential Channel 4 Channels
J. Biol. Chem., February 15, 2008; 283(7): 4395 - 4407.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
K. M. Abdi and V. Bennett
Adducin Promotes Micrometer-Scale Organization of {beta}2-Spectrin in Lateral Membranes of Bronchial Epithelial Cells
Mol. Biol. Cell, February 1, 2008; 19(2): 536 - 545.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Li, H.-Y. Tang, and D. W. Speicher
A Structural Model of the Erythrocyte Spectrin Heterodimer Initiation Site Determined Using Homology Modeling and Chemical Cross-linking
J. Biol. Chem., January 18, 2008; 283(3): 1553 - 1562.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
P. M. Benz, C. Blume, J. Moebius, C. Oschatz, K. Schuh, A. Sickmann, U. Walter, S. M. Feller, and T. Renne
Cytoskeleton assembly at endothelial cell cell contacts is regulated by {alpha}II-spectrin VASP complexes
J. Cell Biol., January 10, 2008; 180(1): 205 - 219.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Kantari, M. Pederzoli-Ribeil, O. Amir-Moazami, V. Gausson-Dorey, I. C. Moura, M.-C. Lecomte, M. Benhamou, and V. Witko-Sarsat
Proteinase 3, the Wegener autoantigen, is externalized during neutrophil apoptosis: evidence for a functional association with phospholipid scramblase 1 and interference with macrophage phagocytosis
Blood, December 1, 2007; 110(12): 4086 - 4095.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. E. Lehnart, M. J. Ackerman, D. W. Benson Jr, R. Brugada, C. E. Clancy, J. K. Donahue, A. L. George Jr, A. O. Grant, S. C. Groft, C. T. January, et al.
Inherited Arrhythmias: A National Heart, Lung, and Blood Institute and Office of Rare Diseases Workshop Consensus Report About the Diagnosis, Phenotyping, Molecular Mechanisms, and Therapeutic Approaches for Primary Cardiomyopathies of Gene Mutations Affecting Ion Channel Function
Circulation, November 13, 2007; 116(20): 2325 - 2345.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
K. L. Weber, R. S. Fischer, and V. M. Fowler
Tmod3 regulates polarized epithelial cell morphology
J. Cell Sci., October 15, 2007; 120(20): 3625 - 3632.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
P. J. Mohler and X. H. T. Wehrens
Mechanisms of Human Arrhythmia Syndromes: Abnormal Cardiac Macromolecular Interactions
Physiology, October 1, 2007; 22(5): 342 - 350.
[Abstract] [Full Text] [PDF]


Home page
Mol Biol EvolHome page
A. Virel and L. Backman
A Comparative and Phylogenetic Analysis of the {alpha}-Actinin Rod Domain
Mol. Biol. Evol., October 1, 2007; 24(10): 2254 - 2265.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
M. Sotomayor and K. Schulten
Single-Molecule Experiments in Vitro and in Silico
Science, May 25, 2007; 316(5828): 1144 - 1148.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. D. Werbeck and L. S. Itzhaki
From the Cover: Probing a moving target with a plastic unfolding intermediate of an ankyrin-repeat protein
PNAS, May 8, 2007; 104(19): 7863 - 7868.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
T. Yamaguchi, S. Ozaki, T. Shimomura, and S. Terada
Membrane Perturbations of Erythrocyte Ghosts by Spectrin Release
J. Biochem., May 1, 2007; 141(5): 747 - 754.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. K. Foskett, C. White, K.-H. Cheung, and D.-O. D. Mak
Inositol Trisphosphate Receptor Ca2+ Release Channels
Physiol Rev, April 1, 2007; 87(2): 593 - 658.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Li, G. Lykotrafitis, M. Dao, and S. Suresh
Cytoskeletal dynamics of human erythrocyte
PNAS, March 20, 2007; 104(12): 4937 - 4942.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Uemoto, S.-i. Suzuki, N. Terada, N. Ohno, S. Ohno, S. Yamanaka, and M. Komada
Specific Role of the Truncated betaIV-Spectrin {Sigma}6 in Sodium Channel Clustering at Axon Initial Segments and Nodes of Ranvier
J. Biol. Chem., March 2, 2007; 282(9): 6548 - 6555.
[Abstract] [Full Text] [PDF]